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The goal of our research is to prepare natural products and related core structures through oxidative 
dearomatization. The development of a stereoselective iron (III)-mediated intramolecular cascade 
dearomatization of phenol allowed access to various spirocyclohexadienones and tropons in one 
step using potassium ferricyanide via single electron transfer (SET). Using this oxidative 
dearomatization reaction, the thesis focuses on three main parts. The first part is the synthetic 
efforts toward total synthesis of Harringtonolide. The second part focused on the synthesis of 
spiro[4.5]decane, a core structure in multiple natural products. The spiro compounds were 
prepared from ortho hydroxyphenyl nitro alkanes using SET reaction with good yield and 
diastereoselectivity. In third part, we worked towards the total synthesis of both Magellanine and 
Megalleninone by applying this novel methodology. The fourth part was the first total synthesis 
of Phaeocauliine D, and L which were achieved from commercially available methyl-4-methyl 
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CHAPTER ONE: HARRINGTONOLIDE 
Introduction: 
Natural products are utilized in a multitude of medications for the treatment of different diseases. 
Natural products continue to play a vital role in innovative research in chemistry, biology, and 
medicinal fields. A lot of different medicines originate from natural products or their derivatives.1 
 Isolation, structure and biological activity of cephaloxae: 
Harringtonolide 1.1 and related product structures are members of the Cephalotaxaceae family. 
This family contains more than 30 discovered compounds; the first of these was harringtonolide. 
Isolated in 1978 from the seed of the Cephalotaxus harringtonolide (Taxaceae) plant2, it was found 
to have potent cytotoxic activities, with an IC50 value of 43 nM against KB tumor cells. A year 
later, a Chinese group isolated harringtonolide 1.1 and hainanolidol 1.2 from the related Chinese 
species Cephalotaxus hainanensis,3 but compound 1.2 did not show any toxicity against KB tumor 
cells. They suggested that the tetrahydrofuran ring played a significant role in the cytotoxity 
activity of harringtonolide. In 1999, a Chinese group isolated fortunolide A 1.3, fortunolide B 1.4, 
and Hainanolidol 1.2 from Cephalotaxus fortune. The structures of the four compounds are 





Figure 1: The structures of harringtonolide, hainanolidol and fortunolide A and B 
Yue and co-workers isolated two more compounds, 6-en-harringtonolide 1.5 and 10-hydroxy-
harringtonolide 1.6, from Cephalotaxus mannii along with three other new diterpenoids 
(mannolide A-C) compounds 1.7-1.9.5 The results showed that norditerpenoids 1.5 and 1.6 with a 
tropone motif showed noTable cytotoxicity against tested tumor cell lines, but the diterpenoids 
without the tropone moiety were inactive against the same cell lines (Figure 2). 
 
Figure 2: Natural products isolated from Cephalotaxus mannii 
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Yue’s group reported another paper on four new compounds (1.10-1.13) which had related 
structures to the Cephalotaxaceae family. These compounds were isolated from the twigs and 
leaves of Cephalotaxus fortune (Figure 3).6 
 
Figure 3: Natural products isolated from the twigs and leaves of Cephalotaxus 
fortuneicompounds 1.10-1.13 
In 2019, 17 new 17-nor-cephalotane-type diterpenoids, fortalpinoids A−Q (1.14-1.30), were found 
in the seeds of Cephalotaxus fortunei var. alpine. Some showed very good activity results. The 
cytotoxicity of compounds 1.14-1.30 were assessed by using the CCK-8 assay13 against two 
human tumor cell lines, A549 and HL-60. The results presented that compounds 1.15, 1.16, and 
1.18 showed significant inhibitory activity against A549 and HL60 cell lines. Compounds 1.24-
1.30, which lack a tropone ring, did not show any toxicity against A549 and HL60 cell lines. 




             
         
Figure 4: The structures of Fortalpinoids A−Q 
 
Previous total synthesis of Hurringtonolide: 
There are three previously reported total syntheses of harringtonolide 1. In 1998, Mander reported 
the first total synthesis of 1.1 and 1.2. Tang’s group also completed the total synthesis of 1.1 and 
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1.2 in 2013, both prepared racemic harringtonolide. Zhai and co-workers described the asymmetric 
total synthesis of 1.1. 
Mander’s total synthesis: 
The first synthesis of harrintonolide was published by Mander’s group in 1998.8 They started with 
ozonolysis of compound 1.31, followed by esterification of the acid, and then Wittig reaction of 
the aldehyde to produce 1.32. Epoxidation of enol ether 1.32 with m-chloroperbenzoic acid (m-
CPBA) in methanol gave α-hydroxy methyl acetal 1.33 that was directly protected with tert-
butyldimethylsilyl trifluoromethanesulfonate (TBSOTf), followed by saponification of the ester in 
potassium hydroxide. They converted the acid to the corresponding acid chloride via Vilsmeier 
reagent, and then added the acid chloride to an excess of diazomethane to produce compound 1.34. 
Rhodium catalyst and 1,8-diazabicycloundec-7-ene (DBU) were used to afford 1.35. Zinc bromide 
was added to dimethyl acetal 1.35 to release aldehyde 1.36, followed by reacting with basic 
alumina to produce 1.37. Treatment with potassium carbonate gave an acid that reacted with the 
free alcohol to produce the lactone ring 1.38. Deprotection of the (TBS) group using 
tetrabutylammonium fluoride (TBAF) and reduction of the ketone produced compound 1.39. The 
resulting diol was treated with hydrochloric acid to afford 1.40, addition of base led to 1.2 






Scheme 1: Mander’s total synthesis 
Tnag’s total synthesis: 
In 2013, Tang and co-workers reported the total synthesis of 1.1 and 1.2.9 The key step for this 
synthesis was an intermolecular [5+2] cycloaddition. Starting from compound 1.41, oxidation by 
oxone produced 1.42 in two diastereomers (4:1 ratio). Both diastereomers were converted to a 
ketone in a later step. Triethylsilyl (TES) protection of the hydroxy group in the presence of lithium 
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diisopropylamide (LDA) followed by osmium tetroxide gave selective hydroxylation to afford 
1.43. Reducing the ketone by sodium borohydride then TBS protection of the diol using TBSOTf 
and deprotection of the TES protection group in acidic media produced 1.44. After oxidation of 
the diastereomeric allyl alcohol by Dess–Martin periodinane (DMP), reduction by sodium 
borohydride gave 1.45.  
 
Scheme 2: Tang’s total synthesis 1.1 
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Installation of vinyl ether 1.46 using a catalytic amount of mercury (II) trifluoroacetate and 
vinylbutyl ether, followed by a Claisen rearrangement at 110 ºC gave 1.47. Oxidation of aldehyde 
1.47 to the corresponding acid using Pinnick oxidation then to amide by reacting with N-methoxy 
methylamine gave 1.48. The amide was converted to 1.49 through the allyl oxidation using 
manganese (III) acetate. Treatment of enone 1.49 with tosylhydrazine following stereoselective 
[3,3]-sigmatropic rearrangement of the hydrazone intermediate produced compound 1.50. Furfural 
was added in the presence of n-butyl lithium (n-BuLi) and magnesium bromide selectively reacting 
with the amide to afford 1.51. Reduction of the ketone and reaction with vanadyl acetylacetonate 
[V(acac)2] through an Achmatowicz reaction followed by acetate protection of the alcohol gave 
1.52. The [5+2] cycloaddition was the key step to create the tropone from the oxidopyrylium ion 
and alkene in order to produce 1.53. A Grignard reaction was applied to the ketone, followed by 
single deprotection of one of the TBS groups under acidic conditions. Saponification of the ester 
using potassium carbonate generated the lactone in compound 1.54. To open the ether bridge, an 
S-alkylation reaction in the presence of boron trifluoride etherate afforded one diastereomer, 1.55. 
The ether bridge was cleaved by LDA. TES protection of the newly formed hydroxy group 
followed by the thio phenyl ether produced compound 1.57. Then, [4 + 2] cycloaddition of diene 
1.57 with singlet oxygen in the presence of tetraphenylporphyrin (TPP) as a photosensitizer 
followed by addition of DBU provided ketone 1.58. p-Toluene sulfonic acid (p-TsOH) removed 








Zhai’s total synthesis: 
In 2016, Zhai and his co-workers reported the first enantioselective total synthesis of (+)-
harringtonolide (Scheme 4).10 The key synthetic step could be made through an intramolecular 
[3+2] cycloaddition of the intermediate using a rhodium (II) catalyst. Starting with reduction of 
1.59 with Ru catalyst followed by reacting with sorbic acid gave ester 1.60. Diels-Alder reaction 
of 1.60 at 180 ºC for 24 hours provided 1.61 in a 2.5:1 isomer ratio. The two diastereomers were 
then treated with LDA and hexamethylphosphonamide (HMPA) at -78 ºC followed by 
diisobutylaluminium hydride (DIBAL-H) to afford 1.62. The aldehyde 1.62, after treatment with 
allyl magnesium bromide gave two isomers of 1.63 in a 1:1 ratio, followed by TBS protection and 
then DMP oxidation to afford 1.64. Afterwards, the double-bond in 1.64 was treated with 
trichloroisocyanuric acid (CONCl)3 to produce chlorohydrin 1.65. Protection of the new hydroxy 
group with TBS then alkylation with ethyl bromoacetate afforded 1.66. Saponification of the ester 
with lithium hydroxide (LiOH) and activation of the acid using tert-butyl chloroformate followed 
by diazomethane reaction afforded 1.67. Using the procedure reported by Schmalz,11 1.67 was 
treated with [Rh2(OAc)4] in toluene to produce 1.68. The diol was achieved by deprotecting the 
TBS protection groups followed by treatment with sodium hydride (NaH) to generate the THF 





Scheme 4:Zhai’s total synthesis 1.2 
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Reducing the ketone in 1.71 with sodium borohydride (NaBH4) in MeOH, followed by sodium 
carbonate (Na2CO3) to generate the lactone then oxidized with DMP afforded 1.72. Converting the 
ketone in 1.72 to a TBS protected enol in 1.73 followed by treatment with dimethyl aluminum 
chloride (Me2AlCl) afforded (+)–harringtonolide 1.1. 
 
 












After analyzing previous total synthetic pathways, we then developed a retrosynthetic route which 
utilized a key oxidative dearomatization reaction to form the tropone framework. We proposed to 
synthesize the core of compound 1.79 via a Diels-Alder cyclization from 1.78. Compound 1.78 
can be prepared through deprotection and Achmatowicz rearrangement of compound 1.77. 
Compound 1.77 could be prepared from an oxidative dearomatization reaction under basic 
conditions in the presence of potassium ferrocyanide on compound 1.76. Compound 1.76 could 
be synthesized from hydrogenation of the Sonogashira coupling product derived from compounds 
1.74 and 1.75. 
14 
 
                        
Scheme 6: Retrosynthetic analysis of Harringtonolide 
Results and discutions: 
To prepare compound 1.74, we started with formylation of commercially available 1.80 using the 
same procedure of Lee et al,12 using phosphorous oxychloride (POCl3) and dimethylformamide 
(DMF) under anhydrous conditions gave 1.81 in 87% yield (Scheme 7), followed by 
triisopropylsilyl chloride (TIPSCl) protection13 in the presence of triethylamine for 16 hours, 
producing compound 1.82. The reaction of 1.82 with (carbethoxymethylene triphenyl-
15 
 
phosphorane) 1.83 via a Wittig reaction14 afforded 1.84, then hydrogenation of 1.84 using Pd/C 
under hydrogen atmosphere gave 1.85 in high yield. Triflate 1.74 was achieved from 1.85 using 
triflic anhydride (Tf2O)
15 and triethylamine (Et3N) at -78 ºC to 0 ºC in 84% yield.    
           
 
Scheme 7: Synthesis of compound 1.74 
The next step was preparing the other coupling compound 1.75 by converting commercially 
available methyl 3-furoate 1.86 to 1.87 through formylation with POCl3 and DMF at 100 ºC in 
81% yield.16 To prepare 1.88, we used DIBAL-H to convert the aldehyde to an alcohol and to 
convert the methyl ester to an aldehyde but we obtain 1.89 instead (Scheme 8). 
 
Scheme 8: Synthesis of compound 1.89 
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Using a cheaper reducing reagent, NaBH4 in methanol at 0 ºC, we converted the aldehyde to 
alcohol 1.89 in 65% yield.17 
Next, we decided to optimize the reduction conditions. Using different alcohols (methanol, 
ethanol, n-propanol, and n-butanol) as a solvent, we improved the yield. When ethanol was used 
the yield was increased to 69% (Table 1, entry 2), n-propanol gave a better yield of 76% (Table 1, 
entry 3), and finally, we enhanced the yield to 81% by using n-butanol with dichloromethane as a 
co-solvent (Table 1, entry 4). 
Table 1: Optimization reaction of compound 1.89 
                                
Entry Solvent Yield% 
1 Methanol 65 
2 Ethanol 69 
3 n-propanol 76 
4 n-butanol/dichloromethane 81 
 
TBS protection of the alcohol 1.89 using TBS-Cl and imidazole in dry DMF under argon at room 
temperature for 14 h gave 1.90 (Scheme 9) in high yield.18 We could not reduce ester 1.90 to 
aldehyde 1.92 using DIBAL-H, so we reduced ester 1.90 to alcohol 1.91 using lithium aluminum 
hydride (LiAlH4) at 0 ºC in good yield.
19 Then DMP oxidization of alcohol 1.91 in 
dichloromethane at room temperature afforded aldehyde 1.92.20 Finally, alkene 1.93 was prepared 





Scheme 9: Synthesis of compound 1.93 
We attempted hydroboration of 1.93 with 9-borabicyclo[3.3.1]nonane (9-BBN) using the same 
procedure in the literature22, but it did not give us the desired product 1.94, even after increasing 
the temperature from 25 ºC to 60 ºC for 16 h (Scheme 10). 
                       
Scheme 10: Hydroboration of compound 1.94 
Therefore, another strategy was used to convert aldehyde 1.92 to furfuryl-3-acetylene 1.75. Using 
diethyl (1‐diazo‐2‐oxopropyl) phosphonate (Bestmann–Ohira reagent) 1.95 with 1.92 at 0 ºC to 
room temperature in MeOH in the presence of potassium carbonate for 14 hours afforded 1.75 





Scheme 11: Synthesis of alkyne 1.75 
The next step in the synthesis was the coupling reaction of 1.74 with 1.75 to prepare compound 
1.96. We scanned multiple conditions, but none of them afforded the desired product, Table 2 
shows the conditions for the coupling reaction. 
Table 2: Optimizing coupling reaction 






1 1.1 1.0 Pd(PPh3)2Cl2 (5 mol%), DIPEA (3.0 eq.) 
DMF, 80 °C, 5 h 
RSM 
2 1.0 0.97 Pd(PPh3)2Cl2 (5 mol%), DIPEA (2.0 eq.), 
MeCN, CuI , MW (70 w), 100 °C, 20 min. 
RSM 
3 1.0 1.4 Pd(PPh3)4 (5 mol%), DIPEA (3.0 eq.) 
CuI (5 mol%), THF, 50 °C, 12 h 
RSM 
4 1.0 1.0 Pd(PPh3)4 (5 mol%), DIPEA (3.0 eq.) 
DMF, 100 °C, 12 h 
RSM 
5 1.0 1.5 Pd(OAc)2-PPh3 (1:4), DMSO 
K3PO4 (1.2 eq.), 80 °C, 24 h 
RSM 
 RSM=recovered starting material 
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An alkyne hydrostannylation reaction was applied on compound 1.75 using tributyltin hydride [(n-
Bu)3SnH] and azobisisobutyronitrile (AIBN) to afford 1.97 in 50% yield (Scheme 12).
24 
                     
Scheme 12: Hydrostannylation reaction 
Stille coupling of 1.74 with 1.97 was performed using two different procedures; one using 
tertakis(triphenyphosphine)palladium [Pd(PPh3)4]in 1,4-dioxane
25 at 100 °C and the other using  
bis(triphenylphosphine)palladium dichloride [Pd(PPh3)2Cl2]in THF at 60 °C with LiCl.
26 Both 
procedures did not give desired product 1.98 (Scheme 13). 
 
Scheme 13: Stille coupling reaction 
We assumed that the TIPS protection group was hindering the coupling reaction, so we decided 




                                  
Scheme 14: Synthesis of compound 1.99 
Sonogashira coupling reaction of 1.99 with two equivalents of acetylene 1.75 using Pd(PPh3)2Cl2, 
CuI and diisopropyl ethyl amine (DIPEA) afforded 1.100 in 80% yield (Scheme 15).28  
 
 
Scheme 15: Sonogashira coupling 
The hydrogenation of alkyne 1.100 was a big challenge because the furan ring was also susceptible 
when using Pd/C under hydrogen atmosphere at room temperature. The problem was solved by 
running the hydrogenation at 0 ºC producing 1.101 in 81% yield.29 The aldehyde 1.102 was 
achieved through DIBAL-H reduction at -78 ºC in good yield.30 The reaction of aldehyde 1.102 
with nitromethane via a Henry reaction in the presence of catalytic amounts of 1,1,3,3-
tetramethylguanidine (TMG) afforded β-nitro alcohol 1.76 in 74% yield (Scheme 16).31 The 
tropone32 formation was performed using 4.0 equivalents of 0.1 N KOH and potassium 
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ferrocyanide K3[Fe(CN)6], but this did not afford  tropone 1.103. Instead we got spiro[5,4] decane 
1.104 in 63% yield. 
 
 
Scheme 16: Synthesis of compound 1.104 
We decided to change the route by preparing the lactone first and then preparing the tropone moiety 
second. Starting from compound 1.101, we reduced the ethyl ester to alcohol 1.105.33 Then 
deprotection of TBS with TBAF afforded 1.106. Achmatowicz rearrangement was utilized to 
convert 1.106 to 6-hydroxy pyranone 1.107.34 Oxidation of the two hydroxy groups in one reaction 
with DMP in DCM at room temperature oxidized only the primary alcohol to give 1.108’ without 




               
Scheme 17: Synthesis of compound 1.108 
After this result, we tried to prepare compound 1.78 through coupling of the two moieties 
(compounds 1.109 and 1.110) separately then connecting them via Suzuki coupling (Scheme 18).           
 
Scheme 18: Suzuki coupling reaction 
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To prepare 1.109, we started with Suzuki coupling of 1.99 with potassium vinyltrifluoroborate in 
the presence of Pd(dppf)·CH2Cl2 and Et3N which afforded 1.111 in high yield (Scheme 19)
35 
followed by protection of the phenol with TBS-Cl (hydroboration with free phenol did not work) 
presented 1.112. A hydroboration reaction of 1.112 with Bis(pinacolato) diboron, a catalytic 
amount of triphenylphosphine (PPh3), and copper(II) oxide (CuO) produced 1.113.
36 Reduction of 
the ester to an aldehyde via DIBAL-H followed by a Henry reaction gave nitro alcohol 1.115. 
Deprotection of TBS with TBAF afforded 1.116. Tropone cyclization using the standard condition 




Scheme 19: Synthesis of compound 1.118 
 We tried to prepare compound 1.110 through oxidation of 6-hydroxy-5-bromo-2H-pyran-3(6H)-
one 1.123 (Scheme 20). In order to synthesize 1.123, we started with a bromination reaction of 
methyl-2-furoate 1.119 using bromine in the presence of aluminum chloride to obtain 4,5-dibromo 
methyl-2-furoate 1.120 followed by elimination of bromide on C-5 using zinc and NH4Cl gave 
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1.121.37 Reduction of the ester to alcohol with lithium aluminum hydride (LiAlH4) at 0 ºC afforded 
(4-bromofuran-2-yl)methanol 1.122.38 Finally, Achmatowicz rearrangement of 1.122 using 
VO(acac)2 and tert-butyl hydroperoxide gave 5-bromo-6-hydroxy pyran 1.123 in 66% yield, and 
81% yield by using N-bromo succinimide (NBS) and sodium acetate (NaOAc).39 
            
Scheme 20: Synthesis of compound 1.123 










Table 3: Optimizing oxidation condition 
                                                
Entry Oxidant Outcome 
1 PCC RSM  
2 DMP Decomposition 
3 Jones reagent Decomposition 
4 NMO RSM 
5 MnO2 RSM 
                         RSM=recovered starting material 
After all the procedures failed to prepare lactone 1.110, we decided to analyze the mechanism of 
the rearrangement (Scheme 21). At key intermediate step V in the rearrangement, the alcohol is 
attacking the aldehyde and converting it into an alcohol giving compound VI. Since oxidation of 
alcohol 1.123 proved to be too challenging, we hypothesized an alternative route to form 
compound 1.110. We thought to replace the proton with a potential leaving group such as bromine. 
Therefore, when the alcohol attacks the aldehyde it will kick out the leaving group, keeping the 
27 
 
carbonyl intact avoiding the need for any further oxidation.
 
Scheme 21: Achmatowicz rearrangement mechanism 
We tried to synthesize lactone 1.110 by reducing the ester in 1.120 to alcohol 1.124 before  
rearrangement to 1.110, but the reaction failed because it was too fast and the starting material 
decomposed, even when running the reaction at -78 ºC (Scheme 22). 
 
Scheme 22: Synthesis compound 1.110 
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We assumed that from 5-methoxy-4-bromo-2-furanmethanol 1.129 we could achieve our target. 
Starting from the bromination of methyl-2-furoate 1.119 with bromine at 50 ºC we were afforded 
1.125,40 then a substitution reaction of 1.126 with sodium methoxide (MeONa) at 40 ºC produced 
compound 1.127.41 Another bromination on the C4 of the furan ring using NBS afforded 1.128 
followed by reduction of the ester to an alcohol gave furfuryl alcohol 1.129 (Scheme 23).  
         
 
Scheme 23: Synthesis of compound 1.129 
Achmatowicz rearrangement of 1.129 under different conditions did not give the desired product 
1.110. We modified the procedure by running the reaction at different temperatures (-78 °C to 
rt), but those also resulted in no observed conversion (Scheme 24). 
                                      
Scheme 24: Achmatowicz rearrangement of compound 1.129 
Since oxidation of 1.123 failed and without an effective way to afford 1.110, we resorted to using 
the same compound that was reported in the literature.41 We prepared known 6-hydroxy-2-
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substituted pyran 1.131 from 1.130 and oxidized it using Jones reagent which afforded lactone 
1.132 in good yield (Scheme 25).42 
                         
Scheme 25: Synthesis of compound 1.132 
From an in-depth literature search, all the oxidations of pyran were successful when the pyran-6-
ol had a substituent on the C2 position, so we changed our strategy to achieve 1.110. 
Tang’s group showed that an iridium catalyst can isomerize Achmatowicz rearrangement products. 
Treatment of 6-hydroxy-5-bromo-2H-pyran-3(6H)-one 1.123 with catalytic amount of the 
complex [{Ir(cod)Cl}2] in the presence of 2,6-dichloro benzoic acid afforded 3-bromo-5,6-
dihydro-5-hydroxy-2H-pyran-2-one 1.133 in good yield (Scheme 26).43  
                                    
Scheme 26: Rearrangement of 5-bromo-3-hydroxy pyran-6-one 
The oxidation of 1.133 with DMP, pyridinium chlorochromate (PCC), and Jones reagent did not 
give any product (Scheme 27). 
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Scheme 27: Oxidation of 5-bromo-6-hydroxy pyran-3-one 
Conclution: 
We tried to synthesize harringtonolide by preparing the tropone moiety first and then coupling it 
to a pyranone ring via a Diels-Alder reaction. Unfortunately, we were unable to synthesize the 
tropone skeleton and instead formed spiro compounds 1.104 and 1.118. Despite extensive efforts 
to form the pyranone ring using different procedures and strategies, more investigation is required 





 2,4-dihydroxy-6-methylbenzaldehyde (Compound 1.81): 
 
Phosphorus oxychloride (POCl3) (10 mL) was added dropwise to dry DMF (40 mL) below 10 °C 
with stirring over 30 minutes. 3,5- Dihydroxy toluene (11.0 gm, 88.7 mmol) in dry DMF (40 mL) 
was added slowly with keeping the temperature below 10 °C. The reaction mixture was warmed 
to room temperature and stirred for 1 h., cooled to 0 °C and 10% aqueous NaOH was then added 
slowly until the pH was 9-10. The mixture was heated to boiling for 10 min, cooled to 0º C and 
adjusted to pH 3 with conc. HCl. The solid product was collected, washed with water until neutral, 
filtered and dried to give 87% yield as a pale yellow solid m.p. 152-4 °C that used for another 
reaction without further purification; 1H NMR (400 MHz, CDCl3) δ 10.26 (s, 1H), 10.08 (s, 1H), 
6.20 (s, 2H), 2.51 (s, 3H), 2.25 (s, 1H). 
2-hydroxy-6-methyl-4-((triisopropylsilyl)oxy)benzaldehyde (Compound 1.82): 
  
To a suspension of compound 1.81 (10 g, 65.8 mmol) in dry dichloromethane (100 mL), 
triethylamine (9.7 mL, 69 mmol, 1.05 eq.) was added, then TIPSCl (13.9 mL, 65.8 mmol) was 
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added dropwise over 10 minutes. After stirring at room temperature for 12 hours, the reaction 
mixture was quenched with saturated aqueous solution of sodium bicarbonate, washed with water 
and brine, dried over anhydrous sodium sulfate, evaporated the solvent under reduce pressure and 
purified by flash column chromatography, yield 96% as a colorless oil; 1H NMR (400 MHz, 
CDCl3) δ 10.31 (s, 1H), 6.74 (dt, J = 2.3, 0.7 Hz, 1H), 6.69 (d, J = 2.3 Hz, 1H), 2.60 (s, 3H), 1.54 
(s, 1H), 1.32 – 1.21 (m, 4H), 1.09 (d, J = 7.3 Hz, 18H); 13C NMR (100 MHz, CDCl3) δ 187.4, 
161.4, 153.1, 145.6, 123.4, 120.6, 111.7, 21.7, 18.1, 12.9; HRMS (ESI) m/z  [M+H]+ calc’d for 
C17H29O3Si
+: 309.1886, found 308.1816. 
Ethyl (E)-3-(2-hydroxy-6-methyl-4-((triisopropylsilyl)oxy)phenyl)acrylate (Compound 
1.83): 
 
A mixture of compound 1.82 (12.34 gm, 40.0 mmol) and (Carbethoxymethylene)
triphenylphosphoran (16.72 gm, 1.2 equiv) in dry THF (60 mL) was stirred for 3 hours at room 
temperature under argon, After the reaction was completed. The solvent was removed in a vacuum. 
The crude residue was purified by flash chromatography to yield the desired cinnamate in high 
yield as a white solid; 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 16.2 Hz, 1H), 6.76 – 6.67 (m, 
1H), 6.30 (d, J = 2.3 Hz, 1H), 6.27 (d, J = 2.0 Hz, 1H), 4.26 (q, J = 7.1 Hz, 2H), 2.33 (s, 3H), 1.32 
(t, J = 7.1 Hz, 3H), 1.27 – 1.17 (m, 3H), 1.07 (d, J = 7.3 Hz, 18H); 13C NMR (100 MHz, CDCl3) δ 
157.9, 141.2, 139.4, 118.9, 114.9, 114.1, 105.6, 60.5, 21.1, 18.1, 17.9, 17.9, 14.4, 12.7, 12.7. 
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Ethyl 3-(2-hydroxy-6-methyl-4-((triisopropylsilyl)oxy)phenyl)propanoate (Compound 
1.84): 
  
To a solution of compound 1.83 (7.0 gm, 18.5 mmol) in a mixture of Ethyl acetate and Ethanol 
(4:1, 50 mL), Pd/C (350 mg, 5% w/w) was added and the solution was stirred under hydrogen 
atmosphere for 3 hours, the palladium catalyst was removed by filtration, and the solvent was 
evaporated in vacuo. The residue was purified by column chromatography on silica gel to afford 
100% yield as a colorless oil; 1H NMR (400 MHz, CDCl3) δ 7.57 (s, 1H), 6.32 (d, J = 2.5 Hz, 1H), 
6.29 (d, J = 2.5 Hz, 1H), 4.13 (q, J = 7.2 Hz, 2H), 2.83 (dd, J = 7.2, 5.6 Hz, 2H), 2.64 – 2.59 (m, 
2H), 2.20 (s, 3H), 1.24 – 1.20 (m, 5H), 1.07 (d, J = 7.3 Hz, 17H); 13C NMR (100 MHz, CDCl3) δ 









propanoate (Compound 1.85): 
 
To a solution of compound 1.84 (6 gm, 15.77 mmol) in dry dichloromethane (60 mL), (4.42 mL, 
31.5 mmol, 2 eq.) of triethylamine was added. The reaction flask was cooled to -78 °C, after 15 
minutes triflic anhydride (3.18 mL, 18.92 mmol, 1.2 eq.) was added dropwise and the reaction 
mixture was left to warm up to room temperature. After 2 hours, the reaction mixture was diluted 
with dichloromethane and washed with water and brine, the aqueous layers were extracted with 
dichloromethane and the combined organic layers dried over sodium sulfate. The crude product 
was purified via flash chromatography as a colorless liquid to obtain 89% yield as a colorless oil; 
1H NMR (400 MHz, CDCl3) δ 6.70 (d, J = 2.4 Hz, 1H), 6.65 (d, J = 2.4 Hz, 1H), 4.12 (q, J = 7.1 
Hz, 2H), 2.97 – 2.89 (m, 2H), 2.51 – 2.43 (m, 2H), 2.30 (s, 3H), 1.21 (h, J = 7.1 Hz, 6H), 1.07 (d, 
J = 7.3 Hz, 18H); 13C NMR (100 MHz, CDCl3) δ 172.4, 154.9, 148.2, 139.8, 123.9, 121.9, 110.5, 
60.6, 33.6, 21.9, 19.7, 17.8, 14.1, 12.5; HRMS (ESI) m/z  [M+H]+calc’d for C22H36F3O5SSi
+: 









A solution of compound 1.184 (5 gm, 9.75 mmol) in THF (25 mL), TBAF (10 mL) was added, 
the reaction mixture was stirred for 1 hour then quenched with water and extracted two times with 
ethyl acetate, the organic layer was dried over sodium sulfate, evaporated the solvent and purified 
using column chromatography to afford 91% of free alcohol as a white solid; 1H NMR (400 MHz, 
CDCl3) δ 6.63 (dd, J = 2.5, 0.7 Hz, 1H), 6.61 (d, J = 2.5 Hz, 1H), 5.86 (s, 1H), 4.14 (q, J = 7.2 Hz, 
2H), 2.97 – 2.89 (m, 2H), 2.52 – 2.45 (m, 2H), 2.29 (s, 3H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 173.3, 155.0, 148.7, 140.7, 123.6, 117.8, 106.8, 61.3, 34.0, 22.3, 20.0, 14.4; 
HRMS (ESI) m/z  [M+H]+calc’d for C13H16F3O6S
+: 357.0620, found 357.0711. 
Methyl-5-formyl-3-Furan carboxylate (Compound 1.87):  
 
Phosphorous oxychloride (4.8 mL, 51.5 mmol) was added dropwise over 10 min to stirred DMF 
(5.2 mL, 67.4 mmol) under nitrogen atmosphere at 0 °C. After the reaction mixture reached room 
temperature, methyl 2-furoate (5 gm, 39.65 mmol) was added and the temperature was gradually 
raised to 100°C. The reaction mixture was stirred at the same temperature for 3 hours and then 
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cooled. The resulting brown tar was poured onto stirred ice-water (30 mL) and the organic phase 
extracted with ether (6 x 25 mL), the organic layers washed with water, NaHCO3 and brine, and 
dried over Magnesium sulfate. The solvent was evaporated under reduced pressure and the 
resulting solid was purified by flash chromatography to give 79% yield as a white solid MP 99-
100 °C; 1H NMR (400 MHz, CDCl3) δ 9.67 (s, 1H), 8.18 (s, 1H), 7.51 (s, 1H), 3.86 (s, 3H); 
13C 
NMR (100 MHz, CDCl3) δ 177.8, 162.0, 153.2, 151.5, 121.5, 119.6, 52.1. 
Methyl-5-(hydroxymethyl)-3-Furoate (Compound 1.89): 
 
Compound 1.87 (3.50 g, 22.7 mmol) was dissolved in a mixture of dichloromethane and n-butanol 
(1:1, 50 mL), NaBH4 (1.04 gm, 27.27 mmol) was added at 0 ºC in portions and the mixture was 
stirred for 2 hours, then the reaction was quenched with saturated solution of ammonium chloride. 
The aqueous phase was extracted with dichloromethane and the combined organic phases dried 
over sodium sulfate. The solvent was removed under vacuum and the crude product was purified 
by flash column chromatography on silica gel to afford 81% yield as a colorless oil; 1H NMR (400 
MHz, CDCl3) δ 7.92 (s, 1H), 6.58 (s, 1H), 4.55 (s, 2H), 3.78 (s, 3H); 
13C NMR (100 MHz, CDCl3) 
δ 163.7, 155.5, 147.6, 119.7, 107.6, 57.0, 51.7; HRMS (ESI) m/z  [M+H]+ calc’d for C7H9O4
+: 






Methyl 5-(((tert-butyldimethylsilyl)oxy)methyl)furan-3-carboxylate (Compound 1.90): 
 
(3 g, 19.2 mmol) of furfural alcohol 1.89 (3.46 g, 23 mmol) of tert-butyldimethychlorosilane, and 
(3.14 g, 46.1 mmol) of imidazole were dissolved in DMF (20 mL), and the reaction was stirred 
overnight at room temperature under argon atmosphere. Ethyl acetate was added and extracted 
with water and brine, dried over sodium sulfate then the solvent evaporated under reduced 
pressure, the crude product purified by flash column chromatography to afford 91% as a colorless 
oil; 1H NMR (400 MHz, CDCl3) δ 7.91 (s, 1H), 6.54 (s, 1H), 4.59 (s, 2H), 3.79 (s, 3H), 0.87 (s, 
9H), 0.06 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 163.6, 155.8, 147.1, 119.7, 107.0, 57.9, 51.5, 
25.8, 18.4, -5.3. 
(5-(((tert-butyldimethylsilyl)oxy)methyl)furan-3-yl)methanol (Compound 1.91): 
 
To a solution  of compound 1.90 (4 g, 14.8 mmol) in dry diethyl ether (50 mL) at 0 ºC, (730 mg, 
19.2 mmol) of Lithium aluminum hydride was added in portions, after stirring the reaction for two 
hours at the same temperature, the reaction mixture was quenched with water (1 mL) followed by 
10% NaOH (1 mL) then water (1 mL), the mixture was stirred for 10 minutes after the organic 
layer was separated, the organic layers dried over sodium sulfate, evaporated the solvent under 
reduced pressure, and purified by flash column chromatography to yield 87% as a colorless oil; 1H 
NMR (400 MHz, CDCl3) δ 7.33 (d, J = 0.9 Hz, 1H), 6.26 (dd, J = 0.3 Hz, 1H), 4.59 (d, J = 0.7 Hz, 
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2H), 4.50 (d, J = 0.4 Hz, 2H), 0.89 (s, 9H), 0.07 (s, 6H), 13C NMR (100 MHz, CDCl3) δ 155.2, 
139.3, 125.9, 107.4, 58.2, 56.7, 25.9, 18.4, -5.3; HRMS (ESI) m/z  [M+H]+calc’d for C12H24O3Si
+: 
243.1416, found 243.1376. 
5-(((tert-butyldimethylsilyl)oxy)methyl)furan-3-carbaldehyde (Compound 1.92): 
 
To a solution of compound 1.91 (3.5 g, 14.5 mmol) in dry dichloromethane (30 mL), DMP (6.76 
g, 15.9 mmol) was added in one portion. The reaction mixture was stirred for 30 minutes before it 
quenched with 10% sodium carbonate, the organic layer was separated, and the solvent was 
evaporated then purified by flash column chromatography to obtain 87% of aldehyde as an orange 
solid; 1H NMR (400 MHz, CDCl3) δ 9.88 (t, J = 0.4 Hz, 1H), 7.98 (dd, J = 0.9, 0.3 Hz, 1H), 6.60 
(tt, J = 0.5 Hz, 1H), 4.63 (dd, J = 0.8, 0.3 Hz, 2H), 0.89 (s, 9H), 0.08 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 184.4, 157.2, 151.0, 129.3, 103.9, 57.9, 25.8, 18.3, -5.3; HRMS (ESI) m/z  [M+H]
+calc’d 
for C12H21O3Si
+: 241.1260, found 241.1216. 
tert-butyldimethyl((4-vinylfuran-2-yl)methoxy)silane (Compound 1.93): 
   
To a solution of MePPh3Br (1.785 g, 5 mmol) in anhydrous THF (15 mL), n-BuLi (3.12 ml of 1.6 
M solution in Hexane, 5 mmol) was added dropwise at -10 °C and the reaction solution stirred for 
1 h at room temperature. A solution of compound 1.92 (1 gm, 4.16 mmol) in THF (10 mL) at 0 °C 
was added and the reaction stirred for 30 min at room temperature. Water was added to the mixture 
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and the organic material was extracted with Ethyl acetate two times. The organic phase washed 
with water and brine, dried over Sodium sulfate, and concentrated in vacuo. The residue was 
purified by flash column chromatography to obtain desired product in 50 % yield as a colorless 
oil;  1H NMR (400 MHz, CDCl3) δ 7.24 (s, 1H), 6.41 (dd, J = 17.5, 10.8 Hz, 1H), 6.29 (s, 1H), 
5.32 (dd, J = 17.5, 1.3 Hz, 1H), 5.00 (dd, J = 10.8, 1.4 Hz, 1H), 4.49 (s, 2H), 0.80 (s, 9H), -0.02 
(s, 6H); 13C NMR (100 MHz, CDCl3) δ 155.5, 140.5, 126.9, 113.5, 104.9, 58.5, 29.9, 26.1, 26.0, -
5.0. 
 tert-butyl((4-ethynylfuran-2-yl)methoxy)dimethylsilane (Compound 1.75): 
 
Compound 1.92 (3 g, 12.5 mmol) was and dissolved in dry MeOH (30 mL), then potassium 
carbonate (3.45 g, 25 mmol) was added at 0 °C, Ohira-Bestmann reagent (3.6 g, 18.75 mmol) was 
added dropwise at 0 ºC and the reaction mixture was stirred at room temperature for 14 hours. The 
reaction was then quenched by addition of a saturated sodium carbonate solution and the aqueous 
layer was extracted three times with dichloromethane. The organic layers were combined, dried 
over anhydrous sodium sulfate, and concentrated under reduced pressure. The crude product was 
purified by column chromatography. Yield 74% as a pale yellow oil; 1H NMR (400 MHz, CDCl3) 
δ 7.56 (dd, J = 0.9, 0.4 Hz, 1H), 6.28 (q, J = 0.7 Hz, 1H), 4.57 (d, J = 0.7 Hz, 2H), 3.00 (d, J = 0.4 
Hz, 1H), 0.88 (s, 9H), 0.06 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 155.1, 146.4, 110.2, 107.3, 





methylphenyl)propanoate (Compound 1.100):  
 
Compound 1.99 (2 g, 5.61 mmol) in dry DMF (30 mL) and diisopropylamine (5 mL) under argon 
atmosphere. Then Pd(PPh3)2Cl2 (197 mg, 0.28 mmol), CuI (10.5 mg, 0.5 mmol) and furylacetylene 
1.75 (2.12 gm, 9.0 mmol) were sequentially added. The resulting mixture was stirred at 80 ºC for 
16 h. The mixture was filtered through a pad of celite and diluted with ethyl acetate. The organic 
layer was washed with water and brine, dried over sodium sulfate, and concentrated under reduced 
pressure. The crude product was purified by flash chromatography on silica gel, yield 80%. As a 
brown solid; 1H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 0.9 Hz, 1H), 6.78 (dd, J = 2.8, 0.6 Hz, 
1H), 6.61 (dd, J = 2.7, 0.7 Hz, 1H), 6.33 (d, J = 0.8 Hz, 1H), 4.60 (d, J = 0.7 Hz, 2H), 4.13 (q, J = 
7.1 Hz, 3H), 3.11 – 3.04 (m, 2H), 2.55 – 2.49 (m, 2H), 2.28 (d, J = 0.7 Hz, 4H), 1.23 (t, J = 7.1 
Hz, 5H), 0.89 (s, 9H), 0.08 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 173.6, 155.1, 153.6, 145.4, 








phenyl)propanoate (Compound 1.101): 
 
To a solution of compound 1.100 (500 mg, 1.13 mmol) in Ethyl acetate: Ethaol (4:1, 10 mL) was 
added palladium on carbon (Pd/C) (50 mg, 10% w/w). A vacuum was applied to the reaction 
mixture and back filled with H2 (4 times). The reaction was then allowed to stir at 0 °C for 3 hours 
under an atmosphere of H2 before being filtered through a plug of celite pad. The reaction was 
then concentrated in vacuo and purified by flash column chromatography to give 82% as a 
colorless oil; 1H NMR (400 MHz, CDCl3) δ 7.14 – 7.13 (m, 1H), 6.51 (dd, J = 2.7, 0.7 Hz, 1H), 
6.49 (d, J = 2.8 Hz, 1H), 6.12 – 6.11 (m, 1H), 4.57 (d, J = 0.7 Hz, 2H), 4.14 (q, J = 7.1 Hz, 2H), 
2.91 – 2.85 (m, 2H), 2.76 (dd, J = 10.0, 6.3 Hz, 2H), 2.61 (dd, J = 9.9, 6.2 Hz, 2H), 2.41 – 2.34 (m, 









phenyl)propanal (Compound 1.102): 
 
To a solution of compound 1.101 (300 mg, 0.74 mmol) in dry dichloromethane (10 mL) at -78 °C, 
(0.9 mL, 1.2 eq.) of 1M DIBAL-H was added dropwise. The reaction mixture was stirred for two 
hours before it quenched with ammonium chloride at -78 °C. Saturated solution of potassium 
sodium tartrate was added and stirred for three hours at room temperature. The organic layer was 
separated, the solvent was evaporated and the crude product was purified by flash column 
chromatography to obtain 72% of aldehyde; 1H NMR (400 MHz, CDCl3) δ 9.81 (t, J = 1.3 Hz, 
1H), 7.11 (d, J = 1.0 Hz, 1H), 6.52 (d, J = 2.5 Hz, 1H), 6.50 (d, J = 2.8 Hz, 1H), 6.09 (s, 1H), 4.99 
(s, 1H), 4.57 (d, J = 0.6 Hz, 2H), 2.88 – 2.82 (m, 2H), 2.76 – 2.70 (m, 2H), 2.63 – 2.51 (m, 4H), 









nitrobutyl)-5-methylphenol (Compound 1.103): 
 
 A solution of compound 1.102 (0.5 g, 1.08 mmol) and nitromethane (0.6 mL, 10.8 mmol) in THF 
(10 mL) was stirred for 4 hours at room temperature. Upon completion, saturated solution of 
NH4Cl was added and extracted two times with ethyl acetate, the combined organic layer washed 
with water and brine, then dried over Sodium sulfate. the solvent was evaporated, and the crude 
product was purified by flash column chromatography to obtain nitro alcohol in 66% as a colorless 
oil; 1H NMR (400 MHz, CDCl3) δ 7.11 (t, J = 1.1 Hz, 1H), 6.49 (q, J = 2.8 Hz, 2H), 6.12 – 6.10 
(m, 1H), 4.58 (d, J = 0.5 Hz, 2H), 4.38 (dt, J = 7.7, 2.3 Hz, 2H), 4.34 (t, J = 4.2 Hz, 1H), 2.81 – 
2.69 (m, 4H), 2.63 – 2.53 (m, 4H), 2.25 – 2.23 (m, 3H), 1.60 – 1.51 (m, 2H), 1.27 – 1.21 (m, 1H), 
0.90 (d, J = 0.4 Hz, 11H), 0.09 – 0.08 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 153.0, 152.9, 140.1, 
137.5, 136.7, 128.0, 124.2, 114.5, 112.9, 108.1, 79.5, 67.6, 57.4, 33.2, 32.4, 25.7, 24.9, 24.6, 23.1, 







[4.5]deca-1,6,9-trien-8-one (Compound 1.104): 
 
To a solution of compound 1.103 (100 mg, 0.29 mmol) in acetonitrile (1mL), (377 mg, 1.15 mmol, 
4.0 eq.) of potassium ferrocyanide was added, followed by (6.4 mL, 1.15 mmol) of 0.1N potassium 
hydroxide. The reaction mixture was stirred for 2 hours before it quenched by 1M citric acid to 
make the pH 3. Chloroform was added and stirred for 30 minutes. The organic layer was separated, 
and the aqueous layer extracted two times with chloroform. The combined organic layers washed 
with water and brine, evaporated the solvent under reduce pressure. The crude product was purified 
by flash column chromatography to obtain 62% of compound 1.104 as pale yellow oil; 1H NMR 
(400 MHz, CDCl3) δ 7.39 (t, J = 2.7 Hz, 1H), 7.12 (d, J = 1.0 Hz, 1H), 6.22 (q, J = 1.6 Hz, 1H), 
6.14 (t, J = 1.5 Hz, 1H), 6.07 – 6.05 (m, 1H), 4.54 (d, J = 0.6 Hz, 2H), 2.80 (dddd, J = 9.0, 6.2, 2.9, 
1.4 Hz, 2H), 2.61 (dddd, J = 8.8, 6.2, 5.0, 0.9 Hz, 2H), 2.42 – 2.30 (m, 2H), 2.30 – 2.23 (m, 3H), 
1.91 (d, J = 1.3 Hz, 3H), 0.87 (s, 9H), 0.06 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 186.0, 161.5, 
159.0, 155.2, 153.3, 144.2, 138.9, 127.2, 125.5, 124.3, 108.5, 58.6, 57.7, 36.3, 32.4, 29.9, 26.2, 









To a solution of compound 1.101 (250 mg, 0.56 mmol) in THF (2 mL), 0.56 mL of TBAF was 
added and stirred for 30 minutes. Water was added and extracted two times with Ethyl acetate, the 
two organic layers combined and dried over sodium sulfate, evaporated the solvent and purified 
using flash column chromatography to obtain 82% as a colorless oil ;1H NMR (400 MHz, CDCl3) 
δ 7.09 (d, J = 1.0 Hz, 1H), 6.51 (dd, J = 2.7, 0.7 Hz, 1H), 6.45 – 6.43 (m, 1H), 6.15 – 6.14 (m, 1H), 
4.53 (d, J = 0.6 Hz, 2H), 4.14 (q, J = 7.1 Hz, 2H), 2.88 – 2.81 (m, 2H), 2.78 – 2.71 (m, 2H), 2.64 




To a solution of compound 1.105 (100 mg, 0.3 mmol) in dry diethyl ether (5 mL), LiAlH4 (23 mg, 
0.6 mmol) was added at 0 C. the reaction mixture was stirred for two hours at 0 C. After all the 
starting material was consumed, water (0.1 mL) was added followed by 10% NaOH (0.1 mL). The 
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solution was stirred for 15 minutes, and the organic layer was separated by decantation, dried over 
sodium sulfate, evaporated the solvent, and purified the crude product by flash column 
chromatography to obtain 83% of compound 1.106 as a colorless oil; 1H NMR (400 MHz, CDCl3) 
δ 7.11 (d, J = 1.0 Hz, 1H), 6.49 (q, J = 2.8 Hz, 2H), 6.12 – 6.10 (m, 1H), 4.58 (d, J = 0.6 Hz, 2H), 
3.69 (t, J = 6.4 Hz, 2H), 2.75 (dd, J = 10.0, 6.4 Hz, 2H), 2.63 – 2.57 (m, 4H), 2.26 – 2.24 (m, 3H), 
1.71 – 1.62 (m, 2H), 0.90 (s, 8H), 0.09 (s, 6H); 13C NMR (100 MHz, Acetone-d6) δ 155.6, 155.1, 
141.0, 138.2, 137.4, 128.7, 125.6, 115.3, 113.8, 108.4, 81.2, 68.9, 56.5, 34.8, 33.5, 26.8, 24.0, 19.2. 
Ethyl 3-(4-hydroxy-2-methyl-6-vinylphenyl) propanoate (Compound 1.111): 
 
A solution of potassium vinyltrifluoroborate (450 mg, 3.36 mmol), PdCl2(dppf).CH2Cl2 (114 mg, 
0.14 mmol), compound 1.99 (1 gm, 2.8 mmol) and Et3N (400 µL, 3.36 mmol) in degassed i-PrOH 
(20 mL) was heated at reflux under a argon atmosphere for 3 h, then cooled to room temperature 
and diluted with water 10 mL then extracted with ether (20 mL x 3). The ethereal solution washed 
with brine and dried over Magnesium sulfate. The solvent was removed under vacuum and the 
crude product was purified by flash column chromatography to obtain 92% as a colorless oil; 1H 
NMR (400 MHz, CDCl3) δ 6.93 (dd, J = 17.2, 10.9 Hz, 1H), 6.84 (d, J = 2.7 Hz, 1H), 6.64 – 6.61 
(m, 1H), 6.54 (s, 1H), 5.53 (dd, J = 17.2, 1.5 Hz, 1H), 5.25 (dd, J = 10.9, 1.5 Hz, 1H), 4.17 (q, J = 
7.1 Hz, 2H), 2.98 – 2.91 (m, 2H), 2.45 – 2.38 (m, 2H), 2.25 (s, 3H), 1.26 (t, J = 7.2 Hz, 3H); 13C 
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NMR (100 MHz, CDCl3) δ 173.6, 153.9, 138.4, 137.9, 134.7, 128.5, 117.1, 116.5, 110.6, 60.7, 
34.5, 23.9, 19.9, 14.2. 
Ethyl 3-(4-((tert-butyldimethylsilyl)oxy)-2-methyl-6-vinylphenyl)propanoate (Compound 
1.112): 
 
To a solution (0.5 gm, 2.13 mmol) of 1.111 in DMF (10 mL), (385 mg, 2.56 mmol) of TBS-Cl and 
(348 mg, 5.12 mmol) of Imidazole were added. The solution was stirred for 14 hours at room 
temperature under argon atmosphere, diluted with ethyl acetate and washed three times with water, 
the organic layer was dried over Sodium sulfate then the solvent was evaporated and the crude 
product was purified by flash column chromatography to obtain in 87% as a colorless oil; 1H NMR 
(400 MHz, CDCl3) δ 6.96 (dd, J = 17.2, 10.9 Hz, 1H), 6.80 (d, J = 2.5 Hz, 1H), 6.60 (d, J = 2.6 Hz, 
1H), 5.55 (dd, J = 17.2, 1.5 Hz, 1H), 5.28 (dd, J = 10.9, 1.5 Hz, 1H), 4.14 (q, J = 7.1 Hz, 2H), 2.99 
– 2.91 (m, 2H), 2.44 – 2.37 (m, 2H), 2.28 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H), 0.98 (s, 9H), 0.20 (s, 
6H); 13C NMR (100 MHz, CDCl3) δ 173.0, 153.8, 138.2, 137.5, 135.0, 129.3, 121.7, 116.1, 115.2, 







borolan-2-yl) ethyl)phenyl)propanoate (Compound 1.113): 
 
Cuprous oxide (14 mg, 0.17 mmol), PPh3 (67 mg, 0.26 mmol), K2HPO4 (600 mg, 3.45 mmol), 
bis(pinacolato)diboron (814 mg, 3.2 mmol) and compound 1.112 (600 mg, 1.72 mmol) in flame 
dried flask under argon atmosphere in dry menthol (10 mL) was added. The reaction was occurred 
at room temperature for 18 hours. After reaction is over, the reaction mixture was quenched with 
water and extracted three times with ethyl acetate. The organic phases were dried over Sodium 
sulfate, followed by evaporation under reduced pressure to remove the solvent. The product was 
purified by flash column chromatography to obtain in 83% as a colorless oil; 1H NMR (400 MHz, 
CDCl3) δ 6.54 (d, J = 2.6 Hz, 1H), 6.45 (d, J = 1.9 Hz, 1H), 4.13 (q, J = 7.2 Hz, 2H), 2.92 – 2.84 
(m, 2H), 2.68 – 2.61 (m, 2H), 2.43 – 2.36 (m, 2H), 2.23 (s, 3H), 1.25 (t, J = 7.2 Hz, 4H), 1.21 (s, 
12H), 1.08 – 1.02 (m, 2H), 0.94 (s, 9H), 0.15 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 173.3, 153.5, 
143.7, 137.3, 129.3, 119.4, 117.9, 83.1, 77.4, 77.1, 76.7, 60.3, 34.6, 26.7, 25.7, 24.8, 23.9, 20.0, 
18.1, 14.3, -4.3; HRMS (ESI) m/z  [M+H]+calc’d for C26H46BO5Si







dioxaborolan-2-yl)ethyl)phenyl)propanal (Compound 1.114): 
 
To a solution (700 mg, 1.47 mmol) of compound 1.113 in dry dichloromethane (20 mL) cooled to 
-78 °C under nitrogen was added dropwise (1.9 mL, 1.9 mmol) of 1 M di-isobutyl-aluminum 
hydride DIBAL-H in Heptane, keeping the internal temperature below -78°C. When the addition 
was complete, the reaction was quenched with saturated solution of NH4Cl under -78° C, and 
saturated solution of potassium sodium tartrate was added. The stirring continued until the organic 
layer be clear, the organic layer was separated, dried over magnesium sulfate. Concentration under 
reduced pressure gave the crude product that was purified by flash column chromatography to 
obtain 76% as a colorless oil; 1H NMR (400 MHz, CDCl3) δ 6.56 (d, J = 2.6 Hz, 1H), 6.46 (d, J = 
2.6 Hz, 1H), 2.91 – 2.81 (m, 1H), 2.72 – 2.53 (m, 4H), 2.21 (s, 3H), 1.83 – 1.64 (m, 1H), 1.21 (s, 
9H), 1.05 (td, J = 8.0, 1.5 Hz, 2H), 0.95 (s, 10H), 0.16 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 
202.1, 153.6, 143.5, 137.1, 129.0, 119.5, 118.0, 83.2, 77.4, 77.1, 76.8, 44.2, 26.8, 25.7, 25.7, 25.6, 
24.8, 24.8, 20.7, 20.0, 18.1, -4.3, -4.4. 
4-(4-((tert-butyldimethylsilyl)oxy)-2-methyl-6-(2-(4,4,5,5-tetramethyl-1,3,2-




A solution of nitromethane (0.7 mL, 12.5 mmol) and compound 1.114 (544 mg, 1.26 mmol) in 
THF (10 mL) was stirred for 4 hours at room temperature. Upon completion, saturated solution of 
NH4Cl (4 mL) was added and extracted two times with ethyl acetate, the combined organic layer 
was washed with water and brine then dried over Sodium sulfate. the solvent was evaporated, and 
the crude product was purifed by flash column chromatography using to obtain nitro alcohol in 
66% as a colorless oil; 1H NMR (400 MHz, CDCl3) δ 6.53 (d, J = 2.6 Hz, 1H), 6.46 (d, J = 2.6 Hz, 
1H), 4.43 – 4.39 (m, 2H), 4.37 (d, J = 1.4 Hz, 1H), 3.08 (s, 1H), 2.78 (ddd, J = 13.9, 8.8, 6.5 Hz, 
1H), 2.71 – 2.57 (m, 3H), 2.23 (s, 3H), 1.68 – 1.60 (m, 2H), 1.22 (d, J = 1.0 Hz, 13H), 1.06 (ddd, 
J = 9.1, 7.4, 3.7 Hz, 2H), 0.95 (s, 9H), 0.15 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 153.6, 143.7, 
137.3, 129.4, 119.6, 117.8, 83.4, 80.7, 77.3, 77.2, 77.0, 76.7, 68.5, 34.1, 26.6, 25.7, 24.8, 23.9, 
20.1, 18.2, -4.3 HRMS (ESI) m/z  [M+H]+calc’d for C27H49BO6Si









yl)ethyl)phenol (Compound 1.116): 
 
To a solution of compound 1.115 (300 mg, 0.6 mmol) in dry THF (2 mL), TBAF (0.6 mL, 0.6 
mmol, 1M) was added and stirred at room temperature for 30 minutes, then water was added and 
extracted with Ethyl acetate two times. The organic layer washed with water and brine, dried over 
sodium sulfate, and evaporated the solvent. The crude product purified by flash column 
chromatography to obtain 84% of compound 1.116 as a colorless oil; 1H NMR (400 MHz, CDCl3) 
δ 6.53 (d, J = 2.7 Hz, 1H), 6.47 (d, J = 2.7 Hz, 1H), 4.73 (s, 1H), 4.42 – 4.38 (m, 2H), 4.38 – 4.31 
(m, 1H), 3.04 (s, 1H), 2.83 – 2.74 (m, 1H), 2.72 – 2.60 (m, 3H), 2.24 (s, 3H), 1.64 (qd, J = 7.6, 
7.0, 3.1 Hz, 4H), 1.22 (d, J = 1.0 Hz, 12H), 1.07 (ddd, J = 8.9, 7.4, 3.5 Hz, 2H) HRMS (ESI) m/z  
[M+H]+calc’d for C19H31BO6+: 380.2240, found 380.2275. 
Methyl 4,5-dibromofuran-2-carboxylate (Compound 1.120): 
 
A flamed dry flask was charged with AlCl3 (11.6 gm, 87.2 mmol), then Methyl-2-furoate (5 gm, 
39.6 mmol) was slowly added at 0 °C under nitrogen over 30 minutes. To this stirred slurry, 
bromine (4.2 mL, 79.2 mmol) was added under the same condition over 1 h period. The stirring 
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was stopped, and the reaction mixture could stand overnight at room temperature. Icey water was 
added then extracted two times by Et2O. The combined organic fractions were washed with H2O, 
NaHCO3 and brine, dried over Magnesium sulfate and evaporated to dryness to give 9 g of red 
solid that used for next step without further purification; 1H NMR (400 MHz, CDCl3) δ 7.15 (s, 
1H), 3.87 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 157.4, 145.9, 128.4, 122.0, 103.8, 52.4 ; HRMS 
(ESI) m/z  [M+H]+calc;d for C6H5Br2O3
+: 282.8605, found 282.8730. 
Methyl 4-bromofuran-2-carboxylate (Compound 1.121): 
 
To a solution of compound 1.120 (4 g, 14 mmol) in dry MeOH (20 mL), Zn powder (2.8 g, 
42 mmol) and NH4Cl (2.0 g, 40 mmol) were added under nitrogen atmosphere. The reaction 
mixture was stirred at room temperature for 2.5 h, filtered through a pad of celite and the solvent 
evaporated under reduced pressure. The residue was treated with brine (15 mL), extracted 
with Ethyl acetate (3 × 20 mL), dried over Magnesium sulfate and concentrated under reduce 
pressure to   obtain a crude solid, which was purified by flash column chromatography to obtain 
85% as white solid MP. 49-50 °C; 1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 0.9 Hz, 1H), 6.97 (d, 
J = 0.9 Hz, 1H), 3.71 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 157.4, 145.9, 128.4, 122.0, 103.8, 
52.4 ; HRMS (ESI) m/z  [M+H]+calc’d for C6H6BrO3






(4-bromofuran-2-yl)methanol (Compound 1.122): 
 
To a solution of compound 1.121 (3 g, 14.6 mmol) in dry diethyl ether (30 mL) was added slowly 
(1.11 gm, 29.2 mmol) of LiAlH4 at 0 ºC, after the reaction stirred at room temperature for 3 hours, 
cooled in ice bath and 2.5 mL of H2O was carefully added, followed by 2.5 mL of 10% NaOH and 
5 mL of water which led to the immediate appearance of a white precipitate. The mixture was 
filtered, and the white precipitate was washed with Diethyl ether two times. The organic layer 
collected, washed with brine, dried on magnesium sulfate and concentrated under reduced pressure 
to afford the crude product which was purified by flash column chromatography to afford 83% as 
a colorless oil; 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.33 (m, 1H), 6.30 (d, J = 3.2 Hz, 1H), 4.51 
(t, J = 5.5 Hz, 2H), 2.46 (s, 1H). 13C NMR (100 MHz, CDCl3) δ 155.0, 140.7, 111.1, 100.0, 57.0. 
5-bromo-6-hydroxy-2H-pyran-3(6H)-one (Compound 1.123): 
 
To a stirred solution (1.06 gm, 6.0 mmol) of the compound 1.122 in (25 mL THF and H2O, 
4:1) were added (792 mg, 12.0 mmol) of NaHCO3, (502 mg, 6.0 mmol) of NaOAc, and (1.07 gm, 
6.0 mmol) of N-bromosuccinimide  at 0 °C, the reaction could stir at 0 °C for 30 minutes then 
quenched by addition of saturated aqueous NaHCO3 and Na2S2O3 and extracted three times 
with Ethyl acetate . The combined organic fractions washed with brine, dried over Sodium sulfate, 
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and concentrated under reduced pressure. The resulting residue was purified by flash column 
chromatography to obtain a yellow solid; 1H NMR (400 MHz, CDCl3) δ 7.33 – 7.25 (m, 1H), 6.56 
(s, 1H), 5.62 (s, 1H), 5.28 (s, 1H), 4.55 (d, J = 17.1 Hz, 1H), 4.12 (d, J = 17.0 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ 192.0, 146.0, 130.6, 92.8, 65.3; ; HRMS (ESI) m/z  [M+H]
+calc’d for 
C5H6BrO3
+: 192.9500, found 192.9429. 
(4,5-dibromofuran-2-yl)methanol (Compound 1.124): 
 
Using the same procedure that used to prepare compound 1.122, to obtain a colorless oil in 81% 
yield as a colorless oil; 1H NMR (400 MHz, CDCl3) δ 6.32 (s, 1H), 4.47 (s, 2H), 3.01 (s, 1H); 
13C NMR (100 MHz, CDCl3) δ 156.1, 122.7, 113.2, 102.1, 57.0; ; HRMS (ESI) m/z  
[M+H]+calc’d for C5H5Br2O2
+: 254.8656, found 254.8636. 
Methyl 5-bromofuran-2-carboxylate (Compound 1.126): 
 
Bromine (2.2 gm, 27.7 mmol) was added dropwise over 15 minutes to Methyl 2-furanoate (2.5 
gm, 19.8 mmol) at room temperature. The resulting dark orange/brown solution was stirred for an 
additional 15 min at 50 °C. The reaction mixture was poured into cold water and extracted with 
ethyl acetate. The combined extracts were washed with water and brine, dried over Sodium sulfate, 
the solvent was evaporated, and the crude product was purified by flash chromatography; 1H NMR 
(400 MHz, CDCl3) δ 6.93 (dd, J = 10.3, 3.0 Hz, 1H), 6.12 (ddd, J = 10.4, 0.9, 0.4 Hz, 1H), 5.58 
(s, 1H), 4.52 (d, J = 17.0 Hz, 1H), 4.09 (dd, J = 17.0, 0.5 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
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158.0, 146.2, 127.5, 120.1, 113.9, 52.1; HRMS (ESI) m/z  [M+H]+calc’d for C6H6BrO3
+: 
204.9500, found 204.9467. 
Methyl 5-methoxyfuran-2-carboxylate (Compound 1.127): 
 
To a solution of compound 1.126 (1 gm, 4.9 mmol) in dry DMF (20 mL), sodium methoxide (0.5 
gm, 9.8 mmol) was added at room temperature under Argon atmosphere. After stirring for 3 h at 
40 °C, saturated solution of NH4Cl aq. was added, and the organic materials were extracted with 
ethyl acetate. The combined organic layer washed with H2O and brine, dried over Magnesium 
sulfate, and concentrated in vacuo. Purification by flash column chromatography afforded 72% as 
a pale yellow oil; 1H NMR (400 MHz, CDCl3) δ 7.02 (d, J = 3.6 Hz, 1H), 5.24 (d, J = 3.6 Hz, 1H), 
3.83 (s, 3H), 3.73 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 164.0, 158.9, 134.7, 121.6, 83.5, 58.1, 
51.6. 
Methyl 4-bromo-5-methoxyfuran-2-carboxylate (Compound 1.128): 
  
To a solution of compound 1.127 (0.3 gm, 1.92 mmol) in dry DMF (10 mL), (0.41 gm, 2.3 mmol) 
of N-bromosuccinimide was added and stirred at 50 °C overnight. The solution was diluted with 
Ethyl acetate and washed with water 3 times and brine, dried over Sodium sulfate, evaporated the 
solvent and purified by flash column chromatography to obtain 72% as a yellow solid; 1H NMR 
(400 MHz, CDCl3) δ 8.31 (s, 1H), 3.91 (s, 3H), 3.91 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 180.8, 
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162.0, 160.6, 130.6, 128.4, 54.4, 53.6; ; HRMS (ESI) m/z  [M+H]+ calc’d for C7H8BrO4
+: 
234.9606, found 235.1312. 
(4-bromo-5-methoxyfuran-2-yl)methanol (Compound 1.129): 
 
To a suspension (54 mg, 1.4 mmol) of lithium aluminum hydride in the anhydrous diethyl ether, a 
solution of compound 1.128 (0.3 gm, 1.27 mmol) in the anhydrous diethyl ether was added 
dropwise with stirring at 0 °C. The mixture was stirred for 2 h at 0 °C and the reaction mixture 
was quenched with water 1 mL and 10% NaOH 1 mL were added. Organic phase was decanted, 
dried over Sodium sulfate, evaporated the solvent in a vacuum and purified the crude product by 
flash column chromatography to obtain 72% as a colorless oil; 
3-bromo-5-hydroxy-5,6-dihydro-2H-pyran-2-one (Compound 1.133): 
 
a solution of compound 1.123 (1.0 gm, 5.18 mmol), [Ir(COD)Cl]2 (87 mg, 0.13 mmol)  and 2,6-
dichlorobenzoic acid (495 mg, 2.6 mmol) in anhydrous CHCl3 was stirred under argon at room 
temperature for 16 hours, the solvent was evaporated and the residue was purified by flash column 
chromatography to obtain 61% after recover 30% of starting material as a colorless oil; 1H NMR 
(400 MHz, CDCl3) δ 7.31 (dd, J = 4.7, 1.3 Hz, 1H), 4.48 (dd, J = 13.0, 4.9 Hz, 1H), 4.45 – 4.37 
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(m, 2H), 4.08 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 159.5, 146.6, 116.3, 72.6, 62.9; HRMS (ESI) 
m/z  [M+H]+ calc’d for C5H6BrO3





 SPIRO COMPOUNDS 
Introduction: 
 Spirocyclic compounds are molecules that have two rings connected through a single shared atom 
(the spiroatom). Spiro compounds may be comprised solely of carbon atoms (carbocyclic), or one 
or more non-carbon atom such as nitrogen, oxygen, or sulfur (heterocyclic). The nomenclature for 
spiro structures was suggested by Von Baeyer in 1900.44 Spiro compounds play a significant role 
in drug discovery and development. Several natural and non-natural products containing a 
spirocyclic ring are presently used as commercial drugs.45 Spiro compounds with a chiral 
quaternary spiro carbon are the most attractive.46 Spirocycle subunits exist widely among natural 
products that show a broad range of biological and pharmacological activities. Some examples are 
shown in Figure 1. Annosqualine 2.1, with an isoquinoline core, is a spirocyclic alkaloid that was 
isolated from the stem of Annona squamosa.47 Tricycloillicinone 2.2, isolated from Illicium 
tachiroi, can increase Choline Acetyltransferase (CHAT) activity.48 Magellaninone 2.3, a member 
of the Lycopodium alkaloids, was isolated from Lycopodium magellanicum, β-Vetvone 2.4 was 





Figure 5: Examples of some natural spiro compounds 
Overview of methodologies in spiro synthesis 
Synthesis of spiro compounds from iodine (III) reagents: 
Synthesis of spirocyclic compounds using hypervalent iodine reagents was reported in 1991 
by Kita's group, which made spirohexadiones 2.6 from N-acyltyramines 2.5 using an iodine 
(III) reagent.50 Later, many hypervalent iodine-mediated spirocyclizations were explored, and 
phenolic oxidations of substrates were discovered for the preparation of spirodienone motifs 
(Scheme 28).51 
                                         
Scheme 28: Spiro formation using hypervalent iodine 




Scheme 29: The mechanism of ortho and para oxidative cyclization 
In 2005, spiro lactones 2.14 were prepared from carboxylic acids 2.13 by hypervalent iodine 
species generated in situ via the oxidation of iodoarene using meta chloroperbenzoic acid 
(mCPBA) as a terminal oxidant (Scheme 30).52 
 
Scheme 30: Spiro cyclization of carboxylic acid 
Wardrop and Burge reported an iodine (III)-mediated oxidative spiro-cyclization of hydroxamates 
2.15. The reaction afforded azaspiro compounds 2.16 in good yields upon treatment with 




Scheme 31: Spiro cyclization of hydroxamate 
Kita’s research group developed a method for the cyclization of alkyne derivative 2.17 to 
spirolactam 2.18 by using hypervalent iodine species. Specifically, para-substituted amide 2.17 
was cyclized to the corresponding spirolactam 2.18 in 80-99% yield using bis(iodoarene) with 
mCPBA as an oxidant in the presence of toluenesulfonic acid monohydride (TsOH·H2O) in 
trifluoroethanol (TFE) (Scheme 32).54 
 
 
Scheme 32: Spirolactam from amides 
Wang's group reported that hypervalent iodine can be used to make ortho-spirocarbocyclic 
compounds 2.20 via dearomatization of ortho-substituted phenols 2.19 in moderate yields. All the 
reactions were done in a CF3CH2OH/CH2Cl2 (1:1) solvent using (Diacetoxyiodo)benzene (PIDA) 




Scheme 33: Spiro cyclization of phenols on ortho position 
Hypervalent iodine reagents have been used to synthesize spiro[5.5]undeca-1,4-dien-3-one 2.22 
from phenols with terminal alkyne substituents 2.21 using PIDA in hexafluoro isopropyl alcohol 
for two minutes (Scheme 34).56 
 
Scheme 34: Spiro cyclization through alkynes 
Synthesis of spiro compounds using metals: 
Phenol derivatives, which are an essential starting material in organic synthesis, can also work as 
C-nucleophiles in the dearomatization reaction to generate quaternary carbon stereocenters. In 
2010, Hamada and co-workers reported a successful method for synthesizing 
spiro[4.5]cyclohexadienones 2.24 via a Pd-catalyzed intramolecular ipso-Friedel-Crafts allylic 
alkylation of phenols 2.23 (Scheme 35).57 
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Scheme 35: Spiro cyclization using Palladium 
A year later, You and co-workers reported the same dearomatization reaction via the chiral Iridium 
complex produced from phosphoramidite ligand and [Ir(cod)Cl]2 which generated 
spiro[4.5]decane 2.26 (Scheme 36). 
     
    
Scheme 36: Spiro cyclization using Iridium 
Spirocyclohexadienone 2.28 was synthesized from arylative dearomatization, catalyzed by 
palladium using a phosphorous ligand and of phenols 2.27 in good yield and excellent 
enantioselectivity (Scheme 37).58 
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Scheme 37: Spiro cyclization using Palladium 
A palladium-catalyzed [2+2+1] dearomatization reaction of methoxy benzene 2.29 with alkynes 
2.30 provides spirocyclohexadienones 2.31 via para-selective C−H functionalization in moderate 
to excellent yields (Scheme 38).59 
                                  
Scheme 38: Spiro cyclization from anisole and alkynes 
The dearomatization of phenols and naphthols via transition-metal catalysts is still challenging 
because of the energetic barriers and the competition between C and O alkylation. Besides 
palladium, here are some transition metals used in the spirocyclization of phenols and naphthols.  
Hamada and his co-worker reported the use of a gold catalyst to synthesize spiro-
[4.5]cyclohexadienones 2.33 from terminal alkene phenols through an intramolecular ipso 
Friedel–Crafts alkenylation with an exo-cyclic olefin (scheme 39).60  
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Scheme 39: Spiro cyclization using Gold 
In 2014, Gulías’s group reported a [3+2] cyclization reaction of 2-alkenyl phenols with alkynes in 
the presence of a rhodium(III) catalyst via a dearomatization annulation reaction affording para-
spiro cyclic products 2.36 (Scheme 40).61  
 
 
Scheme 40: Spiro cyclization using 2-alkenyl phenols 
Wang's group developed a copper-catalyzed reaction, which involves the trifluoromethylation of 
substituted N-benzylacrylamides and affords 2‑azaspiro[4.5]decanes 2.39 via dearomatization on 
the para position of the phenols (Scheme 41).62 
 
Scheme 41: Spiro cyclization using copper 
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You and co-workers reported a procedure for the asymmetric dearomatization of naphthol 
derivatives by iridium-catalyzed asymmetric allylic substitution reactions in the presence of a 
phosphoramidite ligand to produce naphthalenones 2.41 with a quaternary carbon center (Scheme 
42).63 
 
                   
Scheme 42: Spiro cyclization using Iridium 
Recently, Kozlowski’s group developed a technique using vanadium-catalyzed intramolecular 
coupling of free phenols to generate the para-spiro cyclohexadieneone 2.43 in good yield.64 The 
limitation of this procedure is incompatible with ortho phenols (Scheme 43). 
 
Scheme 43: Spiro cyclization using Vanadium 
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Swenton’s group prepared spiro[5.6]decan 2.45 via electrochemical oxidation. Compared to the 
results with PIDA oxidation, the yield from electrochemical oxidation was better than PIDA 
(Scheme 44).65 
                       
Scheme 44: Spiro cyclization using electrochemistry 
Zhang and co-workers used visible light photocatalyst Ir(ppy)3 to generate spiro[4.5]decan through 
the dearomatization reaction of 2-bromo-2-(4methoxybenzyl) malonate with alkynes under mild 
conditions in high yield (Scheme 45).66 
 
                       
Scheme 45: Spiro cyclization using iridium  
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Results and discutions: 
Spirocyclic structures are widely present in biological active natural products. In order to 
synthesize these natural products, we need an efficient methodology to generate the spiro system 
from common starting materials such as phenols. Under mild condition, currently available 
methods suffer from lower yields or longer reaction times. Luan’s group stated that “the majority 
of the few protocols established in this area were mainly limited by employing preactivated agents 
such as aryl halides as coupling partners.” 67  Our work focuses on a new, and efficient, procedure 
for the synthesis of multi-functional spiro skeletons employing a cost-effective oxidative agent. 
Under mild condition, the development of a stereoselective iron (III)-mediated intramolecular 
cascade dearomatization reaction of phenol compounds allow access to various spirocyclo-
hexadienones in one step. Using potassium ferricyanide, spiro[4,5]decane derivatives were 
prepared via single electron transfer (SET) in good yield. Highlighting the synthetic utility of the 
transformation, reaction products proved amenable to a variety of further chemical modifications. 
Our proposed reaction features 2-(4-nitrobutyl) phenol 2.49a which is treated with K3[Fe(CN)6] in 
the presence of potassium hydroxide at room temperature to afford a chiral [4,5]spiro-cyclic five-
member ring compound. This proposed reaction forms a new quaternary carbon center in one step. 
We used compound 2.49a as a model substrate to explore different oxidants including PIDA, 
copper (II) acetate Cu(OAc)2 and potassium ferrocyanide K3[Fe(CN)6]. PIDA was screened at 
various temperatures ranging from 0 to 40 °C but it failed to show any reactivity. Copper acetate 
also was unable to materialize the spiro compound. Oxidant K3[Fe(CN)6] afforded the spiro 




Table 4: Optimization dearomatization reaction using different oxidant 
 
 
Entry Oxidant Temp Yield % 
1 Cu(OAc)2 RT 0 
2 PhI(OAc)2 0-40 °C 0 
3 K3[Fe(CN)6] RT 41 
 
The reactions were run in an aqueous KOH solution and the substrate had a low solubility in water. 
Because of this, we examined both protic and aprotic solvents as co-solvents. We also surveyed 
the bases’ effect on the reaction to determine the optimal reaction conditions.  
When we used 1,4-dioxane as a co-solvent, the yield improved from 41% to 47%, but tropone 
2.51a was produced as a side product in 13% yield (Table 2, entry 1). We were able to improve 
the yield to 56% using n-butanol, without signs of any tropone side product (Table 2, entry 2). 
Moving to acetonitrile as a co-solvent enhanced the yield to 81%, giving enough product for X-
ray analysis (Table 2, entry 3). Then we trialed varying bases from 0.1 N KOH to 0.1 N NaOH 






Table 5: Optimization dearomatization reaction using different solvent and bases 
 
 
Entry Co-solvent Base Yield of 2.50a 
(%) 
Yield of 2.51a 
(%) 
1 1,4-Dioxane 0.1 N KOH 47 13 
2 n-Butanol 0.1 N KOH 56 0 
3 MeCN 0.1 N KOH 81 0 
4 MeCN 0.1 N NaOH 53 0 
5 MeCN 0.1 N K2CO3 26 0 
 
In order to test the substrate scope, we prepared substituted aldehydes from corresponding 
salicylaldehyde. Reaction of salicylaldehyde with triethyl phosphonoacetate in the presence of 1,8-
diazabicycloundec-7-ene (DBU) at room temperature for 16 hours produced α,β-unsaturated ester 
compounds 2.53a-f in good yield.68 Reduction of the double bond through hydrogenation at room 
temperature afforded compounds 2.54a-f. TBS protection of the phenols gave compounds 2.55a-




Scheme 46: Synthesis of compounds 2.56a-f 
Michael reaction of substituted aldehyde 2.56a with 15 different nitro alkenes 2.57a-o in the 
presence of Jørgensen’s catalyst and p-nitro phenol in toluene followed by reduction of the 
aldehydes to alcohols, and deprotection of TBS by TBAF afforded compounds 2.49a-o (Scheme 
47). All the substituted compounds 2.49a-o gave good yields over three reaction steps. Compound 
2.49k only afforded 50% yield because there was an unexpected side product. Under basic 
conditions, the β-proton to the nitro group was removed which resulted in elimination of the NO2 
group.    
 
Scheme 47: Synthesis of compounds 2.49a-o 
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The d.r. for the aromatic substituents varied between (8:1 to 20:1), and it was determined by 







Figure 6: The structure of compounds 2.49a-o 
Next, we prepared compounds 2.49p-t from the reaction between compounds 2.56b-e and 2.57a 
using the same procedure that was used for compounds 2.49a-o (Scheme 48). 
 
Scheme 48:  Synthesis of compounds 2.49p-t 




Figure 7: the structure of compounds 49p-t 
With the reaction conditions optimized condition, we next set out to explore new substrates, 2.49a-
o to prepare spiro compounds 2.50a-o (Scheme 49). 
 
Scheme 49: Spiro cyclization reaction 
The aliphatic substrates (2.50d and 2.50e) under standard conditions gave their corresponding 
spiro products in good yield. The aromatic substrates (2.50a-c, 2.50f-j, and 2.50l-o) gave their 
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corresponding spiro products in good yield with little impact from electron withdrawing or 
donating substituent groups (Figure 8). Compound 2.50k did not show any product because it 
decomposed under basic conditions. Compounds 2.50b, 2.50c, and 2.50f showed small amounts 
of tropone side product; we resolved this problem by running the reaction at 0 °C which improved 




Figure 8: The structure of compounds 2.50a-o 
Compound 2.50c showed slightly lower yield which we attributed to steric hindrance caused by 
the ortho methyl.  
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Next, we turned our attention to the phenyl ring. Compounds 2.50p and 2.50t provided lower 
yields with 53% and 56% yields respectively, compared to compound 2.50a with 81% yield. 
Compounds 2.50q and 2.50r showed a slight difference in yields of 66% and 61%; compound 
2.50s gave the lowest yield for all with 41% yield compared to the 2.50q which gave 66%. The 
phenols that are substituted with ester, amide, aldehyde, or acid functional groups did not give any 
spiro product (Figure 9). 
 
Figure 9: The structures of compounds 2.50p-t                           
Next, a gram scale reaction was done. Starting with 2.0 grams of compound 2.49a, we were able 
to achieve 79% yield of the spiro product 2.50a. The scalability of this reaction is highly favorable 
with multiple reactions run in the gram scale with comparable yields. Also, the versatility of the 
functional groups present in these spiro compounds makes them ideal candidates for future 
modifications. For example, ketones, hydroxy groups, and nitro groups are easily transformed into 
a large variety of functional groups and these spiro compounds could be key intermediates in a 
multitude of synthetic pathways. To demonstrate this, 2.50a was reduced to an alcohol using 
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sodium borohydride in methanol at 0 °C, which afforded 2.58 in 91% yield. A Nef reaction can be 
applied on this compound to convert the nitro group to a ketone using sodium nitrite in DMSO to 
obtain compound 2.59 in 85% yield. The nitro group was reduced to an amine using zinc powder 
in acetic acid at room temperature to give product 2.60 in 81% yield (Scheme 50). 
 
Scheme 50: Modification reactions on compound 2.50a 
The diene can also be reduced to saturated cyclohexane using Pd/C under hydrogen atmosphere to 
give 2.61. Furthermore, Diels-Alder reactions of the spiro with alkenes and alkynes were explored. 
N-phenyl succinimide and 1,2-acytelyne dicarboxylate were reacted in xylene at 130 °C in a sealed 
tube to give compounds 2.62a-b in 88% and 91% yield, and 2.63 with yield 89% respectively. It 
should also be stated that our spiro compounds showed high levels of stability at room temperature 
compared to other spiro compounds. Unwanted Diels-alder dimerization reactions are common 
with diene products but our spiro compounds resisted dimerization even when kept under solution 




We prepared [4,5]spiro compounds through single electron transfer using K3[Fe(CN)6] in a basic 
media of potassium hydroxide at room temperature in good yield using mild reaction conditions 
and inexpensive reagents. We then went on to screen a range of substituents; seeing only a minor 
change in the yield between electron withdrawing groups and electron donating groups, where as 
having a substiuent on the phenol ring greatly impacted the yield due to steric effects. The single 
X-ray crystallography of the spiro compound shows the identical stereochemistry to some natural 








 A mixture of potassium vinyltrifluoroborate (1 gm, 7.5 mmol), PdCl2 (dppf)CH2Cl2 (146 mg, 0.2 
mmol 0.04 eq.), 2-bromo-6-hydroxy benzaldehyde (1 gm, 5 mmol, 1eq.) and Et3N (2.1 mL, 15 
mmol, 3eq.) in n-PrOH (40 mL) was degassed for 30 min., then heated at 80°C under Argon. The 
reaction mixture was stirred at 80°C for 16 h, then cooled to room temperature and diluted with 
water (10 mL) and extracted with ether (25 mL x 3). The organic layer was washed with brine (20 
mL) and dried over Magnesium sulfate. The solvent was removed under vacuum and the crude 
product was purified by flash column chromatography to obtain (550 mg, 75%) as a yellow oil; 
1H NMR (400 MHz, CDCl3) δ 11.84 (s, 1H), 10.27 (s, 1H), 7.42 (t, J = 8.0 Hz, 1H), 7.17 (dd, J = 
17.2, 11.0 Hz, 1H), 6.93 – 6.83 (m, 2H), 5.67 – 5.49 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
195.4, 162.7, 143.2, 137.2, 132.0, 121.4, 118.6, 117.3. 
 
Wittig reaction (Compounds 2.53a-f): 
To a stirred solution of triethylphosphonoacetate (1.1eq.) and DBU (1.1eq) in dry THF (40 mL), 
salicylaldehyde derivative (1.0 eq.) was added. The reaction stirred at room temperature for 18 h, 
then the reaction mixture was diluted with Ethyl acetate, washed with saturated aqueous solution 
of NH4Cl.The organic layer was separated, and the aqueous layer was further extracted with Ethyl 
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acetate. The combined organic layers washed with water and brain, dried over sodium sulfate, 
evaporated the solvent, and purified using flash chromatography to give the desired product. 
 
Ethyl (E)-3-(2-hydroxyphenyl) acrylate (Compound 2.53a): 
 
 
white solid MP.83-85°C, (Yield 93%); 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J = 16.2 
Hz, 1H), 7.46 – 7.44 (m, 1H), 7.43 (s, 1H), 7.21 (ddd, J = 8.2, 7.2, 1.6 Hz, 1H), 6.91 
– 6.85 (m, 2H), 6.66 (d, J = 16.2 Hz, 1H), 4.29 (q, J = 7.0 Hz, 2H), 1.34 (t, J = 7.1 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 169.2, 156.0, 141.3, 131.7, 129.4, 121.9, 
120.7, 118.3, 116.7, 61.1, 14.5.  
Ethyl (E)-3-(2-hydroxy-3-methylphenyl) acrylate (Compound 2.53b): 
 
White solid, MP. 128-130°C, (yield 86%); 1H NMR (400 MHz, CDCl3) δ 8.21 (dd, J = 16.0, 0.6 
Hz, 1H), 7.35 (dt, J = 7.8, 1.2 Hz, 1H), 7.12 (ddd, J = 7.4, 1.6, 1.0 Hz, 1H), 6.81 (t, J = 7.6 Hz, 
1H), 6.55 (s, 1H), 6.51 (d, J = 16.0 Hz, 1H), 4.26 (q, J = 7.2 Hz, 2H), 2.30 (s, 3H), 1.33 (t, J = 7.0 
Hz, 3H), 13C NMR (100 MHz, CDCl3) δ 168.6, 154.0, 141.1, 133.0, 126.2, 124.6, 124.6, 121.9, 








White solid, MP. 106-108°C; 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J = 16.0 Hz, 1H), 7.33 (d, J 
= 7.8 Hz, 1H), 6.92 (s, 1H), 6.70 (ddd, J = 8.6, 1.2, 0.6 Hz, 1H), 6.69 – 6.64 (m, 2H), 6.59 (d, J = 
16.0 Hz, 1H), 4.27 (q, J = 7.2 Hz, 2H), 2.27 (s, 3H), 1.33 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 169.3, 155.9, 142.6, 141.4, 129.3, 121.7, 119.2, 117.2, 117.1, 60.9, 21.6, 14.5. 
 
Ethyl (E)-3-(2-hydroxy-5-methylphenyl) acrylate (Compound 2.53d): 
 
 
White solid, MP. 100-102°C (Yield 94%); 1H NMR (400 MHz, CDCl3) δ 8.01 (dd, J = 16.0, 0.6 
Hz, 1H), 7.23 (d, J = 2.4 Hz, 1H), 7.01 (ddd, J = 8.2, 2.2, 0.8 Hz, 1H), 6.89 (s, 1H), 6.76 (d, J = 
8.2 Hz, 1H), 6.60 (d, J = 16.0 Hz, 1H), 4.27 (q, J = 7.2 Hz, 2H), 2.25 (s, 3H), 1.33 (t, J = 7.2 Hz, 
3H). 13C NMR (100 MHz, CDCl3) δ 169.3, 155.9, 142.6, 141.4, 129.3, 121.7, 119.2, 117.2, 117.1, 










White solid, MP. 125-127°C, (yield 94%); 1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 16.2 Hz, 
1H), 7.48 (s, 1H), 7.29 (dd, J = 8.0, 0.6 Hz, 1H), 7.06 – 7.00 (m, 2H), 6.63 (d, J = 16.2 Hz, 1H), 
4.29 (q, J = 7.0 Hz, 2H), 1.34 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 168.9, 156.4, 
140.1, 130.4, 125.0, 124.1, 121.1, 119.9, 118.9, 61.2, 14.5. 
 




White solid MP.120-122°C, (yield 93%); 1H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 16.2 Hz, 1H), 
7.18 – 7.12 (m, 1H), 7.05 (s, 1H), 7.01 (dd, J = 7.8, 0.8 Hz, 1H), 6.98 – 6.92 (m, 1H), 6.82 (dd, J 
= 8.0, 1.0 Hz, 1H), 6.66 (d, J = 16.2 Hz, 1H), 5.59 (dd, J = 17.2, 1.4 Hz, 1H), 5.34 (dd, J = 11.0, 
1.4 Hz, 1H), 4.29 (q, J = 7.0 Hz, 2H), 1.34 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 




Hydrogenation: (Compounds 3a-c, 3e): 
To a solution of (5mmol) of Compounds 2.53a-e in a mixture of Ethyl acetate and Ethanol (4:1, 
20 mL) Palladium over carbon (5% w/w) was added and charged with hydrogen gas for 3 hrs. 
Filtrated over celite, evaporated the solvent under reduce pressure and used for another step 
without any purification.  
 
Ethyl 3-(2-hydroxyphenyl) propanoate (Compound 2.54a): 
 
 
Colorless oil (yield 99%); 1H NMR (400 MHz, CDCl3) δ 7.30 (s, 1H), 7.12 – 7.06 (m, 2H), 6.88 – 
6.82 (m, 2H), 4.13 (q, J = 7.1 Hz, 2H), 2.90 (dd, J = 7.1, 6.1 Hz, 2H), 2.73 – 2.67 (m, 2H), 1.23 (t, 
J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 175.7, 154.5, 130.7, 128.1, 127.5, 120.9, 117.1, 
61.4, 35.3, 25.0, 14.2.  
 
Ethyl 3-(2-hydroxy-3-methylphenyl) propanoate (Compound 2.54b): 
 
 
Colorless oil (Yield 98%); 1H NMR (400 MHz, CDCl3) δ 7.27 (s, 1H), 7.00 (dd, J = 7.3, 0.9 Hz, 
1H), 6.93 (dd, J = 7.5, 1.7 Hz, 1H), 6.77 (t, J = 7.5 Hz, 1H), 4.15 (q, J = 7.2 Hz, 2H), 2.89 (dd, J 
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= 7.2, 5.5 Hz, 2H), 2.71 (dd, J = 7.2, 5.5 Hz, 2H), 2.27 (s, 3H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 176.0, 152.8, 129.4, 128.2, 127.1, 126.0, 61.5, 35.5, 24.8, 16.5, 14.2. 
 




Colorless oil (Yield 99%); 1H NMR (CDCl3) δ 7.24 (s, 1H), 7.00 – 6.93 (m, 1H), 6.73 – 6.67 (m, 
2H), 6.71 – 6.64 (m, 2H), 4.14 (q, J = 7.2 Hz, 2H), 2.87 (t, J = 6.6 Hz, 2H), 2.68 (t, J = 6.8 Hz, 
2H), 2.26 (s, 3H), 1.24 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 175.7, 154.2, 138.0, 
130.4, 124.4, 121.6, 117.7, 61.3, 35.4, 24.6, 21.1, 14.2. 
 




Colorless oil (Yield 99%); 1H NMR (400 MHz, CDCl3) δ 6.92 – 6.85 (m, 2H), 6.77 (d, J = 8.6 Hz, 
1H), 4.14 (q, J = 7.0 Hz, 2H), 2.88 (t, J = 6.8 Hz, 2H), 2.69 (t, J = 6.6 Hz, 2H), 2.24 (s, 3H), 1.23 
(t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 175.5, 152.1, 131.1, 129.8, 128.4, 127.1, 116.7, 
61.2, 35.2, 25.1, 20.5, 14.2. 
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To a solution of Ethyl-(2-hydroxy-4-bromo) phenyl propionate (500 mg, 1.8 mmol) in methanol 
(10 mL), CoCl2.6H2O (43.5 mg, 0.1 eq.) and NaBH4 (140 mg , 2 eq.) were added at 0°C, the 
reaction mixture was stirred at 0 °C for 2 h then saturated solution of ammonium chloride was 
added and extracted with ethyl acetate (2x20 mL). The organic layer washed with water and brain 
(10 mL), dried over anhydrous sodium sulfate, evaporated the solvent under reduced pressure and 
purified using flash column chromatography to obtain the desired product (yield 91%) as a 
colorless oil; 1H NMR (400 MHz, CDCl3) δ 7.03 (d, J = 1.8 Hz, 1H), 6.96 (dd, J = 8.0, 1.8 Hz, 
1H), 6.91 (d, J = 8.0 Hz, 1H), 4.13 (q, J = 7.2 Hz, 2H), 3.68 (s, 1H), 2.85 – 2.80 (m, 2H), 2.70 – 
2.64 (m, 3H), 1.22 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 176.0, 155.5, 131.9, 126.7, 















Colorless oil; 1H NMR (CDCl3) δ 7.28 (s, 1H), 7.05 (t, J = 7.8 Hz, 1H), 6.78 – 6.72 (m, 2H), 4.14 
(q, J = 7.2 Hz, 2H), 2.94 (dd, J = 7.2, 5.8 Hz, 2H), 2.66 (dd, J = 7.2, 5.8 Hz, 2H), 2.59 (q, J = 7.4 
Hz, 2H), 1.25 – 1.18 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 176.1, 154.8, 143.8, 127.8, 125.5, 
121.0, 115.1, 61.6, 34.6, 25.7, 20.4, 15.6, 14.3. 
 
TBS protection: (Compounds 2.55a-f):  
 
To a solution of Phenol (2.0 mmol) in DMF (10 mL), imidazole (4.8 mmol) was added and the 
solution was cooled to 0 °C, TBS (1.2 eq.) in dry DMF (10 mL) was added, the reaction mixture 
was stirred for 16 hours at room temperature. The mixture was poured into water and extracted 
with ethyl acetate (3x20 mL). The organic layer was washed with water (10 mL) and brine (10 
ML), dried over anhydrous magnesium sulfate, and concentrated under reduced pressure then 








Ethyl 3-(2-((tert-butyldimethylsilyl)oxy)phenyl) propanoate (Compound 2.55a): 
 
 
Colorless oil (yield 93%); 1H NMR (400 MHz, CDCl3) δ 7.13 (dd, J = 7.4, 1.9 Hz, 1H), 7.07 (td, 
J = 7.7, 3.3 Hz, 1H), 6.86 (ddd, J = 7.4, 6.6, 1.3 Hz, 1H), 6.79 – 6.73 (m, 1H), 4.11 (q, J = 6.4, 5.7 
Hz, 2H), 2.90 (dd, J = 8.8, 7.0 Hz, 2H), 2.57 (dd, J = 8.4, 7.6 Hz, 2H), 1.22 (t, J = 7.1 Hz, 3H), 
1.01 (s, 9H), 0.23 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 173.4, 153.8, 131.3, 130.3, 127.5, 121.3, 
118.5, 60.4, 34.7, 26.6, 26.0, 18.4, 14.4, -4.0. 
Ethyl 3-(2-((tert-butyldimethylsilyl)oxy)-3-methylphenyl) propanoate (Compound 2.55b): 
 
Colorless oil (Yield 89%); 1H NMR (400 MHz, CDCl3) δ 7.00 – 6.94 (m, 2H), 6.83 – 6.79 (m, 
1H), 4.12 (q, J = 7.1 Hz, 2H), 2.95 – 2.88 (m, 2H), 2.59 – 2.51 (m, 2H), 2.21 (s, 3H), 1.23 (t, J = 
7.1 Hz, 3H), 1.02 (s, 8H), 0.20 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 173.4, 152.0, 131.3, 129.6, 












Colorless oil (yield 97%); 1H NMR (400 MHz, CDCl3) δ 7.01 (d, J = 7.6 Hz, 1H), 6.68 (ddd, J = 
7.6, 1.7, 0.7 Hz, 1H), 6.60 – 6.58 (m, 1H), 4.11 (q, J = 7.1 Hz, 2H), 2.88 – 2.83 (m, 2H), 2.54 (dd, 
J = 8.7, 7.1 Hz, 2H), 2.26 (s, 3H), 1.22 (t, J = 7.1 Hz, 3H), 1.00 (s, 8H), 0.23 (s, 6H); 13C NMR 
(101 MHz, CDCl3) δ 173.63, 153.82, 137.50, 130.21, 128.35, 122.12, 119.55, 77.70, 77.39, 77.07, 
60.55, 35.01, 26.44, 26.14, 21.53, 18.57, 14.60, -3.76. 
 
Ethyl 3-(2-((tert-butyldimethylsilyl)oxy)-5-methylphenyl) propanoate (Compound 2.55d): 
 
 
Colorless oil (yield 96%): 1H NMR (400 MHz, CDCl3) δ 6.96 – 6.91 (m, 1H), 6.86 (ddd, J = 8.2, 
2.4, 0.8 Hz, 1H), 6.66 (d, J = 8.1 Hz, 1H), 4.11 (q, J = 7.2 Hz, 2H), 2.90 – 2.80 (m, 2H), 2.60 – 
2.51 (m, 2H), 2.23 (d, J = 0.8 Hz, 3H), 1.22 (t, J = 7.1 Hz, 3H), 0.99 (s, 9H), 0.21 (s, 6H). 13C NMR 
(100 MHz, CDCl3) δ 173.6, 151.7, 131.2, 131.1, 130.5, 128.0, 118.5, 77.6, 60.6, 34.9, 26.8, 26.1, 




Ethyl 3-(4-bromo-2-((tert-butyldimethylsilyl)oxy)phenyl) propanoate (Compound 2.55e): 
 
 
A colorless oil (87%); 1H NMR (400 MHz, CDCl3) δ 6.99 (d, J = 1.5 Hz, 2H), 6.90 (dd, J = 1.4, 
0.8 Hz, 1H), 4.10 (d, J = 7.2 Hz, 2H), 2.83 (dd, J = 8.6, 7.1 Hz, 2H), 2.52 (dd, J = 8.5, 7.0 Hz, 2H), 
1.21 (t, J = 7.1 Hz, 4H), 0.99 (s, 9H), 0.24 (s, 6H).; 13C NMR (100 MHz, CDCl3) δ 173.21, 154.78, 
131.59, 130.64, 124.49, 121.91, 120.23, 77.72, 77.40, 77.08, 60.68, 34.50, 26.05, 18.55, 14.58, -
3.87. 
 
Ethyl 3-(2-((tert-butyldimethylsilyl)oxy)-6-ethylphenyl) propanoate (Compound 2.55f): 
 
 
colorless oil (89%); 1H NMR (400 MHz, CDCl3) δ 7.05 (t, J = 7.8 Hz, 1H), 6.82 (dd, J = 7.6, 1.2 
Hz, 1H), 6.70 (dd, J = 8.0, 1.2 Hz, 1H), 4.19 (q, J = 7.0 Hz, 2H), 3.05 – 2.98 (m, 2H), 2.70 (q, J = 
7.6 Hz, 2H), 2.58 – 2.50 (m, 2H), 1.30 (d, J = 7.2 Hz, 3H), 1.27 – 1.23 (m, 3H), 1.07 (s, 9H), 0.30 
(s, 6H); 13C NMR (100 MHz, CDCl3) δ 173.3, 153.9, 143.9, 129.1, 126.8, 121.4, 115.7, 60.2, 34.4, 






To a solution of Compounds 2.56a-f (2 mmol) in dry dichloromethane (20 mL) at -78°C, a solution 
of Diisobutylaluminum hydride (1M solution in heptane, 1.2 eq.) was added dropwise at -78 °C. 
The reaction mixture was stirred for 1 h, after all the starting material was consumed, the reaction 
was quenched by adding saturated solution of ammonium chloride at -78°C and stirred for 10 
minutes then the solution was warmed to room temperature. Then saturated solution of potassium 
sodium tartrate was added and stirred for 2 h at room temperature. The organic layer was separated, 
dried over sodium sulfate, evaporated the solvent and purified using flash column. 
3-(2-((tert-butyldimethylsilyl)oxy)phenyl) propanal (Compound 2.56a):  
 
colorless oil, (Yield 76%); 1H NMR (400 MHz, CDCl3) δ 9.82 (t, J = 1.5 Hz, 1H), 7.20 – 7.14 (m, 
1H), 7.12 (dddd, J = 8.2, 7.6, 1.8, 0.8 Hz, 1H), 6.93 – 6.88 (m, 1H), 6.82 (dd, J = 8.0, 1.2 Hz, 1H), 
2.99 – 2.92 (m, 2H), 2.77 – 2.72 (m, 1H), 2.71 – 2.65 (m, 1H), 1.05 (d, J = 4.8 Hz, 9H), 0.28 (d, J 
= 1.8 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 202.3, 153.8, 131.0, 130.4, 127.6, 121.4, 118.6, 








3-(2-((tert-butyldimethylsilyl)oxy)-3-methylphenyl) propanal (Compound 2.56b): 
 
 
colorless oil, (Yield 71%); 1H NMR (400 MHz, CDCl3) δ 9.78 (t, J = 1.5 Hz, 1H), 6.99 (ddd, J = 
7.2, 1.8, 0.8 Hz, 1H), 6.93 (ddt, J = 7.6, 1.8, 0.6 Hz, 1H), 6.81 (t, J = 7.5 Hz, 1H), 2.90 (dd, J = 
8.4, 6.8 Hz, 2H), 2.71 – 2.66 (m, 2H), 2.20 (s, 3H), 1.00 (s, 9H), 0.18 (s, 6H). 13C NMR (100 MHz, 
CDCl3) δ 202.2, 152.0, 131.1, 129.8, 129.1, 127.6, 121.8, 44.4, 26.3, 24.0, 19.0, 18.1, -2.7. 
3-(2-((tert-butyldimethylsilyl)oxy)-4-methylphenyl) propanal (Compound 2.56c): 
 
Colorless oil (yield 71); 1H NMR (400 MHz, CDCl3) δ  9.81 (d, J = 1.6 Hz, 1H), 6.95 (d, J = 2.3 
Hz, 1H), 6.92 – 6.87 (m, 1H), 6.70 (dd, J = 8.1, 1.0 Hz, 1H), 2.89 (t, J = 7.6 Hz, 2H), 2.72 (ddd, J 
= 7.8, 6.4, 1.4 Hz, 2H), 2.26 (s, 3H), 1.02 (s, 9H), 0.25 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 







3-(2-((tert-butyldimethylsilyl)oxy)-5-methylphenyl) propanal (Compound 2.56d): 
 
Colorless oil, (Yield 80%); 1H NMR (400 MHz, CDCl3) δ 9.81 (d, J = 1.6 Hz, 1H), 6.95 (d, J = 
2.2 Hz, 1H), 6.90 (dd, J = 8.6, 2.5 Hz, 1H), 6.70 (dt, J = 8.2, 1.6 Hz, 1H), 2.89 (t, J = 7.6 Hz, 2H), 
2.72 (ddt, J = 9.2, 7.8, 1.4 Hz, 2H), 2.26 (s, 3H), 1.02 (s, 9H), 0.25 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 202.5, 179.7, 151.5, 131.0, 130.6, 128.0, 118.4, 44.3, 34.5, 26.0, 23.8, 20.7, 18.4, -4.0. 
 
3-(4-bromo-2-((tert-butyldimethylsilyl)oxy)phenyl) propanal (Compound 2.56e): 
     
Colorless oil (Yield 85%); 1H NMR (400 MHz, CDCl3) δ 9.77 (t, J = 1.4 Hz, 1H), 6.99 (d, J = 1.6 
Hz, 2H), 6.91 – 6.90 (m, 1H), 2.83 (td, J = 7.2, 6.8, 0.8 Hz, 2H), 2.68 (dddd, J = 7.8, 7.2, 1.4, 0.8 
Hz, 2H), 0.98 (s, 9H), 0.24 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 201.7, 154.6, 131.5, 130.2, 







3-(2-((tert-butyldimethylsilyl)oxy)-6-ethylphenyl) propanal (Compound 2.56f): 
 
Colorless oil (yield 73%); 1H NMR (400 MHz, CDCl3) δ 9.84 (t, J = 1.5 Hz, 1H), 7.04 (t, J = 7.8 
Hz, 1H), 6.80 (dd, J = 7.6, 1.2 Hz, 1H), 6.68 (dd, J = 8.2, 1.2 Hz, 1H), 2.98 – 2.92 (m, 2H), 2.69 
– 2.59 (m, 4H), 1.21 (t, J = 7.6 Hz, 3H), 1.01 (s, 9H), 0.26 (s, 6H); 13C NMR (100 MHz, CDCl3) 
δ 202.4, 153.7, 144.0, 130.1, 128.1, 120.8, 118.2, 44.3, 28.7, 26.0, 23.5, 18.4, 15.7, -3.9. 
General procedure for compound 249 a-t: 
A solution of aldehydes 256a-e (1.00 mmol), nitro alkene 257 a-o (1.00 mmol), p-nitrophenol 
(0.20 mmol), and catalyst (0.10-0.20 mmol) in dry toluene (4 mL) was stirred for 2-8h. After all 
starting materials consumed, methanol (1 mL) was added and the solution was cooled to 0 °C. 
Sodium borohydride (2.00 mmol) was added in portions and stirred at 0 °C for 15 minutes before 
it quenched with saturated solution of ammonium chloride (2 mL), the reaction mixture was diluted 
with ethyl acetate (25 mL). The organic layer was saperated and washed with water (10 mL) and 
brine (10 mL), dried over sodium sulfate and consetrated under reduced pressure. The crude 
product was dissolved in dry THF (2mL) then TBAF (1 mL, 1M solution in THF) was added at 
room temperature with stirring. The reaction was stirred for 30 minutes before it quenched with 
water (10 mL). Extracted with ethyl acetate (2x20 mL), the combined organic layers washed with 
water (10 mL) and brine (10 mL), dried over sodium sulfate and the solvent was evaporated under 




2-((2R,3R)-2-(hydroxymethyl)-4-nitro-3-phenylbutyl) phenol (Compound 2.49a): 
 
White solid, MP. 133-135°C, (Yield 81%), (dr 20:1); IR: 3437, 3072, 1547, 1456, 1373, 1349, 
1240, 1114, 1019; 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.23 (m, 6H), 7.07 (td, J = 7.6, 1.8 Hz, 
1H), 6.88 (dd, J = 7.5, 1.8 Hz, 1H), 6.86 – 6.73 (m, 2H), 4.89 (dd, J = 12.6, 5.4 Hz, 1H), 4.79 (dd, 
J = 12.6, 9.8 Hz, 1H), 3.75 (ddd, J = 9.8, 8.2, 5.4 Hz, 1H), 3.62 (dd, J = 11.8, 3.0 Hz, 1H), 3.50 
(dd, J = 11.8, 3.6 Hz, 1H), 2.66 (dd, J = 13.9, 10.8 Hz, 1H), 2.47 (dd, J = 13.9, 4.2 Hz, 1H), 2.12 
– 2.02 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 154.4, 138.7, 131.3, 129.3, 128.3, 128.2, 128.1, 
125.8, 121.3, 116.1, 78.6, 60.7, 46.1, 45.4, 29.2; HRMS (ESI-TOF) m/z: [M+H]+  Calc’d for 
C17H20NO4
 +  302.1387; Found 302.1372. 
 
2-((2R,3S)-2-(hydroxymethyl)-4-nitro-3-(p-tolyl)butyl) phenol (Compound 2.49b): 
 
Semisolid, (Yield 76%), (dr 11:1) ; IR; 3292, 2924, 2361, 2335, 1547, 1453, 1373, 1232, 
1110,1023; 1H NMR (400 MHz, CDCl3) δ 7.15 (s, 4H), 7.07 (ddd, J = 8.0, 7.2, 1.8 Hz, 1H), 6.89 
(dd, J = 7.6, 1.8 Hz, 1H), 6.84 – 6.75 (m, 2H), 6.61 (s, 1H), 4.87 (dd, J = 12.4, 5.6 Hz, 1H), 4.76 
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(dd, J = 12.4, 9.8 Hz, 1H), 3.70 (ddd, J = 9.6, 8.2, 5.5 Hz, 1H), 3.62 (dd, J = 11.7, 3.1 Hz, 1H), 
3.50 (dd, J = 11.7, 3.7 Hz, 1H), 2.65 (dd, J = 13.9, 10.9 Hz, 1H), 2.48 (dd, J = 13.8, 4.2 Hz, 1H), 
2.33 (s, 3H), 2.05 (td, J = 7.2, 3.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 154.5, 137.8, 135.6, 
131.3, 130.0, 128.2, 128.1, 125.8, 121.3, 116.2, 78.8, 60.8, 45.8, 45.4, 29.1, 21.3; HRMS (ESI-
TOF) m/z: [M+H]+  Calc’d for C18H22NO4 
+  316.1543; Found 316.1539. 
2-((2R,3R)-2-(hydroxymethyl)-4-nitro-3-(o-tolyl)butyl) phenol (Compound 2.49c): 
 
White solid, MP. 204-206°C, (86%), (dr 8:1); IR: 3159, 2981, 2357, 1593, 1547, 1453, 1371, 1251, 
1198, 1118, 1019; 1H NMR (400 MHz, COD6) δ 8.40 (s, 1H), 7.46 (dd, J = 7.2, 1.0 Hz, 1H), 7.20 
(td, J = 7.4, 1.8 Hz, 1H), 7.19 – 7.07 (m, 2H), 7.08 – 6.99 (m, 2H), 6.84 (dd, J = 8.4, 1.2 Hz, 1H), 
6.76 (td, J = 7.4, 1.2 Hz, 1H), 5.21 (dd, J = 13.4, 4.6 Hz, 1H), 5.12 (dd, J = 13.4, 11.2 Hz, 1H), 
4.15 – 4.04 (m, 2H), 3.69 – 3.62 (m, 1H), 3.54 – 3.46 (m, 1H), 2.92 (d, J = 12.2 Hz, 2H), 2.73 (dd, 
J = 13.4, 9.4 Hz, 1H), 2.62 (dd, J = 14.0, 4.8 Hz, 1H), 2.27 (s, 3H); 13C NMR (100 MHz, Acetone-
d6) δ 156.3, 139.4, 138.0, 132.0, 131.5, 128.2, 127.6, 127.6, 127.0, 120.5, 116.1, 78.7, 60.9, 45.9, 
41.2, 19.7; HRMS (ESI-TOF) m/z: [M+H]+  Calc’d for C18H22NO4 






2-((2R,3S)-2-(hydroxymethyl)-5-methyl-3-(nitromethyl)hexyl) phenol (Compound 2.49e): 
 
colorless oil, (77%), (dr 6:1):IR, 3289, 2958, 2932, 2357, 2339, 1547, 1460, 1380, 1240,1016; 1H 
NMR (400 MHz,CDCl3) δ 7.09 (dtd, J = 7.4, 4.0, 1.6 Hz, 2H), 6.87 (td, J = 7.4, 1.2 Hz, 1H), 6.78 
(dd, J = 8.4, 1.2 Hz, 1H), 4.64 (dd, J = 12.6, 5.6 Hz, 1H), 4.38 (dd, J = 12.6, 7.8 Hz, 1H), 3.63 (dd, 
J = 11.2, 3.6 Hz, 1H), 3.51 (dd, J = 11.2, 4.2 Hz, 1H), 2.85 (dd, J = 13.6, 10.2 Hz, 1H), 2.58 (dd, 
J = 13.6, 4.8 Hz, 2H), 1.86 (dt, J = 9.8, 4.0 Hz, 1H), 1.57 (dt, J = 13.2, 6.6 Hz, 1H), 1.44 (dt, J = 
14.0, 7.0 Hz, 1H), 1.21 (dt, J = 14.0, 7.2 Hz, 1H), 0.89 (d, J = 6.5 Hz, 3H), 0.86 (d, J = 6.6 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 154.2, 131.4, 128.2, 126.3, 121.4, 116.1, 78.5, 61.1, 42.9, 
39.1, 38.3, 29.0, 25.5, 22.8, 22.5; HRMS (ESI-TOF) m/z: [M+H]+ Calc’d for C15H24NO4 
+  
282.1700; Found 282.1703. 
 
2-((2R,3S)-2-(hydroxymethyl)-3-(nitromethyl)hexyl)phenol (Compound 2.49f): 
 
colorless oil, (69%), (dr 4:1):IR:3295, 2954, 2930, 2339, 1541, 1462, 1380, 1242, 1016; 1H NMR 
(400 MHz, CDCl3) δ 7.32 (s, 1H), 7.11 – 7.05 (m, 2H), 6.86 (td, J = 7.4, 1.2 Hz, 1H), 6.77 (dd, J 
= 8.4, 1.2 Hz, 1H), 4.62 (dd, J = 12.6, 5.6 Hz, 1H), 4.40 (dd, J = 12.6, 8.0 Hz, 1H), 3.60 (d, J = 
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10.8 Hz, 1H), 3.49 (dd, J = 11.4, 4.2 Hz, 1H), 3.31 (s, 1H), 2.84 (dd, J = 13.6, 10.4 Hz, 1H), 2.58 
(dd, J = 13.6, 4.6 Hz, 1H), 2.54 – 2.45 (m, 1H), 1.86 (dt, J = 10.4, 4.2 Hz, 1H), 1.59 – 1.49 (m, 
1H), 1.42 – 1.27 (m, 3H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 154.2, 131.3, 
128.1, 126.3, 121.3, 116.0, 78.3, 61.0, 42.7, 40.1, 31.9, 28.8, 20.3, 14.2; HRMS (ESI-TOF) m/z: 
[M+H]+  Calc’d for C14H22NO4 
+  268.1543; Found 268.1535. 
2-((2R,3R)-3-(4-methoxyphenyl)-2-(hydroxymethyl)-4-nitrobutyl)phenol (Compound 2.49f): 
 
Pale-yellow oil (79%), (dr. 12:1); 1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 8.1 Hz, 2H), 7.51 (d, 
J = 8.1 Hz, 2H), 7.10 (ddd, J = 9.8, 5.9, 1.7 Hz, 1H), 6.54 (ddd, J = 9.6, 1.7, 0.9 Hz, 1H), 6.36 
(ddd, J = 9.6, 5.9, 0.9 Hz, 1H), 6.28 – 6.23 (m, 1H), 5.99 (d, J = 10.9 Hz, 1H), 4.40 (t, J = 10.3 
Hz, 1H), 3.44 (dd, J = 11.4, 4.6 Hz, 1H), 3.34 (dd, J = 11.5, 5.2 Hz, 1H), 2.81 (dddd, J = 9.9, 8.2, 
6.6, 4.9 Hz, 1H), 2.33 (dd, J = 13.9, 8.3 Hz, 1H), 2.21 (dd, J = 13.9, 6.7 Hz, 1H), 2.08 (d, J = 4.9 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 158.1, 153.4, 130.3, 129.5, 128.3, 127.1, 124.9, 120.2, 







2-((2R,3R)-3-(4-chlorophenyl)-2-(hydroxymethyl)-4-nitrobutyl)phenol (Compound 2.49g): 
 
White solid, MP. 112-114°C, (72 %), (dr 8:1); IR; 3269,3155, 2946, 2361, 1593, 1547, 1376, 1269, 
1236, 1087; 1H NMR (400 MHz, CDCl3) δ 7.34 – 7.29 (m, 2H), 7.22 – 7.17 (m, 2H), 7.07 (ddd, J 
= 8.0, 7.0, 1.8 Hz, 1H), 6.88 (dd, J = 7.6, 1.8 Hz, 1H), 6.82 (td, J = 7.2, 1.0 Hz, 1H), 6.75 (dd, J = 
8.0, 1.2 Hz, 1H), 4.87 (dd, J = 12.8, 5.2 Hz, 1H), 4.75 (dd, J = 12.8, 10.2 Hz, 1H), 3.73 (ddd, J = 
10.1, 8.2, 5.2 Hz, 1H), 3.57 (dd, J = 11.8, 3.2 Hz, 1H), 3.47 (dd, J = 11.8, 3.8 Hz, 1H), 2.62 (dd, J 
= 13.8, 10.8 Hz, 1H), 2.43 (dd, J = 13.8, 4.3 Hz, 1H), 2.02 (ddd, J = 11.4, 7.8, 4.0 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 154.2, 137.2, 133.8, 131.3, 129.6, 129.4, 128.3, 125.6, 121.4, 115.9, 
78.4, 60.5, 45.3, 45.2, 29.3; HRMS (ESI-TOF) m/z: [2M+H]+ Calc’d for C34H37Cl2N2O8 
+  









2-((2R,3S)-3-(4-fluorophenyl)-2-(hydroxymethyl)-4-nitrobutyl) phenol (Compound 2.49h): 
 
pale yellow oil, (Yield 78%), (dr 8:1); IR: 3369, 3159, 3095, 2985, 2920, 1547, 1456, 1376, 1251, 
1220, 1159, 1114, 1019; 1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 5.2 Hz, 2H), 7.23 (d, J = 5.2 
Hz, 2H), 7.12 – 7.00 (m, 3H), 6.87 (dd, J = 7.6, 1.8 Hz, 1H), 6.82 (td, J = 7.4, 1.2 Hz, 2H), 6.76 
(dd, J = 8.0, 1.1 Hz, 1H), 4.88 (dd, J = 12.6, 5.2 Hz, 1H), 4.76 (dd, J = 12.7, 10.1 Hz, 1H), 3.74 
(ddd, J = 10.0, 8.4, 5.2 Hz, 1H), 3.61 (dd, J = 11.6, 3.0 Hz, 1H), 3.49 (dd, J = 11.6, 3.8 Hz, 1H), 
2.63 (dd, J = 13.8, 10.8 Hz, 1H), 2.45 (dd, J = 13.8, 4.2 Hz, 1H), 2.04 (ddd, J = 11.0, 7.6, 3.8 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δ 163.6, 161.2, 154.3, 134.5, 134.5, 131.3, 129.9, 129.8, 128.3, 
125.6, 121.4, 116.3, 116.1, 116.1, 78.7, 60.6, 45.4, 29.3; HRMS (ESI-TOF) m/z: [M+H]+  Calc’d 
for C17H19FNO4 









2-((2R,3R)-3-(4-bromophenyl)-2-(hydroxymethyl)-4-nitrobutyl) phenol (Compound 2.49i): 
 
colorless oil, (73%), (dr 8:1); IR , 3372, 3144, 2973, 2357, 2339, 1544, 1380, 1247, 1110, 1012; 
1H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 8.4 Hz, 2H), 7.15 (d, J = 8.4 Hz, 2H), 7.08 (ddd, J = 
8.0, 7.2, 1.8 Hz, 1H), 6.88 (dd, J = 7.6, 1.8 Hz, 1H), 6.82 (td, J = 7.2, 1.0 Hz, 1H), 6.76 (dd, J = 
8.0, 1.2 Hz, 1H), 4.89 (dd, J = 12.6, 5.2 Hz, 1H), 4.78 (dd, J = 12.8, 10.2 Hz, 1H), 3.77 – 3.69 (m, 
1H), 3.60 (dd, J = 11.6, 3.2 Hz, 1H), 3.49 (dd, J = 11.6, 3.8 Hz, 1H), 2.63 (dd, J = 13.8, 10.8 Hz, 
1H), 2.46 (dd, J = 13.8, 4.2 Hz, 1H), 2.09 – 1.99 (m, 1H), 1.62 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ 154.2, 137.8, 132.3, 131.3, 130.0, 128.3, 125.6, 121.9, 121.4, 116.0, 78.3, 60.5, 45.5, 
45.2, 29.3; HRMS (ESI-TOF) m/z: [M+H]+  Calc’d for C17H19BrNO4 










2-((2R,3R)-3-(4-nitrophenyl)-2-(hydroxymethyl)-4-nitrobutyl)phenol (Compound 2.49f): 
 
1H NMR (400 MHz, CDCl3) δ 8.20 (d, J = 8.7 Hz, 2H), 7.46 (d, J = 8.7 Hz, 2H), 7.07 (td, J = 7.6, 
1.9 Hz, 1H), 6.90 – 6.86 (m, 1H), 6.82 (td, J = 7.4, 1.2 Hz, 1H), 6.75 (dd, J = 8.1, 1.2 Hz, 1H), 
4.97 (dd, J = 13.1, 4.9 Hz, 1H), 4.87 (dd, J = 13.1, 10.4 Hz, 1H), 3.90 (ddd, J = 10.4, 8.0, 4.9 Hz, 
1H), 3.64 – 3.56 (m, 1H), 3.48 (dd, J = 11.8, 3.8 Hz, 1H), 2.64 (dd, J = 13.7, 10.9 Hz, 1H), 2.43 
(dd, J = 13.7, 4.4 Hz, 1H), 2.11 (ddt, J = 11.3, 7.9, 4.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
154.1, 147.6, 146.7, 131.3, 129.4, 128.4, 125.3, 124.3, 121.5, 115.9, 77.9, 60.3, 45.8, 45.1, 29.6. 
2-((2R,3R)-2-(hydroxymethyl)-4-nitro-3-(4-(trifluoromethyl)phenyl)butyl) phenol (Compound 
2.49j): 
 
Pale yellow solid MP. 93-95 °C; (76%),  (dr 9:1), IR; 3171, 2954, 2361, 1547, 1460, 1323, 1163, 
1114; 1H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 8.2 Hz, 2H), 7.38 (d, J = 8.2 Hz, 2H), 7.08 (ddd, 
J = 8.0, 7.0, 1.8 Hz, 1H), 7.01 (s, 1H), 6.88 (dd, J = 7.6, 1.8 Hz, 1H), 6.83 (td, J = 7.2, 1.2 Hz, 1H), 
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6.76 (dd, J = 8.0, 1.2 Hz, 1H), 4.93 (dd, J = 13.0, 5.0 Hz, 1H), 4.82 (dd, J = 13.0, 10.2 Hz, 1H), 
3.84 (ddd, J = 10.0, 8.0, 5.2 Hz, 1H), 3.58 (dd, J = 12.0, 3.0 Hz, 1H), 3.48 (dd, J = 11.8, 3.8 Hz, 
1H), 3.32 (s, 1H), 2.64 (dd, J = 13.8, 10.8 Hz, 1H), 2.43 (dd, J = 13.8, 4.4 Hz, 1H), 2.09 (td, J = 
7.5, 3.7 Hz, 1H; 13C NMR (100 MHz, CDCl3) δ 154.1, 142.9, 131.3, 128.7, 128.3, 126.1, 126.1, 
125.5, 125.5, 121.4, 115.9, 78.1, 60.4, 45.7, 45.1, 29.4; HRMS (ESI-TOF) m/z: [M+H]+  Calc’d 
for C18H19F3NO4 
+  370.1261; Found 370.1232. 
4-((2R,3R)-4-hydroxy-3-(2-hydroxybenzyl)-1-nitrobutan-2-yl) benzonitrile (Compound 2.49l): 
 
Colorless oil, (82%), (dr 11:1);IR : 3369, 2920, 2228, 1605, 1544, 1453, 1373, 1236, 1175, 1103; 
1H NMR (400 MHz, CDCl3) δ 7.67 – 7.63 (m, 2H), 7.43 – 7.38 (m, 2H), 7.08 (ddd, J = 8.0, 7.2, 
1.9 Hz, 1H), 6.88 (dd, J = 7.4, 1.8 Hz, 1H), 6.83 (td, J = 7.4, 1.2 Hz, 1H), 6.76 (dd, J = 8.0, 1.0 
Hz, 1H), 4.94 (dd, J = 13.0, 5.0 Hz, 1H), 4.85 (dd, J = 13.0, 10.4 Hz, 1H), 3.84 (ddd, J = 10.2, 8.0, 
5.0 Hz, 1H), 3.58 (dd, J = 11.8, 3.0 Hz, 1H), 3.48 (dd, J = 11.6, 3.8 Hz, 1H), 2.64 (dd, J = 13.6, 
10.8 Hz, 1H), 2.43 (dd, J = 13.2, 4.4 Hz, 1H), 2.09 (ddt, J = 11.2, 7.6, 3.8 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 154.1, 144.6, 132.9, 131.3, 129.3, 128.4, 125.3, 121.5, 118.6, 116.0, 111.9, 77.9, 
60.4, 46.1, 45.1, 29.6; HRMS (ESI-TOF) m/z: [2M+H]+  Calc’d for C36H37N4O8 
+  653.2606; 




2-((2R,3R)-2-(hydroxymethyl)-3-(naphthalen-1-yl)-4-nitrobutyl) phenol (Compound 2.49m) 
 
White solid MP.73-75°C, (66%); IR: 3251, 2920, 1544, 1453, 1373, 1236, 1163, 1012; . 1H NMR 
(400 MHz,CDCl3 ) δ 8.05 (d, J = 8.1 Hz, 1H), 7.89 – 7.83 (m, 1H), 7.77 (dd, J = 7.2, 2.0 Hz, 1H), 
7.56 – 7.41 (m, 4H), 7.07 (td, J = 7.6, 1.8 Hz, 1H), 6.98 – 6.88 (m, 1H), 6.82 (t, J = 7.2 Hz, 1H), 
6.76 (dd, J = 8.0, 1.2 Hz, 1H), 5.12 – 4.99 (m, 2H), 4.75 (s, 1H), 3.62 (d, J = 11.8 Hz, 1H), 3.47 
(dd, J = 11.8, 3.2 Hz, 1H), 3.11 (s, 1H), 2.86 (t, J = 12.0 Hz, 1H), 2.58 (d, J = 13.8 Hz, 1H), 2.20 
(s, 1H); 13C NMR (100 MHz, CDCl3) δ 154.3, 135.3, 134.4, 132.1, 131.3, 129.3, 128.4, 128.2, 
126.9, 126.1, 125.8, 125.4, 123.6, 122.8, 121.3, 116.0, 60.5, 46.0, 39.6, 29.5; HRMS (ESI-TOF) 
m/z: [M+H]+  Calc’d for C21H21NO4 




colorless oil, (63%), (dr 8:1), IR, 3376, 2942, 2361, 1590, 1547, 1453, 1240, 1228, 1126, 1000; 1H 
NMR (400 MHz, CDCl3) δ 7.10 (s, 1H), 7.04 (ddd, J = 7.8, 7.2, 1.8 Hz, 1H), 6.85 (dd, J = 7.4, 1.8 
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Hz, 1H), 6.77 (ddd, J = 11.8, 7.6, 1.2 Hz, 2H), 6.45 (s, 2H), 4.84 (dd, J = 12.6, 5.2 Hz, 1H), 4.74 
(dd, J = 12.6, 10.0 Hz, 1H), 3.81 (s, 3H), 3.80 (s, 5H), 3.68 – 3.60 (m, 1H), 3.59 – 3.45 (m, 1H), 
3.17 (s, 1H), 2.65 (dd, J = 13.8, 10.6 Hz, 1H), 2.47 (dd, J = 13.8, 4.2 Hz, 1H), 2.04 (q, J = 8.6, 6.3 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 154.5, 153.6, 137.4, 134.6, 131.2, 128.1, 125.9, 121.0, 
116.0, 105.4, 78.7, 61.1, 60.7, 56.4, 46.4, 45.3, 29.5; HRMS (ESI-TOF) m/z: [M+H]+  Calc’d for 
C20H26NO7 
+  392.1704; Found 392.1741. 
 
2-((2R,3S)-3-(furan-2-yl)-2-(hydroxymethyl)-4-nitrobutyl)phenol (Compound 2.49o): 
 
colorless oil,(70%), (dr 4:1), IR: 3212, 2924, 2357, 2339, 1711, 1551, 1453, 1380, 1236, 1190,              
1H NMR (400 MHz, CDCl3) δ 7.38 (dd, J = 1.8, 0.8 Hz, 1H), 7.09 (ddd, J = 8.0, 7.2, 1.6 Hz, 1H), 
7.01 (dd, J = 7.4, 1.8 Hz, 1H), 6.85 (td, J = 7.4, 1.2 Hz, 1H), 6.77 (dd, J = 8.0, 1.2 Hz, 1H), 6.32 
(dd, J = 3.2, 1.8 Hz, 1H), 6.22 (dt, J = 3.2, 0.8 Hz, 1H), 4.83 – 4.77 (m, 2H), 3.93 (dt, J = 8.2, 6.6 
Hz, 1H), 3.58 (dd, J = 11.7, 3.4 Hz, 1H), 3.49 (dd, J = 11.7, 4.4 Hz, 1H), 2.97 (s, 1H), 2.68 (dd, J 
= 13.8, 10.4 Hz, 1H), 2.54 (dd, J = 13.8, 4.4 Hz, 1H), 2.24 – 2.14 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 154.3, 152.0, 142.6, 131.4, 128.3, 125.7, 121.3, 116.1, 110.7, 108.5, 76.6, 61.3, 43.8, 
40.0, 28.9; HRMS (ESI-TOF) m/z: [M+H]+  Calc’d for C15H18NO5 






2-((2R,3R)-2-(hydroxymethyl)-4-nitro-3-phenylbutyl)-6-methylphenol (Compound 2.49p): 
 
White solid M.P 117-119°C, (72%); IR: 3342, 3067, 2960, 1547, 1453, 1373, 1221, 1180, 1113. 
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.25 (m, 5H), 6.99 – 6.95 (m, 1H), 6.72 (d, J = 4.8 Hz, 2H), 
4.87 (dd, J = 12.6, 5.4 Hz, 1H), 4.78 (dd, J = 12.6, 9.8 Hz, 1H), 4.30 (s, 1H), 3.78 – 3.69 (m, 1H), 
3.60 (dd, J = 11.5, 3.2 Hz, 1H), 3.49 (dd, J = 11.4, 3.7 Hz, 1H), 2.66 (dd, J = 14.0, 10.8 Hz, 1H), 
2.47 (dd, J = 13.8, 4.2 Hz, 1H), 2.22 (d, J = 0.8 Hz, 3H), 2.11 – 2.02 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 152.9, 138.7, 129.5, 129.2, 128.8, 128.2, 128.0, 125.3, 124.6, 120.6, 78.7, 60.5, 46.1, 
45.2, 29.4, 16.4; HRMS (ESI-TOF) m/z: [2M+H] + Calc’d for C36H43N2O8 
+ 631.3014; Found 
631.2972. 
 
2-((2R,3R)-2-(hydroxymethyl)-4-nitro-3-phenylbutyl)-5-methylphenol (Compound 2.49q): 
 
White solid, MP. 123-125°C (Yield 69%), IR: 3159, 2981, 2357, 1593, 1547, 1453, 1371, 1251, 
1198, 1118, 1019; 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.25 (m, 5H), 6.76 (d, J = 7.6 Hz, 1H), 
6.63 (ddd, J = 7.6, 1.6, 0.8 Hz, 1H), 6.61 – 6.58 (m, 1H), 4.88 (dd, J = 12.6, 5.4 Hz, 1H), 4.79 (dd, 
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J = 12.6, 9.8 Hz, 1H), 3.77 – 3.70 (m, 1H), 3.61 (dd, J = 11.6, 3.2 Hz, 1H), 3.50 (dd, J = 11.6, 3.8 
Hz, 1H), 2.84 (s, 1H), 2.62 (dd, J = 14.0, 10.8 Hz, 1H), 2.44 (dd, J = 13.8, 4.4 Hz, 1H), 2.23 (s, 
3H), 2.04 (dqd, J = 11.6, 7.2, 3.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 152.1, 138.8, 131.7, 
130.5, 129.2, 128.6, 128.3, 128.0, 125.5, 115.9, 78.7, 60.7, 46.2, 45.5, 29.3, 20.6; HRMS (ESI-
TOF) m/z: [M+H] + Calc’d for C18H22NO4 
+ 316.1543; Found 316.1539. 
2-((2R,3R)-2-(hydroxymethyl)-4-nitro-3-phenylbutyl)-4-methylphenol (Compound 2.49r): 
 
White solid MP.113-115°C, (Yield 76%); IR: 3155, 2969, 2916, 1547, 1453, 1376, 1220, 1110, 
1019; 1H NMR (400 MHz, CDCl3) δ 7.39 – 7.25 (m, 5H), 6.86 (ddd, J = 8.0, 2.4, 0.8 Hz, 1H), 6.69 
– 6.63 (m, 2H), 4.89 (dd, J = 12.6, 5.4 Hz, 1H), 4.80 (dd, J = 12.6, 9.8 Hz, 1H), 3.73 (ddd, J = 9.8, 
8.2, 5.4 Hz, 1H), 3.61 (dd, J = 11.6, 3.1 Hz, 1H), 3.50 (dd, J = 11.6, 3.6 Hz, 1H), 2.64 (dd, J = 
13.8, 10.8 Hz, 1H), 2.41 (dd, J = 13.8, 4.3 Hz, 1H), 2.18 (s, 3H), 2.10 – 1.99 (m, 1H); 13C NMR 
(100 MHz, CDCl3) δ 154.2, 138.8, 138.2, 131.1, 129.2, 128.3, 128.0, 122.5, 122.1, 116.8, 78.6, 
60.7, 46.1, 45.5, 28.9, 21.2; HRMS (ESI-TOF) m/z: [M+H]+  Calc’d for C18H22NO4 








5-bromo-2-((2R,3R)-2-(hydroxymethyl)-4-nitro-3-phenylbutyl) phenol (Compound 2.49s): 
 
Colorless oil, (yield 60%), (dr 9:1); IR, 3220, 2924, 2361,2335, 1551, 1498, 1411, 1376, 1251, 
1110; 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.32 (m, 2H), 7.32 – 7.24 (m, 3H), 7.23 (d, J = 1.2 Hz, 
1H), 6.95 (d, J = 2.0 Hz, 1H), 6.92 (dd, J = 8.0, 1.8 Hz, 1H), 6.69 (d, J = 8.0 Hz, 1H), 4.86 (dd, J 
= 12.6, 5.6 Hz, 1H), 4.76 (dd, J = 12.6, 9.4 Hz, 1H), 3.71 (td, J = 9.0, 5.6 Hz, 1H), 3.62 (dd, J = 
11.6, 3.2 Hz, 1H), 3.49 (dd, J = 11.6, 3.8 Hz, 1H), 2.58 (dd, J = 14.0, 10.6 Hz, 1H), 2.42 (dd, J = 
14.0, 4.2 Hz, 1H), 2.09 – 2.00 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 155.5, 138.5, 132.4, 129.4, 
128.3, 128.2, 128.2, 124.9, 124.2, 120.8, 119.5, 78.6, 60.8, 46.0, 45.0, 28.9; HRMS (ESI-TOF) 
m/z: [2M+H]+  Calc’d for C34H37Br2N2O8 
+  759.0911, Found 759.0917. 
3-ethyl-2-((2R,3S)-2-(hydroxymethyl)-4-nitro-3-phenylbutyl) phenol (Compound 2.49t): 
 
White solid, MP. 132-134°C, (Yield 76%), (dr 9:1); IR: 3414, 3061, 2965, 1582, 1547, 1460, 1373, 
1331, 1267, 1167; 1H NMR (400 MHz, CDCl3) δ 7.39 – 7.26 (m, 5H), 7.01 (t, J = 7.8 Hz, 1H), 
6.72 (dd, J = 7.6, 1.2 Hz, 1H), 6.63 (dd, J = 8.0, 1.2 Hz, 1H), 4.94 (dd, J = 12.6, 5.0 Hz, 1H), 4.82 
(dd, J = 12.4, 10.2 Hz, 1H), 3.75 (td, J = 9.6, 5.0 Hz, 1H), 3.63 (d, J = 12.0 Hz, 1H), 3.49 (dd, J = 
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12.2, 2.6 Hz, 1H), 3.09 (s, 1H), 2.76 (dd, J = 14.2, 12.0 Hz, 1H), 2.42 – 2.35 (m, 1H), 2.26 (qd, J 
= 7.4, 4.2 Hz, 2H), 2.00 – 1.91 (m, 1H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
154.6, 144.8, 139.1, 129.2, 128.2, 128.1, 127.7, 123.5, 121.7, 113.4, 78.6, 60.0, 46.4, 44.5, 25.4, 
15.5; HRMS (ESI-TOF) m/z: [2M+H]+  Calc’d for C38H47N2O8 
+ 659.3327 ; Found 659.3362. 
Spiro compounds 2.50a-t 
To a solution of the compounds 2.49a-t  (0.3 mmol) in acetonitrile (2 mL), a (0.6 mmol) of 
potassium ferricyanide and (0.6 mmol) of 0.1 N solution of potassium hydroxide were added, the 
reaction was stirred until the all the SM was consumed, then quenched with 1M citric acid solution 
and extracted with dichloromethane (3x10 mL), the organic layers combine and washed with water 




   
White crystal, MP: 133-134 °C,  yield 81% ;IR: 3437, 2928, 2339, 1723, 1658, 1623, 1547, 1369, 
1114, 1087; 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.33 (m, 4H), 7.30 – 7.25 (m, 1H), 7.07 (ddd, J 
= 9.8, 5.8, 1.8 Hz, 1H), 6.57 (ddd, J = 9.6, 1.8, 1.0 Hz, 1H), 6.35 (ddd, J = 9.6, 5.8, 1.0 Hz, 1H), 
6.23 (dt, J = 9.8, 1.0 Hz, 1H), 5.94 (d, J = 10.6 Hz, 1H), 4.36 (t, J = 10.4 Hz, 1H), 3.41 (dd, J = 
11.4, 5.4 Hz, 1H), 3.33 (dd, J = 11.4, 5.6 Hz, 1H), 2.87 – 2.77 (m, 1H), 2.26 (dd, J = 13.8, 8.0 Hz, 
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1H), 2.16 (dd, J = 13.8, 7.7 Hz, 1H), 2.03 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 201.8, 141.9, 
139.7, 136.5, 129.2, 128.5, 127.9, 126.6, 123.3, 96.6, 63.8, 59.1, 48.6, 43.0, 42.6; HRMS (ESI-
TOF) m/z: [M+H]+  Calc’d for C17H18NO4 





 White solid MP: 98-99°C, (yield 74%) :IR:3437, 2938, 2365, 1657, 1551, 1506, 1460, 1369, 1122; 
1H NMR (400 MHz, CDCl3) δ 7.23 (d, J = 7.0 Hz, 2H), 7.16 – 7.13 (m, 2H), 7.06 (ddd, J = 9.8, 
5.8, 1.7 Hz, 1H), 6.56 (ddd, J = 9.6, 1.8, 0.9 Hz, 1H), 6.33 (ddd, J = 9.6, 5.8, 0.9 Hz, 1H), 6.22 (dt, 
J = 9.8, 1.0 Hz, 1H), 5.89 (d, J = 10.6 Hz, 1H), 4.31 (t, J = 10.4 Hz, 1H), 3.40 (dd, J = 11.4, 5.6 
Hz, 1H), 3.32 (dd, J = 11.4, 5.8 Hz, 1H), 2.84 – 2.74 (m, 1H), 2.30 (s, 3H), 2.22 (dd, J = 13.6, 8.0 
Hz, 1H), 2.13 (dd, J = 13.6, 7.8 Hz, 1H), 2.02 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 201.7, 141.8, 
139.7, 137.6, 133.4, 129.8, 128.3, 126.6, 123.2, 96.6, 63.8, 59.1, 48.1, 42.8, 42.6, 21.2  HRMS 
(ESI-TOF) m/z: [M+H]+  Calc’d for C18H20NO4 














White solid MP. 132-133, (yield 65 %); IR: 3357, 2962, 2935, 2365, 1723, 1666, 1544, 1646, 
1369, 1156, 1122; 1H NMR (400 MHz, CDCl3) δ 7.39 – 7.34 (m, 1H), 7.23 – 7.14 (m, 3H), 7.08 
(ddd, J = 9.8, 5.8, 1.6 Hz, 1H), 6.62 (ddd, J = 9.6, 1.8, 0.9 Hz, 1H), 6.36 (ddd, J = 9.6, 5.8, 1.0 Hz, 
1H), 6.25 (dt, J = 9.8, 1.0 Hz, 1H), 5.99 (d, J = 11.1 Hz, 1H), 4.57 (t, J = 10.6 Hz, 1H), 3.36 (dd, 
J = 11.4, 5.8 Hz, 1H), 3.27 (dd, J = 11.4, 5.6 Hz, 1H), 2.94 – 2.83 (m, 1H), 2.44 (s, 3H), 2.26 (dd, 
J = 13.6, 8.2 Hz, 1H), 2.16 (dd, J = 13.6, 7.8 Hz, 1H), 1.74 (s, 1H); 13C NMR (100 MHz, CDCl3) 
δ 201.5, 141.7, 139.5, 137.0, 134.7, 131.1, 127.8, 126.8, 126.7, 126.5, 123.4, 96.3, 64.0, 59.0, 43.9, 
42.5, 40.7, 20.1; HRMS (ESI-TOF) m/z: [M+H] + Calc’d. for C18H20NO4 













Colorless oil, (yield 71%);IR: 3425, 2954, 2920, 2357, 1658, 1627, 1540, 1365, 1220, 1137; 1H 
NMR (400 MHz, CDCl3) δ 7.03 (ddd, J = 9.8, 5.8, 1.6 Hz, 1H), 6.38 (ddd, J = 9.6, 1.8, 1.0 Hz, 
1H), 6.24 (ddd, J = 9.6, 5.8, 1.0 Hz, 1H), 6.14 (dt, J = 9.8, 1.0 Hz, 1H), 5.23 (d, J = 10.6 Hz, 1H), 
3.75 (dd, J = 4.8, 1.8 Hz, 2H), 3.01 (dtd, J = 10.6, 8.8, 5.6 Hz, 1H), 2.54 (td, J = 8.6, 4.4 Hz, 1H), 
2.18 (dd, J = 14.0, 8.4 Hz, 1H), 2.01 (dd, J = 14.0, 5.2 Hz, 1H), 1.68 – 1.56 (m, 1H), 1.53 – 1.42 
(m, 2H), 1.40 – 1.27 (m, 3H), 0.93 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 203.6, 142.2, 
141.0, 126.2, 122.3, 98.3, 63.6, 59.0, 43.8, 42.0, 40.6, 29.9, 21.3; HRMS (ESI-TOF) m/z: [M+H] 
+ Calc’d for C14H20NO4 




Colorless oil, (Yield 76 %)  : IR: 3406, 2954, 2361, 1730, 1654, 1544, 1365, 1232, 1145; 1H NMR 
(400 MHz, CDCl3) δ 7.04 (ddd, J = 9.8, 5.8, 1.6 Hz, 1H), 6.39 (ddd, J = 9.6, 1.8, 1.0 Hz, 1H), 6.25 
(ddd, J = 9.6, 5.8, 1.0 Hz, 1H), 6.15 (dt, J = 9.8, 1.0 Hz, 1H), 5.24 (d, J = 10.6 Hz, 1H), 3.76 (d, J 
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= 4.6 Hz, 2H), 3.09 (dtd, J = 10.8, 8.8, 5.2 Hz, 1H), 2.53 (tt, J = 8.6, 4.6 Hz, 1H), 2.21 (dd, J = 
14.0, 8.6 Hz, 1H), 2.03 (dd, J = 14.0, 4.6 Hz, 1H), 1.66 – 1.56 (m, 2H), 1.30 – 1.22 (m, 1H), 0.95 
(d, J = 6.4 Hz, 3H), 0.92 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 203.7, 142.3, 141.1, 
126.2, 122.2, 98.5, 63.7, 58.8, 41.9, 40.5, 36.5, 26.4, 23.5, 22.2; HRMS (ESI-TOF) m/z: [M+H] + 
Calc’d for C15H22NO4 




 As a yellow solid, MP.188-189°C, (yield 65%); IR:3410, 2920, 2848, 1658, 1540, 1365, 1228, 
1141, 1019; 1H NMR (400 MHz, CDCl3) δ 7.29 (d, J = 8.4 Hz, 2H), 7.08 (ddd, J = 9.8, 5.8, 1.7 
Hz, 1H), 6.89 (d, J = 8.6 Hz, 2H), 6.56 (ddd, J = 9.6, 1.8, 1.0 Hz, 1H), 6.35 (ddd, J = 9.4, 5.8, 1.0 
Hz, 1H), 6.24 (d, J = 9.8 Hz, 1H), 5.87 (d, J = 10.6 Hz, 1H), 4.31 (t, J = 10.4 Hz, 1H), 3.78 (s, 3H), 
3.46 (dd, J = 11.4, 5.4 Hz, 1H), 3.37 (dd, J = 11.6, 5.4 Hz, 1H), 2.83 – 2.73 (m, 1H), 2.25 (dd, J = 
13.6, 8.0 Hz, 1H), 2.14 (dd, J = 13.6, 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 201.9, 159.3, 
141.9, 139.8, 129.6, 128.3, 126.7, 123.3, 114.6, 97.0, 64.0, 59.0, 55.5, 48.0, 43.0, 42.5; HRMS 
(ESI-TOF) m/z: [M+H]+ Calc’d for C18H20NO5 









As a yellow solid, MP. 112-113, (yield 71%); IR: 3414, 2932, 2357, 1658, 1627, 1540, 1490, 1365, 
1228, 1087; 1H NMR (400 MHz, CDCl3) δ 7.30 (s, 4H), 7.08 (ddd, J = 9.8, 5.8, 1.7 Hz, 1H), 6.52 
(ddd, J = 9.6, 1.8, 1.0 Hz, 1H), 6.34 (ddd, J = 9.6, 5.8, 1.0 Hz, 1H), 6.22 (dt, J = 9.8, 1.0 Hz, 1H), 
5.89 (d, J = 10.8 Hz, 1H), 4.36 – 4.25 (m, 1H), 3.40 (dd, J = 11.4, 4.8 Hz, 1H), 3.31 (dd, J = 11.4, 
5.6 Hz, 1H), 2.75 (dtd, J = 10.0, 7.8, 3.6 Hz, 1H), 2.27 (dd, J = 13.8, 8.2 Hz, 1H), 2.15 (dd, J = 
13.8, 7.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 202.1, 142.1, 139.6, 135.0, 133.7, 129.9, 129.2, 
126.5, 123.3, 96.5, 63.6, 58.8, 48.3, 42.8, 42.3; HRMS (ESI-TOF) m/z: [M+H] + Calc’d for 
C17H17ClNO4 





As a colorless oil (yield 68%); IR: 3392, 2965, 2339, 1658, 1627, 1365, 1232, 1108; 1H NMR (400 
MHz, CDCl3) δ 7.63 – 7.58 (m, 2H), 7.53 – 7.48 (m, 2H), 7.10 (ddd, J = 9.8, 5.8, 1.6 Hz, 1H), 6.54 
115 
 
(ddd, J = 9.6, 1.8, 1.0 Hz, 1H), 6.36 (ddd, J = 9.6, 6.0, 1.0 Hz, 1H), 6.25 (dt, J = 9.8, 0.8 Hz, 1H), 
5.99 (d, J = 10.8 Hz, 1H), 4.40 (t, J = 10.2 Hz, 1H), 3.43 (dd, J = 11.4, 4.6 Hz, 1H), 3.33 (dd, J = 
11.4, 5.2 Hz, 1H), 2.80 (dddt, J = 9.8, 8.2, 6.6, 4.9 Hz, 1H), 2.44 (s, 1H), 2.33 (dd, J = 13.9, 8.3 
Hz, 1H), 2.20 (dd, J = 13.9, 6.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 202.1, 142.1, 139.7, 
130.2, 130.1, 126.5, 123.2, 116.1, 115.9, 96.7, 63.7, 58.8, 48.2, 42.8, 42.4; HRMS (ESI-TOF) m/z: 
[M+H] + Calcd for C17H17FNO4 





As a white solid, MP. 199-200 °C, (yield 61%); IR: 3412, 2357, 2345, 1661, 1604, 1543, 1443, 
1364, 1182, 1103; 1H NMR (400 MHz, CDCl3) δ 7.47 (d, J = 8.4 Hz, 2H), 7.25 (d, J = 9.8 Hz, 2H), 
7.08 (ddd, J = 9.8, 5.8, 1.6 Hz, 1H), 6.52 (ddd, J = 9.6, 1.8, 1.0 Hz, 1H), 6.34 (ddd, J = 9.6, 5.8, 
1.0 Hz, 1H), 6.23 (d, J = 9.8 Hz, 1H), 5.89 (d, J = 10.8 Hz, 1H), 4.29 (t, J = 10.2 Hz, 1H), 3.43 (dd, 
J = 11.4, 4.8 Hz, 1H), 3.34 (dd, J = 11.4, 5.2 Hz, 1H), 2.82 – 2.72 (m, 1H), 2.28 (dd, J = 13.8, 8.2 
Hz, 1H), 2.16 (dd, J = 13.8, 7.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 202.1, 142.0, 139.6, 
135.5, 132.2, 130.3, 126.6, 123.4, 121.9, 96.5, 63.7, 58.8, 48.5, 42.9, 42.4;  HRMS (ESI-TOF) 
m/z: [M+H]+ Calc’d for C17H17BrNO4 






6-one (Compound 2.50j): 
 
As a colorless oil (yield 73%);IR: 3418, 2941, 2365, 1655, 1621, 1540, 1365, 1223, 1141; 1H NMR 
(400 MHz, CDCl3) δ 7.63 – 7.58 (m, 2H), 7.53 – 7.48 (m, 2H), 7.10 (ddd, J = 9.8, 5.8, 1.6 Hz, 
1H), 6.54 (ddd, J = 9.6, 1.6, 1.0 Hz, 1H), 6.36 (ddd, J = 9.6, 6.0, 1.0 Hz, 1H), 6.25 (dt, J = 9.8, 1.0 
Hz, 1H), 5.99 (d, J = 10.8 Hz, 1H), 4.40 (t, J = 10.2 Hz, 1H), 3.43 (dd, J = 11.4, 4.6 Hz, 1H), 3.33 
(dd, J = 11.4, 5.2 Hz, 1H), 2.80 (dddt, J = 9.8, 8.2, 6.8, 4.8 Hz, 1H), 2.44 (s, 1H), 2.33 (dd, J = 
13.8, 8.4 Hz, 1H), 2.20 (dd, J = 13.8, 6.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 202.2, 142.1, 
140.7, 139.6, 129.0, 126.6, 126.0, 126.0, 125.9, 123.4, 96.3, 63.6, 58.7, 48.9, 43.0, 42.3; HRMS 
(ESI-TOF) m/z: [M+H]+ Calc’d for C18H17F3NO4 





As a white solid, MP. 172-174°C, (yield 69%); IR: 3422, 2958, 2924, 2339, 1726, 1658, 1544, 
1365, 1232, 1175; 1H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 8.5 Hz, 2H), 7.52 (d, J = 8.0 Hz, 
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2H), 7.11 (ddd, J = 9.8, 5.8, 1.6 Hz, 1H), 6.51 (ddd, J = 9.6, 1.6, 1.0 Hz, 1H), 6.37 (ddd, J = 9.6, 
5.8, 1.0 Hz, 1H), 6.26 (dt, J = 9.8, 0.8 Hz, 1H), 5.99 (d, J = 11.0 Hz, 1H), 4.37 (dd, J = 10.8, 9.8 
Hz, 1H), 3.45 (dd, J = 11.5, 4.4 Hz, 1H), 3.37 – 3.28 (m, 1H), 2.84 – 2.74 (m, 1H), 2.54 (s, 1H), 
2.35 (dd, J = 14.0, 8.4 Hz, 1H), 2.20 (dd, J = 14.0, 6.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
202.3, 142.2, 142.1, 139.5, 132.8, 129.5, 126.6, 123.5, 118.6, 111.9, 96.1, 63.6, 58.5, 49.3, 43.1, 
42.2; HRMS (ESI-TOF) m/z: [M+H] + Calcd for C18H17N2O4 
+ 325.1183; Found 325.1160. 
(1S,2S,3R,5R)-3-(hydroxymethyl)-1-nitro-2-(3,4,5-trimethoxyphenyl)spiro[4.5]deca-7,9-dien-6-
one (Compound 2.50m): 
 
As light-yellow semisolid; (Yield 71%); IR: 3475, 2938, 2357, 1658, 1590, 1506, 1460, 1365, 
1232, 1122; 1H NMR (400 MHz, CDCl3) δ 7.08 (ddd, J = 9.8, 5.8, 1.6 Hz, 1H), 6.60 (s, 2H), 6.54 
(ddd, J = 9.6, 1.6, 1.0 Hz, 1H), 6.34 (ddd, J = 9.6, 5.8, 1.0 Hz, 1H), 6.22 (dt, J = 9.8, 1.0 Hz, 1H), 
5.88 (d, J = 10.2 Hz, 1H), 4.27 (t, J = 10.0 Hz, 1H), 3.85 (s, 6H), 3.80 (s, 3H), 3.48 (dd, J = 11.4, 
5.2 Hz, 1H), 3.39 (dd, J = 11.6, 5.4 Hz, 1H), 2.78 (dddd, J = 9.8, 7.8, 4.8, 2.4 Hz, 1H), 2.25 (dd, J 
= 13.6, 8.0 Hz, 1H), 2.17 (dd, J = 13.6, 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 202.2, 153.7, 
142.0, 139.8, 137.6, 132.2, 126.5, 123.2, 105.6, 97.0, 63.8, 61.0, 58.9, 56.4, 49.3, 43.3, 42.5; 
HRMS (ESI-TOF) m/z: [M+H] + Calcd for C20H24NO4 







White solid MP. °C. (Yield 65 %); IR: 3414, 2920, 2365, 1659, 1623, 1540, 1365, 1233, 1141; 1H 
NMR (400 MHz, CDCl3) δ 8.10 (d, J = 8.6 Hz, 1H), 7.88 (dd, J = 8.0, 1.6 Hz, 1H), 7.79 (d, J = 
8.2 Hz, 1H), 7.60 – 7.56 (m, 1H), 7.54 – 7.50 (m, 2H), 7.47 – 7.42 (m, 1H), 7.10 (ddd, J = 9.8, 5.8, 
1.6 Hz, 1H), 6.73 (ddd, J = 9.6, 1.6, 1.0 Hz, 1H), 6.38 (ddd, J = 9.6, 5.8, 1.0 Hz, 1H), 6.28 (s, 1H), 
6.26 (dd, J = 1.8, 0.8 Hz, 1H), 5.12 (dd, J = 11.6, 9.8 Hz, 1H), 3.24 (dd, J = 11.2, 4.6 Hz, 1H), 3.16 
(dd, J = 11.3, 5.7 Hz, 1H), 3.07 (ddd, J = 10.4, 8.5, 4.5 Hz, 1H), 2.40 (dd, J = 13.9, 8.3 Hz, 1H), 
2.31 (dd, J = 13.8, 6.2 Hz, 1H), 1.83 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 202.0, 141.9, 139.9, 
134.2, 132.1, 131.9, 129.5, 128.6, 126.9, 126.7, 126.2, 125.6, 123.7, 123.2, 122.9, 95.1, 63.9, 58.6, 
44.1, 41.9, 41.3; HRMS (ESI-TOF) m/z: [M+H] + Calc’d for C21H20NO4 














As a colorless oil (yield 62%); IR: 3422, 2938, 2365, 1657, 1627, 1544, 1367, 1227, 1144; 1H 
NMR (400 MHz CDCl3) δ 7.34 (dd, J = 2.0, 0.8 Hz, 1H), 7.05 – 6.99 (m, 1H), 6.44 (ddd, J = 9.6, 
1.6, 1.0 Hz, 1H), 6.31 – 6.22 (m, 3H), 6.14 (d, J = 9.8 Hz, 1H), 5.57 (d, J = 11.0 Hz, 1H), 4.14 (t, 
J = 11.2 Hz, 1H), 3.65 (qd, J = 10.8, 4.0 Hz, 2H), 2.78 – 2.66 (m, 1H), 2.28 (dd, J = 13.6, 9.0 Hz, 
1H), 2.01 (dd, J = 13.4, 8.8 Hz, 1H), 1.77 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 201.5, 151.1, 
142.6, 141.6, 139.9, 125.8, 122.4, 110.7, 107.9, 95.0, 62.1, 58.1, 42.9, 42.4, 39.1; HRMS (ESI-
TOF) m/z: [M+H] + Calc’d for C15H16NO5 




As a yellow semisolid, (Yield 53%); IR: 3414, 2950, 2920, 2357, 1635, 1544, 1449, 1361, 1236, 
1026; 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.23 (m, 6H), 6.87 (dt, J = 6.0, 1.6 Hz, 1H), 6.47 – 
6.39 (m, 1H), 6.25 (dd, J = 9.6, 6.0 Hz, 1H), 5.91 (d, J = 10.6 Hz, 1H), 4.34 (t, J = 10.2 Hz, 1H), 
3.40 (dd, J = 11.4, 5.4 Hz, 1H), 3.32 (dd, J = 11.4, 5.6 Hz, 1H), 2.86 – 2.74 (m, 1H), 2.23 (dd, J = 
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13.6, 8.0 Hz, 1H), 2.14 (dd, J = 13.8, 7.4 Hz, 2H), 1.95 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
202.5, 138.5, 137.2, 136.7, 134.4, 129.1, 128.5, 127.9, 123.5, 97.0, 63.9, 58.7, 48.6, 43.0, 42.6, 
15.8; HRMS (ESI-TOF) m/z: [M+H]+ Calc’d for C18H20NO4 





A colorless semisolid (yield 65%); IR: 3414, 2920, 2357, 1670, 1635, 1544, 1445, 1365, 1224, 
1069; 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.24 (m, 5H), 6.51 (d, J = 9.7 Hz, 1H), 6.20 (dd, J = 
9.6, 1.4 Hz, 1H), 6.08 (td, J = 1.4, 0.8 Hz, 1H), 5.94 (d, J = 10.8 Hz, 1H), 4.34 (dd, J = 10.8, 9.8 
Hz, 1H), 3.43 (dd, J = 11.4, 5.0 Hz, 1H), 3.34 (dd, J = 11.4, 5.6 Hz, 1H), 2.82 – 2.73 (m, 1H), 2.37 
(s, 1H), 2.24 (dd, J = 13.8, 8.1 Hz, 1H), 2.14 (dd, J = 13.8, 7.0 Hz, 1H), 2.09 (d, J = 1.4 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 201.5, 154.9, 139.2, 136.6, 129.3, 128.6, 128.1, 127.2, 124.3, 96.6, 











As a colorless oil (yield 61%) ; IR: 3406, 2920, 2361, 1670, 1639, 1544, 1369, 1224, 1137; 1H 
NMR (400 MHz, CDCl3) δ 7.42 – 7.28 (m, 5H), 7.30 – 7.23 (m, 2H), 6.88 (dd, J = 9.8, 2.2 Hz, 
1H), 6.10 (dt, J = 9.8, 0.6 Hz, 1H), 6.06 (ddd, J = 2.4, 1.6, 0.8 Hz, 1H), 5.49 (d, J = 11.2 Hz, 1H), 
3.92 (t, J = 11.4 Hz, 1H), 3.60 (dd, J = 10.8, 3.6 Hz, 1H), 3.48 (dd, J = 10.8, 5.0 Hz, 1H), 2.70 – 
2.56 (m, 1H), 2.28 (dd, J = 13.4, 8.2 Hz, 1H), 2.05 – 1.95 (m, 2H), 1.93 (d, J = 1.6 Hz, 3H), 1.59 
(s, 1H); 13C NMR (100 MHz, CDCl3) δ 202.3, 146.1, 137.9, 134.3, 130.4, 129.2, 128.2, 128.1, 
125.0, 98.1, 62.1, 57.3, 49.9, 44.9, 39.7, 21.5; HRMS (ESI-TOF) m/z: [M+H]+ Calc’d for 
C18H20NO4 




Colorless oil (yield 41%); IR: 3353, 2357, 2339, 1654, 1605, 1544, 1449, 1365, 1183, 1118; 1H 
NMR (400 MHz, CDCl3) δ 7.38 – 7.27 (m, 5H), 6.68 (dd, J = 1.4, 0.8 Hz, 1H), 6.50 (dd, J = 3.0, 
1.0 Hz, 2H), 5.94 (d, J = 10.6 Hz, 1H), 4.34 (t, J = 10.4 Hz, 1H), 3.40 (dd, J = 11.4, 5.4 Hz, 1H), 
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3.33 (dd, J = 11.4, 5.8 Hz, 1H), 2.82 (dddd, J = 10.2, 7.8, 6.4, 2.4 Hz, 1H), 2.27 (dd, J = 13.8, 8.0 
Hz, 1H), 2.18 (dd, J = 13.6, 7.8 Hz, 1H), 1.87 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 198.2, 142.3, 
139.4, 136.2, 129.2, 128.6, 128.5, 128.5, 128.1, 96.2, 63.7, 58.3, 48.6, 42.9, 42.6; HRMS (ESI-
TOF) m/z: [M+H]+ Calc’d for C17H17BrNO4





White solid, MP.137-139°C, (Yield 52 %); 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.26 (m, 6H), 
7.03 (dd, J = 9.6, 6.2 Hz, 1H), 6.19 (dd, J = 6.4, 1.0 Hz, 1H), 5.93 (d, J = 9.6 Hz, 1H), 5.47 (d, J = 
9.0 Hz, 1H), 4.68 (dd, J = 11.2, 9.0 Hz, 1H), 3.28 (dd, J = 11.2, 5.6 Hz, 1H), 3.21 (dd, J = 11.0, 
5.6 Hz, 1H), 2.96 – 2.87 (m, 1H), 2.58 – 2.51 (m, 1H), 2.47 – 2.41 (m, 1H), 2.25 (dd, J = 13.8, 7.8 
Hz, 1H), 2.06 (dd, J = 13.8, 10.1 Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 202.0, 155.3, 141.9, 139.0, 129.0, 128.3, 128.0, 127.5, 122.9, 118.3, 92.7, 64.5, 63.4, 48.4, 39.7, 












To a solution of (50 mg, 0.16 mmol ) in Methanol (1 mL) at 0 °C, 2 eq. of NaBH4 was added and 
stirred for 20 minutes before it quenched with saturated solution of NH4Cl and extracted with ethyl 
acetate, water , brine, dried over anhydrous sodium sulfate , evaporated the solvent and purified 
using flash column to obtain the 42 mg (84%) as a white solid (M.P. >200 °C), IR: 3398, 2924, 
2867, 2357, 2339, 1707, 1540, 1449, 1365, 1259, 1126, 1061; 1H NMR (400 MHz, CDCl3) δ 7.34 
– 7.25 (m, 5H), 6.05 – 5.92 (m, 3H), 5.90 – 5.78 (m, 2H), 4.57 (dd, J = 3.2, 1.4 Hz, 1H), 4.22 (dd, 
J = 11.6, 9.8 Hz, 1H), 3.34 (dd, J = 11.0, 5.0 Hz, 1H), 3.27 (dd, J = 10.8, 4.8 Hz, 1H), 2.64 (td, J 
= 10.2, 9.4, 5.0 Hz, 1H), 2.26 – 2.14 (m, 2H), 2.09 (d, J = 4.0 Hz, 1H), 2.03 (dd, J = 13.8, 6.4 Hz, 
1H). 13C NMR (100 MHz, CDCl3) δ 136.60, 130.84, 129.44, 129.23, 129.14, 128.30, 127.95, 








(2S,3R,5S)-3-(hydroxymethyl)-2-phenylspiro[4.5]deca-7,9-diene-1,6-dione (Compound 2.59): 
 
A solution of compound (8a) (60 mg, 0.2 mmol, 1 eq.), and sodium nitrite (27 mg 0.4 mmol, 2 
eq.), in DMSO/water (6:2 V: V) was stirred at 65 °C until disappearance of the starting material 
(TLC). Water was added and the aqueous layer was extracted several times with ethyl acetate. The 
combined organic layers were dried over Sodium sulfate, concentrated and the resulting crude was 
purified by column chromatography to obtain desired product in 86% yield as an orange oil (Yield 
86%); 1H NMR (400 MHz, CDCl3) δ 7.31 – 7.20 (m, 3H), 7.10 (dd, J = 5.8, 1.8 Hz, 2H), 7.06 – 
7.01 (m, 2H), 6.81 (dd, J = 8.2, 2.3 Hz, 2H), 4.53 (dd, J = 8.4, 2.0 Hz, 1H), 3.37 (dd, J = 10.8, 6.1 
Hz, 1H), 3.27 (dd, J = 10.8, 7.5 Hz, 1H), 3.18 (dd, J = 18, 7.4 Hz, 1H), 2.94 – 2.76 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δ 185.2, 152.6, 141.2, 138.7, 136.0, 134.7, 132.9, 129.3, 129.0, 127.6, 




To a solution of compound (8a ) ,(60 mg, 0.2 mmol, 1 eq.) in 3 ml of acetic acid , Zinc powder ( 
261 mg, 4.0 mmol, 20 eq.) was added at room temperature. The reaction mixture was stirred at 
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ambient temperature for 2 hours. The reaction mixture was filtered over Celite, and the filtrate was 
neutralized by adding saturated solution of sodium bicarbonate and extracted with Ethyl acetate. 
The combined organic layer was dried over sodium sulfate. Solvent was removed under reduced 
pressure and product was purified using flash column chromatography to obtain the desired 
product in 84% yield as a colorless oil; 
(1S,2S,3R,5S)-3-(hydroxymethyl)-1-nitro-2-phenylspiro[4.5]decan-6-one (Compound 2.61): 
 
A solution of (30 mg, 0.1 mmol) of compound… in a mixture of Ethyl acetate and Ethanol (4:1) 
was charged with 5 mg of Pd/C and stirred under hydrogen atmosphere for 2 hours. The solution 
was filtered through a pad of ceilet, evaporated the solvent and purified it using flash column 
chromatography to obtain 97% yield, (dr 7:1), 1H NMR (400 MHz, CDCl3) δ 7.32 – 7.21 (m, 5H), 
7.23 – 7.15 (m, 2H), 5.46 (d, J = 6.1 Hz, 1H), 4.00 (t, J = 6.0 Hz, 1H), 3.89 – 3.81 (m, 1H), 3.21 
(dt, J = 11.0, 2.3 Hz, 1H), 2.39 (d, J = 11.8 Hz, 1H), 2.33 (d, J = 5.8 Hz, 1H), 2.05 – 1.87 (m, 4H), 
1.60 (dtd, J = 21.1, 14.3, 3.6 Hz, 6H), 1.52 – 1.27 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 136.6, 








A mixture of spiro compound (0.2 mmol) and N-phenylsuccinimide (0.2 mmol) were dissolved in 
xylene (3 mL) and heated at 130 °C in a sealed tube for 24 hrs. The solvent was evaporated, and 
the crude product purified using flash column chromatography to obtain desired product. 
 
(1R,3S,4R,4'S,7'R)-4-(hydroxymethyl)-2-nitro-2',3-diphenyl-3a',4',7',7a'-tetrahydro-1'H-
spiro[cyclopentane-1,9'-[4,7]ethanoisoindole]-1',3',8'(2'H)-trione (Compound 2.62a): 
 
A white solid, MP. (89%); 1H NMR (400 MHz, CDCl3) δ 7.54 – 7.25 (m, 14H), 7.19 – 7.13 (m, 
2H), 6.37 (ddd, J = 7.7, 6.1, 1.3 Hz, 1H), 6.20 – 6.14 (m, 1H), 5.64 (d, J = 12.2 Hz, 1H), 4.84 – 
4.78 (m, 1H), 4.75 (d, J = 6.5 Hz, 1H), 4.30 (dd, J = 12.2, 9.2 Hz, 1H), 4.03 – 3.95 (m, 2H), 3.93 
– 3.87 (m, 1H), 3.81 – 3.76 (m, 1H), 3.57 (dd, J = 8.3, 3.4 Hz, 1H), 3.45 – 3.33 (m, 4H), 3.29 (dd, 
J = 11.1, 5.7 Hz, 1H), 3.21 (s, 1H), 2.71 (dd, J = 13.7, 5.8 Hz, 2H), 2.36 (ddd, J = 29.0, 14.1, 7.6 
Hz, 2H), 2.09 (dd, J = 14.0, 4.9 Hz, 1H), 1.95 (dd, J = 14.3, 8.7 Hz, 1H); 13C NMR (100 MHz, 
Acetone-d6) δ 207.0, 206.1, 176.3, 175.4, 174.9, 174.0, 138.2, 136.1, 134.4, 132.6, 132.3, 128.9, 
128.6, 128.6, 128.5, 128.1, 127.9, 127.4, 127.0, 126.8, 126.5, 126.2, 93.0, 78.1, 75.8, 74.2, 63.3, 
61.5, 55.8, 53.7, 50.1, 49.9, 47.8, 46.2, 41.4, 41.3, 41.1, 40.4, 39.9, 39.7, 38.2, 38.0, 37.4; HRMS 
(ESI-TOF) m/z: [M+H]+ Calcd for C26H30NO6 







a pale yellow solid, MP. 147-149°C, (Yield 84%); IR: 3539, 2937, 2357, 2339, 1699, 1547, 1509, 
1380, 1251, 1175, 1023. 1H NMR (400 MHz, CDCl3) δ 7.50 – 7.36 (m, 4H), 7.19 – 7.13 (m, 4H), 
6.85 (d, J = 8.6 Hz, 2H), 6.35 (ddd, J = 8.0, 6.0, 1.4 Hz, 1H), 6.15 (ddd, J = 8.0, 6.2, 1.6 Hz, 1H), 
5.56 (d, J = 12.2 Hz, 1H), 4.22 (dd, J = 12.2, 9.0 Hz, 1H), 3.97 (ddd, J = 6.2, 2.8, 1.4 Hz, 1H), 3.87 
(ddd, J = 6.0, 3.4, 1.6 Hz, 1H), 3.76 (s, 3H), 3.54 (dd, J = 8.2, 3.4 Hz, 1H), 3.40 (dd, J = 6.2, 2.4 
Hz, 2H), 3.33 (dd, J = 8.2, 2.8 Hz, 1H), 2.60 (dt, J = 14.6, 7.6 Hz, 1H), 2.28 (dd, J = 14.0, 7.8 Hz, 
1H), 2.05 (dd, J = 14.0, 5.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 207.5, 176.1, 174.7, 159.6, 
134.5, 131.7, 129.7, 129.5, 129.3, 126.9, 126.6, 126.5, 114.8, 93.8, 77.7, 77.6, 77.4, 77.1, 63.0, 
55.8, 55.6, 50.2, 50.1, 42.1, 41.4, 40.8, 40.3, 38.6; ); HRMS (ESI-TOF) m/z: [M+H]+ Calc’d for 
C28H27N2O7 







1'H-spiro[cyclopentane-1,9'-[4,7]ethanoisoindole]-1',3',8'(2'H)-trione (Compound 2.62c): 
 
White solid, MP. 145-145 °C  (84%) 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.33 (m, 4H), 7.13 (d, 
J = 7.4 Hz, 2H), 6.62 – 6.55 (m, 1H), 6.31 (ddd, J = 7.9, 5.9, 1.5 Hz, 1H), 4.68 (d, J = 5.2 Hz, 1H), 
3.86 (dt, J = 5.9, 2.0 Hz, 1H), 3.73 (dd, J = 10.6, 4.4 Hz, 1H), 3.60 (dd, J = 10.6, 6.4 Hz, 1H), 3.51 
– 3.46 (m, 1H), 3.32 (qd, J = 8.5, 2.9 Hz, 2H), 2.66 (tt, J = 9.8, 4.8 Hz, 1H), 2.11 (tt, J = 10.6, 6.0 
Hz, 1H), 2.03 – 1.87 (m, 2H), 1.71 (ddd, J = 14.3, 10.1, 4.7 Hz, 1H), 1.38 (ddd, J = 13.7, 9.3, 4.5 
Hz, 2H), 0.92 (d, J = 6.5 Hz, 3H), 0.82 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 175.3, 
174.5, 135.4, 129.4, 129.2, 127.7, 126.5, 100.2, 96.6, 64.2, 56.4, 50.4, 47.7, 45.8, 42.7, 42.1, 41.8, 
41.5, 40.5, 26.5, 23.7, 22.0. 
Dimethyl (1R,2R,2'S,3'S,4R,4'R)-4'-(hydroxymethyl)-2'-nitro-3-oxo-3'-phenylspiro[bicyclo-
[2.2.2]octane-2,1'-cyclopentane]-5,7-diene-5,6-dicarboxylate (Compound 2.63): 
 
A mixture of compound 2.50a (60 mg, 0.2 mmol) and dimethyl acetylenedicarboxylate (28.4 mg, 
0.2 mmol) in toluene (3 mL) were heated at 100 °C for 18 h. After the reaction was completed, the 
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solvent was evaporated, and the residue was purified using flash column chromatography to get a 
white solid (MP. 194-196°C), (yield 86%); IR:3535, 2950, 2327, 2339, 1719, 1696, 1547, 1331, 
1240, 1137, 1061,1034. 1H NMR (400 MHz, CDCl3) δ 7.34 – 7.24 (m, 5H), 6.51 (ddd, J = 6.8, 
6.0, 1.8 Hz, 1H), 6.43 (ddd, J = 6.8, 6.0, 1.6 Hz, 1H), 5.57 (d, J = 12.2 Hz, 1H), 4.67 (dd, J = 6.0, 
1.6 Hz, 1H), 4.49 (dd, J = 6.0, 1.8 Hz, 1H), 4.33 (dd, J = 12.2, 9.0 Hz, 1H), 3.84 (s, 3H), 3.80 (s, 
3H), 3.32 (d, J = 5.6 Hz, 2H), 2.61 (td, J = 8.6, 4.8 Hz, 1H), 2.19 (dd, J = 14.4, 8.1 Hz, 1H), 1.94 
(dd, J = 14.4, 4.8 Hz, 1H), 1.59 (d, J = 13.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 201.9, 165.9, 
164.4, 142.4, 139.5, 135.3, 133.5, 130.5, 129.2, 128.1, 127.9, 92.9, 62.8, 57.3, 53.2, 53.0, 52.2, 
51.3, 46.7, 42.1, 41.9.; HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C23H24NO8 




CHAPTER THREE: MAGELLANINE 
Magellanine and magellaninone: 
Three natural alkaloids were isolated from Lycopodium magellanicum and Lycopodium 
paniculatum, magellanine 3.1, magellaninone 2.3, and aniculatine 3.3. These natural products have 
a fused tetracyclic framework decorated with several functional groups and 5-7 contiguous 
stereogenic centers and one quaternary carbon center (Figure 10)70. 
                                       
Figure 10: Structures of magellanine 3.1, magellaninone 2.3, and paniculatine 3.2 
This unique structure was attractive to several groups and some methods have been reported to 
achieve this skeleton.71-72 Overman’s group reported the first enantioselective total synthesis of 
magellanine 3.1 and magellaninone 2.3.73 The critical step of this synthesis was a Prins cyclization, 




               Scheme 51: Key Prins-Pinacol rearrangement of Overman’s approach 
Overman approach: 
Starting with the treatment of bicyclo[3.2.0]hept-2-en-6-one 3.5 with [bis(methylthio)methyl]-
lithium and copper triflate Cu(OTf)2 using Cohen procedure
74 afforded the methyl thiol ether 3.6, 
then treatment with Li-NH3, chlorotrimethylsilyl (Me3SiCl), MeLi, and N-phenyltriflamide 
provided triflate which has converted to iodide by N-iodosuccinimide. The reaction of 3.7 with 3.8 
in the presence of n-BuLi at -110 °C provided 3.9, followed by protecting the alcohol and 
converting the aldehyde to dimethyl acetal produced 3.3. Under the Lewis-acidic condition, a 
rearrangement of 3.3 to 3.4 occurred to achieve the tetracyclic skeleton in 2:1 ratio of β and α 
methoxy epimers. Cyclopentane ring opened by oxidative cleavage followed by piperidine 
formation then replacement of the methoxy group by TBS ether afforded 3.10. Then, 
dehydrogenation using LiMe2Cu-Me3SiCl and palladium(II) acetate [Pd(OAc)2] afforded 3.11. 
Compound 3.11 was treated with trifluoroacetic acid (TFA) to remove the Boc followed by 
methylating the amine and deprotection the TBS afforded magellanine 3.1 and epimagellanine 









In the same year, Paquette and co-workers reported the total synthesis of racemic magellanine 
3.1.75 The significant step was the Michael reaction to enone to form the six-member ring. 
Mesylating of the alcohol followed by reaction with ethyl 5-ethoxy-3-oxo-4-pentanoate 3.13 in 
basic condition generated 3.14. Acid-catalyzed of p-TsOH led to the elimination of the ethanol 
and the cleavage of the ester which afforded 3.15. NaBH4 reduction of ketone followed by TBS 
protection and removal of the 1-5-dithian produced 3.16. DIBAL-H reduction of the dione 
followed by methoxy methyl chloride (MOM-Cl) protection to protect the diol followed by 
deprotection of TBS, then oxidized the alcohol to ketone, and reacted with lithium 
bis(trimethylsilyl)amide [LiN(SiMe3)2] and PhSeCl in pyridine generated α-β-unsaturated ketone 
3.17. The reaction of 3.17 with methyl cyanoformate and NaBH4 afforded 3.18. Removing the 
hydroxy group using tris(trimethylsilyl)silane hydride (Me3Si)3SiH and AIBN followed by 
piperidine ring formation produced 3.19. Deprotection of MOM gave 3.20. Oxidation of the diol 
by MnO2, then methylation followed by reduction with LiAlH4 and oxidation of the diol afforded 






                                        Scheme 53: Paquette’s approach 
Liao’s approach: 
Liao and Yen reported a racemic synthesis of magellanine (Scheme 54).76 The reaction includes a 
Diels-Alder reaction of a masked o-benzoquinone followed by the oxa-di-π-methane 









In 2003, Ishizaki and his coworkers synthesized magellanine in 20 steps. The synthesis included 










                                            Scheme 55: Ishizaki approach 
 
Mukai’s approach: 
Mukai’s group reported the total synthesis of (-)-magellanine, (+)-magellaninone, and (+)-
paniculatine.78 The key steps in these syntheses involved two intramolecular Pauson-Khand 
reactions of enynes: the first Pauson-Khand created the bicyclo[4.3.0] carbon skeleton which 
generated rings A and B. The second Pauson-Khand reaction stereoselectively produced the 







                                                      
Scheme 56: Mukai approach 
Tang’s approach: 
In 2014, Tang’s group synthesized magellanine 3.1, magellaninone 2.3, and paniculatine 3.2. The 
key step for this synthesis was converting 3.72 (rings A, B, C) to 3.73 (rings A, B, C, D) using t-








In 2015, Yan’s group reported the shortest way to synthesize magellanine and magellanone.80 
Depending on acylation/alkylation on compound 3.78 to generate the quaternary center beside 










Barriault’s group reported a new route to synthesize magellanine.81 The key step for this synthesis 
was the dehydro Diels-Alder reaction using gold (I) catalyst to create the four rings with the stereo- 
quaternary center. 
 
                                                        Scheme 59: Barriault’s approach  
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Results and discutions 
Retrosyntetic strategy I:  
We postulated that magellaninone 2.3 could be prepared from spiro 3.101. The spiro should be 
available through dearomatization reaction of compound 3.100 reaction (Chapter Two). 
Compound 3.100 could be prepared through Michael reaction between aldehyde 2.56c and nitro 
alkene 3.99 (Scheme 60). 
                                
Scheme 60: Retrosynthesis of magellanine      
For the Alloc protected nitroalkene, 3.99 was synthesized over four steps (Scheme 61). 
Methylamine was reacted with allyl chloroformate 3.102 in the presence of potassium carbonate 
in an aqueous solution delivering 3.103.82 Aldehyde 3.104 was prepared by acid-catalyzed 
conjugate addition of N-Alloc-protected amine to acrolein in 73% yield.83 Then, a Henry reaction 
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of 3.104 with nitromethane in the presence of catalytic amounts of TMG, followed by dehydration 
of 3.105 with methanesulfonyl chloride and triethylamine at -20 ºC afforded 3.99 in high yield.84  
 
Scheme 61: Synthesis of compound 3.99 
The next step was Michael reaction of 2.55c and 3.99 in toluene using Jørgensen’s reagent85 at 0 
ºC  which afforded 3.100 (Scheme 62). Compound 3.100 was used directly without purification 
for Alloc deprotection using Pd(PPh3)4 and 1,3-dimethylbarbutaric acid
86 followed by reduction 
using NaCNBH3 in methanol at 0 ºC for one hour, which afforded piperidine ring 3.106 (Scheme 
61). 
 
Scheme 62: Synthesis of compound 3.106 
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After TBS deprotection using TBAF at room temperature to give free phenol 3.107, the standard 
condition for the spiro cyclization was applied. We did not get compound 3.101 even when running 
the reaction for 24 hours. Fortunately, the starting material was recovered (Scheme 63).  
                                
Scheme 63: Spiro cyclization of compound 3.101 
To resolve this issue, we decided to form the spirocycle first, followed by the piperidine formation. 
After synthesizing compound 3.100, a reduction reaction was used to convert the aldehyde to an 
alcohol using NaBH4 in methanol at 0 ºC to give 3.109 in 71% over three steps. The spiro 
cyclization was successful, producing 3.110 in 72% yield (Scheme 64). 
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Scheme 64: Synthesis of compound 3.110 
The next step was to prepare the D ring in megallineone. The first proposed scheme was reacting 
the acetaldehyde with the C-NO2 moiety in 3.110 via a Henry reaction to prepare 3.111 (scheme 
65).  
 
Scheme 65: Synthesis of compound 3.111 
This reaction was first trialed with a simple spiro compound 2.50a. Unfortunately, the use of a 
base with the spiro compound did not give us the desired product, and instead generated tropone 




                                       
Scheme 66: Conversion of spiro to tropone 
Next, we tried to add an allyl group on the C5 position of the cyclohexadienone ring and postpone 
the piperidine cyclization to the end of the synthesis.  
Allylation was run on compound 3.110 with allyl magnesium chloride88 in the presence of (CuI) 
at -78 ºC (Scheme 67) and allowed to warm to room temperature for 12 hours. Unfortunately, no 
desired product 3.113 appeared. The same result was also observed when we re-ran the reaction 
with more of allyl magnesium bromide or added catalytic amounts of N,N,N',N'-
tetramethylethylenediamine (TMEDA). 
                      
150 
 
Scheme 67: Allylation reaction of compound 3.110 
Then we replaced the allyl magnesium chloride with allyl magnesium bromide in the presence of 
copper iodide and lithium chloride at -78 ºC but it failed to give 3.113 (Scheme 68). 
                        
Scheme 68: Second allylation reaction of compound 3.110 
Next, we replaced the Alloc group with a Boc protecting group on the nitrogen to test an allylation 
reaction without interference of the protection group. Removal of the Alloc group from 3.109 by 
using Pd(PPh3)4 in the presence of 1,3-dimethylbarbutaric acid in dry DCM under argon 
atmosphere followed by adding Boc2O in methanol with catalytic amounts of DMAP afforded 
3.114 in 75% yield (Scheme 69).  
 
Scheme 69: Synthesis of compound 3.114 
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After several unsuccessful attempts to add an allyl group to the cyclohexyl ring and the 
rearrangement of the spiro to a tropone when we used a base for the Henry reaction, we decided 
to change our proposal. We examined the reaction of Michael product 2.58a with 10 equivalents 
of acetaldehyde in the presence of different bases (TMG, Et3N, Amberlyst 21) after protecting the 
alcohol with TBS 3.116. Still, the reactions were unsuccessful; the result was an unprotected 
Michael product 2.57a (Scheme 70). 
      
Scheme 70: Attempt to synthesis compound 3.117 
The deprotection of TBS through TMG or DBU let us change the protection group on the hydroxyl 
group. We changed to a protecting group that would be stable under basic, nucleophilic, and 
oxidizing (nonacidic) conditions; 1,3-dioxolane. We synthesized 3.119 starting from a Michael 
reaction of aldehyde 2.55a with nitro styrene 2.56a (Scheme 71) in the presence of Jørgensen’s 
reagent and p-nitrophenol. After working up the reaction, the crude product 3.118 was treated with 
ethylene glycol89 and catalytic amounts of p-TsOH and refluxed in toluene using a Dean-Stark 




Scheme 71: Synthesis of compound 3.119 
We proceeded with a Henry reaction of 3.119 with excess amounts of acetaldehyde using 
triethylamine without any product formation. Then, DBU90 showed a low yield of desired product 
3.120 (Scheme) after stirring for 14 h with recovery of 35% of starting material. Extending the 
reaction time led to an improvement in the isolated yield to 52% with 15% recovery of starting 
material. Deprotection of the TBS group of 3.120 with TBAF gave 3.121 in quantitative yield. 




Scheme 72: Synthesis of compound 3.122 
Using the same procedures that we used to synthesized 3.122, we moved forward to prepare 3.124 
from aldehyde 2.55c through a Michael addition with alloc nitroalkene 3.99 in toluene (Scheme 
73). From the crude aldehyde we performed a 1,3-dioxalane protection to afford 3.126. Then Henry 




Scheme 73: Synthesis of compound 3.124 
We changed the protection group for aldehyde 3.100 from 1,3-dioxolane to dimethyl acetal91 by 
reacting with methyl orthoformate, and 10% p-toluene sulfonic acid to produce 3.125 (Scheme 
74). Followed by a Henry reaction with an excess of acetaldehyde with TMG as the base to afford 
desired product 3.126. After purification, TBAF was added to a solution of 3.126 in THF to 
deprotect the TBS of phenol to generate 3.127. Finally, the desired product 3.128 was prepared 
from spiro cyclization of 3.127 using the standard conditions. The steric effect of the ethyl group 




Scheme 74: Synthesis of compound 3.128  
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Retrosynthetic strategy II: 
Due to the difficulty in achieving the desired product for the first proposed route towards 
magellaninone, a second restrosynthetic strategy was planned for the synthesis of magellaninone 
using a phenol with an ethyl group moiety to make the D ring.  
The key steps for this strategy were the spiro cyclization to generate the core skeleton containing 
a quaternary carbon followed by a Henry reaction of the C-NO2 with a terminal aldehyde to create 
the D ring (Scheme 75). 
 
Scheme 75: Second Retrosynthesis of magellaninone 2.3 
To begin, compound 3.136 was synthesized using the same procedures used by Yadav et. al 
(Scheme 76).92 Acetonide protection of 2,6-dihydroxy benzoic acid 3.133 with acetone and thionyl 
chloride (SOCl2) run for 14 hours delivered 3.129. Then treatment of the phenol with triflic 
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anhydride (Tf2O) in Et3N produced the corresponding triflate 3.134, which reacted with allyl 
stannane in the presence of catalytic amounts of [Pd(PPh3)4] and LiCl under argon at 100 ºC in 
DMF afforded terminal olefin 3.135 in 96% yield. Ozonolytic93 cleavage with ozone at the alkene 
bond of compound 3.135 at -78 ºC gave aldehyde 3.135. 
 
Scheme 76: Synthesis of compound 3.136 
Reducing aldehyde 3.136 to corresponding alcohol 3.137 using NaBH4 at 0 ºC in methanol, and 
then protecting it with TBS-Cl afforded 3.138 in high yield. The hydrolysis of the 2,2-dimethyl-
4H-1,3-benzodioxin-4-one with 3.0 equivalents of  DIBAL-H at -78 ºC,40 gave no observable 




Scheme 77: Attempt to synthesize of compound 3.139 
Lithium aluminum hydride was applied at 0 ºC for the reduction of 3.138 to 2-hydroxy benzyl 
alcohol 3.14094 then it was oxidized using PCC42 in DCM to give aldehyde 3.139 in 10% yield 
(Scheme 78).   
 
Scheme 78: Synthesis of compound 3.139 
Because of the low yield of the previous two steps, we proposed to change the protection group 
on alcohol 3.137 with methoxymethyl chloride94 (MOM-Cl) in the presence of DIPEA at 0 ºC for 





Scheme 79: Synthesis of compound 3.142 
Wittig reaction of 3.142 with (Carbethoxymethylene)triphenylphosphoran 1.83 afforded 3.1463 in 
high yield followed by hydrogenation of the double bond under hydrogen atmosphere in the 
presence of palladium over carbon delivered 3.144 in a quantitative amount that was used for the 
next step without any further purification (Scheme 80). TBS protection of phenol 3.144 with TBS-
Cl and imidazole in DMF afforded 3.145, DIBAL reduction of ester 3.145 to corresponding 
aldehyde gave 3.146 in moderate yield along with 8% of the over reduced alcohol.  
 
Scheme 80: Synthesis of compound 3.146 
After preparing aldehyde 3.146, a Michael reaction with 3.99 was performed using 20 mol% of 
Jørgensen’s reagent as a catalyst in dry toluene (Scheme 82); when the reaction was done indicated 
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by TLC, methanol was added and cooled to 0 ºC, then NaBH4 was added and stirred for 30 minutes 
affording 3.147 in 79% yield. Spiro cyclization of 3.147 with 2.0 equivalents of potassium 
hydroxide, and potassium ferrocyanide delivered 3.148.  
 




The research presented in this chapter shows great evidence that the spiro cyclization reaction can 
be applied to the synthesis of magellanine. Our methodology represents a novel and efficient 
approach to formation of the magellanane core, where by adding the ethyl group to the C-NO2 
through a Henry reaction followed by spiro cyclization generated 3.128. We need more 
investigation about generating ring D. The second approach depends on generates the spiro part 
which containes the ethanal group that can react with NO2 to generate ring D via Henry reaction, 




N-Methyl allyl carbamate (Compound 3.103): 
 
A solution of (8.85 mL, 110 mmol) of methylamine in dioxane: water (150 mL, 4:1) was cooled 
to 0 °C. (9.25 gm, 110 mmol) NaHCO3 and (11.7 ml, 110 mmol) allyl chloroformate were added. 
The mixture could warm to room temperature and stir for 6 hours. The organic solvent was 
removed under reduced pressure, and the aqueous phase was extracted three times with ethyl 
acetate. The combined organic layer was dried over (Magnesium sulfate) and concentrated under 
reduced pressure. The crude obtained was purified by flash column chromatography. Yield 89 % 
as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 5.73 (ddt, J = 16.3, 10.7, 5.6 Hz, 1H), 5.30 (s, 
1H), 5.17 – 4.97 (m, 2H), 4.38 (d, J = 5.7 Hz, 2H), 2.60 (d, J = 4.8 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 157.1, 133.0, 117.2, 65.2, 27.3. 
 
N-Allyl-N- Methyl(2-oxopropyl) carbamate (Compound 3.104): 
 
A solution of Carbamate 156 (10.5 g, 100 mmol) and (4.64 gm, 20 mmol) of camphor sulfonic 
acid in dry CH2Cl2 was cooled to 0 °C, and acrolein (46.5 mL, 700 mmol) was added. After stirring 
for 15 min at 0 °C, the reaction mixture was warmed to room temperature for 14 hours, and then 
the solution was diluted with saturated NaHCO3 (50 mL). The organic layer was dried over Sodium 
sulfate, filtered, and concentrated under reduced pressure and Purified of the residue by flash 
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column chromatography gave aldehyde 157 in 71% yield as a yellow oil: 1H NMR (500 MHz, 
CDCl3) δ 9.69 (dd, J = 5.1, 2.4 Hz, 1H), 5.87 – 5.75 (m, 1H), 5.22 – 5.05 (m, 2H), 4.45 (s, 2H), 
3.49 (dd, J = 6.2, 1.9 Hz, 2H), 2.83 (dd, J = 4.2, 2.0 Hz, 3H), 2.62 (d, J = 4.2 Hz, 2H); 13C NMR 
(125 MHz, CDCl3) δ 200.8, 200.4, 132.9, 117.2, 66.0, 43.1, 42.4, 34.6; HRMS (ESI) m/z calculated 
for C8H14NO3
+ [M+H]+: 172.0974, found 172.0943. 
 
Allyl (3-hydroxy-4-nitrobutyl)(methyl)carbamate (Compound 3.105):  
 
To a solution of aldehyde 157 (3.9 gm, 22.8 mmol) in 40 mL of dry THF, 14 mL of anhydrous 
nitromethane was added at room temperature under argon was added 1,1,3,3-tetramethylguanidine 
(0.28 mL, 2,28 mmol). The solution was stirred for 14 hours and then treated with saturated 
solution of ammonium chloride and diluted with Ethyl acetate, washing with water and brine then 
dried over anhydrous sodium sulfate and evaporated the organic solvent to give a crude product, 
which was purified using flash column chromatography to obtain (84%) nitro alcohol as a colorless 
oil: 1H NMR (400 MHz, CDCl3) δ 5.86 (dddd, J = 22.6, 19.2, 10.8, 5.4 Hz, 1H), 5.31 – 5.10 (m, 
2H), 4.57 – 4.46 (m, 2H), 4.44 – 4.29 (m, 2H), 4.28 – 4.12 (m, 1H), 3.87 – 3.63 (m, 1H), 3.06 (dt, 
J = 14.6, 4.8 Hz, 1H), 2.87 (d, J = 18.6 Hz, 3H), 1.68 (dddt, J = 15.6, 9.4, 6.0, 2.6 Hz, 1H), 1.56 – 
1.42 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 157.5, 132.6, 117.6, 80.4, 66.5, 65.5, 45.1, 34.2, 
31.6; HRMS (ESI) m/z calculated for C9H17N2O5





Allyl (E)-methyl(4-nitrobut-3-en-1-yl)carbamate (Compound 3.99): 
 
To a solution of compound 158 (3.0 gm, 12.9 mmol) in dichloromethane (20 mL, dry) at -78° C 
was added methanesulfonyl chloride (1.06 mL, 15.5 mmol) and stirred for 10 minutes then 
followed by addition of triethylamine (4.35 mL, 31.1 mmol). The mixture was warmed up to 0º C, 
stirred for 20 min, then water (20 mL) was added and stirred for 10 minutes.  The organic layer 
was separated, and the aqueous layer extracted with dichloromethane (25 mL). The combine 
organic layers dried over (Sodium sulfate), filtered and the solvent removed under reduced 
pressure. Purified by using flash column chromatography produce as a yellow oil (2.3gm, 83%); 
1H NMR (400 MHz, CDCl3) δ 7.16 – 7.05 (m, 1H), 6.91 (d, J = 13.4 Hz, 1H), 5.78 (ddtd, J = 15.8, 
10.8, 5.6, 2.8 Hz, 1H), 5.21 – 5.02 (m, 2H), 4.44 (ddt, J = 5.6, 3.8, 1.8 Hz, 2H), 3.36 (t, J = 6.8 Hz, 
2H), 2.81 (dd, J = 4.6, 2.0 Hz, 3H), 2.41 (q, J = 6.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 156.0, 
155.7, 140.6, 139.1, 132.8, 132.8, 117.7, 117.2, 66.1, 66.0, 47.3, 46.9, 34.7, 34.3, 27.3, 26.9; 
HRMS (ESI) m/z calculated for C9H15N2O4




A solution of compounds (278 mg, 1 mmol) of 154 and (214 mg, 1 mmol) of 159 in 3 mL of dry 
toluene (65 mg, 0.2 mmol) of (R)-α,α-Diphenyl-O-trimethylsilylpyrrolidine-2-methanol and (27.8 
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mg, 0.2 mmol) were added. The reaction mixture was stirred at 0º C for 8 hours. The ice bath was 
removed then dry DCM was added, followed by (421 mg, 2.7 mmol) of 1,3-dimethylbarbutaric 
acid and (11.5 mg, 0.1 mmol) of Pd(PPh3)4 were added at room temperature, the reaction was 
stirred for one hour (indicated by TLC), the reaction was cooled again to 0º C, 1 mL of methanol 
was added followed by (126 mg, 2.0 mmol) of sodium cyanoborohydride, the reaction was stirred 
for 30 minutes before it quenched by adding a saturated solution of ammonium chloride, extracted 
with ethyl acetate, the organic layer was washed with water and brine, dried over Sodium sulfate, 
evaporated the solvent and purified by flash column chromatography to obtain (279 mg, 71%) as 
pale yellow oil. 
5-methyl-2-(((3S,4S)-1-methyl-4-(nitromethyl)piperidin-3-yl)methyl)phenol (Compound 3.107): 
 
To a solution (100mg, 0.25 mmol) of compound 160 in 1 mL of THF, (0.25 mL, 1M) of TBAF 
was added at room temperature, the reaction was stirred for 30 minutes then water was added and 
extracted with ethyl acetate, the organic layer was washed with water, brine then dried over 
Sodium sulfate, filtered, evaporated the solvent and purified by flash column chromatography to 
obtain (55 mg, 78%) of free phenol as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 6.87 (d, J = 
7.6 Hz, 1H), 6.73 (d, J = 1.7 Hz, 1H), 6.66 – 6.58 (m, 1H), 4.53 (dd, J = 11.9, 8.0 Hz, 1H), 4.38 
(dd, J = 11.9, 7.4 Hz, 1H), 3.04 (ddt, J = 11.2, 4.2, 2.1 Hz, 1H), 2.91 (t, J = 12.8 Hz, 1H), 2.84 – 
2.65 (m, 1H), 2.53 (ddd, J = 12.1, 4.9, 2.9 Hz, 2H), 2.43 (dd, J = 13.4, 6.0 Hz, 1H), 2.26 (s, 3H), 
2.19 (s, 4H), 2.06 (ddd, J = 12.6, 11.3, 3.2 Hz, 2H), 1.96 (tt, J = 12.9, 4.3 Hz, 2H), 1.88 (dd, J = 
12.2, 2.7 Hz, 1H), 1.66 – 1.55 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 156.5, 138.0, 130.3, 122.7, 
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121.1, 118.3, 78.6, 77.4, 77.1, 76.7, 57.5, 55.1, 46.0, 38.0, 36.7, 25.8, 24.2, 21.1; HRMS (ESI) m/z 
calculated for C15H23N2O3
+ [M+H]+ : 279.1709, found 279.1663. 
 
Allyl ((3S,4S)-5-hydroxy-4-(2-hydroxy-4-methylbenzyl)-3-(nitromethyl)pentyl)(methyl)-
carbamate (Compound 3.109): 
     
A solution of compounds (278 mg, 1 mmol) of 154 and (214 mg, 1 mmol) of 159 in 3 mL of dry 
toluene (65 mg, 0.2 mmol) of (R)-α,α-Diphenyl-O-trimethylsilylpyrrolidine-2-methanol and (27.8 
mg, 0.2 mmol) were added. The reaction mixture was stirred at 0º C for 8 hours. Methanol 1 mL 
was added and followed by (76 mg, 2 mmol) NaBH4 with stirring for 30 minutes. A saturated 
solution of ammonium chloride was added then extracted with ethyl acetate; the organic layer was 
washed with water, brine, dried over Sodium sulfate, and evaporated the solvent. The crude 
product dissolved in THF and 1mL of TBAF was added at room temperature with stirring for 20 
minutes before it quenched with water and extracted with ethyl acetate, washed the organic layer 
with brine, dried over Sodium sulfate purified by flash column chromatography to produce (270 
mg, 74%, dr 20:1); 1H NMR (500 MHz, CDCl3) δ 6.90 (d, J = 7.4 Hz, 1H), 6.65 – 6.58 (m, 2H), 
5.96 – 5.84 (m, 1H), 5.31 – 5.22 (m, 1H), 5.22 – 5.14 (m, 1H), 4.66 – 4.49 (m, 3H), 4.45 – 4.24 
(m, 1H), 4.17 (dd, J = 20.3, 6.2 Hz, 1H), 2.82 (s, 3H), 2.75 – 2.66 (m, 1H), 2.54 (dq, J = 14.3, 7.9, 




yl)ethyl)(methyl)carbamate (Compound 3.110): 
 
to a mixture (100 mg, 0.27 mmol) of compound 164 and (180 mg, 0.54 mmol) of potassium 
ferrocyanide in Acetonitrile 1 mL, (30 mg, 0.54 mmol) 0.1 N KOH solution. The mixture was 
stirred for 15 hrs. at 0° C. Citric acid solution (1M) was added and extracted with DCM three 
times, the organic layers were combined and dried over Sodium sulfate evaporated the solvent and 
purified it using column to obtain (71mg ,72%) as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 
6.28 (d, J = 9.7 Hz, 1H), 6.11 (dd, J = 9.5, 1.4 Hz, 1H), 5.99 (d, J = 1.6 Hz, 1H), 5.96 – 5.85 (m, 
1H), 5.32 – 5.22 (m, 2H), 5.18 (dq, J = 10.5, 1.5 Hz, 1H), 4.56 (d, J = 5.5 Hz, 2H), 3.77 (s, 2H), 
3.38 (d, J = 24.7 Hz, 3H), 2.90 (s, 3H), 2.57 (d, J = 46.0 Hz, 1H), 2.15 (dd, J = 14.2, 8.8 Hz, 1H), 
2.05 (d, J = 1.4 Hz, 3H), 1.98 – 1.84 (m, 2H), 1.77 (tt, J = 9.0, 4.0 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 202.3, 156.5, 154.9, 139.6, 133.0, 126.1, 123.6, 117.1, 97.2, 66.0, 63.5, 56.9, 47.3, 41.7, 
40.9, 39.9, 33.7, 30.1, 25.1, 23.0; HRMS (ESI) m/z calculated for C19H27N2O6
+ [M+H]+ : 








(nitromethyl)pentyl)(methyl)carbamate (Compound 3.123): 
 
Aldehyde 154 (100 mg, 0.36 mmol) was added to a solution of catalyst A (20 mol %), nitroalkene 
159 (77 mg, 0.36 mmol) and p-nitrophenol (20 mol%) in dry toluene (2.0 mL) at 0 °C. After 
stirring for 8 hours at the same temperature (monitored by TLC), the suspension was warmed to 
room temperature and diluted with more toluene. Then (40 µL, 0.72 mmol) of ethylene glycol (10 
mol%) of p-TsOH were added and heated to 120 ºC using the Dean-Stark apparatus for 14 hours. 
The reaction mixture was cooled to room temperature and diluted with ethyl acetate, then 10% 
solution of NaHCO3 was added and stirring until the pH=7. The organic layer was separated and 
washed with water and brine, dried over anhydrous Sodium sulfate, evaporated the solvent and 
purified the crude product using flash column chromatography to afford. 13C NMR (100 MHz, 
CDCl3) δ 153.9, 139.1, 130.7, 129.7, 128.7, 128.1, 127.4, 127.3, 121.4, 119.0, 103.6, 76.8, 64.9, 







(nitromethyl)pentyl)(methyl)carbamate (Compound 3.125): 
 
Using the same procedure for 186, instead of ethylene glycol we used trimethyl orthoformate and 
the mixture was stirred at room temperature for 14 hours, the mixture was diluted with Et2O and 
washed with water. The ethereal solution was dried over anhydrous Sodium sulfate, concentrated 
under reduced pressure and purified by flash column chromatography to produce 188 as a colorless 
oil: 1H NMR (500 MHz, CDCl3) δ 6.93 – 6.83 (m, 1H), 6.62 (ddd, J = 11.5, 8.4, 4.9 Hz, 2H), 5.91 
(td, J = 11.5, 10.9, 5.4 Hz, 1H), 5.31 – 5.21 (m, 1H), 5.21 – 5.13 (m, 1H), 4.58 – 4.49 (m, 2H), 
4.40 (dd, J = 13.2, 8.6 Hz, 1H), 4.34 – 4.24 (m, 1H), 4.17 (dd, J = 20.3, 6.2 Hz, 1H), 3.35 (s, 3H), 
3.33 – 3.27 (m, 3H), 3.25 – 3.15 (m, 1H), 2.82 (s, 3H), 2.74 – 2.65 (m, 1H), 2.54 (dq, J = 14.2, 
7.9, 6.9 Hz, 1H), 2.46 – 2.35 (m, 1H), 2.30 (s, 1H), 2.23 (s, 3H), 1.96 – 1.86 (m, 1H), 1.53 (dd, J 
= 14.8, 7.7 Hz, 1H).13C NMR (100 MHz, CDCl3) δ 153.9, 139.1, 130.7, 129.7, 128.7, 128.1, 127.4, 
127.3, 121.4, 119.0, 103.6, 77.4, 77.2, 77.1, 76.8, 64.9, 64.8, 45.1, 45.0, 43.1, 27.8, 25.9, 25.9, 







yl)-5-hydroxy-4-nitrohexyl)(methyl)carbamate (Compound 3.126): 
 
A mixture (150 mg, 0.278 mmol) of 188 , (40 µL, 0.278 mmol) DBU, and (500 µL, 0.49 mmol) 
of acetaldehyde in (2 mL) of dry THF was stirred for 24 hours at room temperature, after competed 
the reaction, saturated solution of NH4Cl was added and the organic material was extracted two 
times with ethyl acetate, the combined organic layers were dried over anhydrous Sodium sulfate, 
evaporated the solvent under reduced pressure and the crude product was purified using flash 
column chromatography to obtain 189 in 62% as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 
6.95 (d, J = 10.5 Hz, 1H), 6.67 (t, J = 8.0 Hz, 1H), 6.57 (d, J = 6.2 Hz, 1H), 5.87 (s, 1H), 5.23 (dd, 
J = 15.5, 7.9 Hz, 1H), 5.14 (s, 1H), 4.56 – 4.47 (m, 2H), 4.47 – 4.18 (m, 2H), 4.15 – 4.03 (m, 1H), 
3.34 (dt, J = 9.8, 2.6 Hz, 3H), 3.30 – 3.22 (m, 4H), 3.03 (d, J = 53.8 Hz, 1H), 2.76 (q, J = 13.7, 
11.8 Hz, 4H), 2.49 (d, J = 54.6 Hz, 1H), 2.31 (s, 2H), 2.23 (dt, J = 11.0, 3.3 Hz, 3H), 2.01 – 1.83 







nitrohexyl)(methyl)carbamate (Compound 3.127): 
 
To a solution (70 mg, 0.14 mmol) of 188 in THF (1mL), (140 µL, 0.14 mmol) of 1M TBAF and 
stirred for 30 minutes before it quenched with water and extracted with ethyl acetate, the organic 
layer was dried over Sodium sulfate, evaporated the solvent and purified the crude product by flash 
column chromatography afforded 189 in 82% as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 
6.31 (d, J = 9.7 Hz, 1H), 6.12 (t, J = 7.8 Hz, 1H), 5.99 (s, 1H), 5.96 – 5.85 (m, 1H), 5.27 (ddd, J = 
17.1, 3.7, 1.9 Hz, 1H), 5.17 (dq, J = 10.5, 1.4 Hz, 2H), 4.62 – 4.50 (m, 2H), 4.50 – 4.31 (m, 2H), 
3.41 (ddd, J = 12.3, 6.1, 3.0 Hz, 2H), 3.36 (dt, J = 5.9, 2.7 Hz, 4H), 3.34 – 3.28 (m, 4H), 2.92 (t, J 
= 3.9 Hz, 1H), 2.89 (s, 3H), 2.88 – 2.78 (m, 2H), 2.26 – 2.08 (m, 2H), 2.05 (s, 4H), 1.89 (dt, J = 
13.1, 7.7 Hz, 3H), 1.68 (p, J = 7.9, 7.4 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 199.8, 138.4, 
133.1, 126.7, 123.7, 117.7, 104.4, 96.6, 66.0, 58.3, 53.8, 47.0, 46.5, 42.2, 41.6, 41.0, 39.9, 34.2, 
33.6, 29.7, 25.7, 25.2, 22.8, 21.0; HRMS (ESI) m/z calculated for C23H36N2O8
+ [M+Na]+ : 







6,8-dien-2-yl)ethyl)(methyl)carbamate (Compound 3.128): 
 
To a solution (100 mg, 0.21 mmol) of 189 in (1mL) of acetonitrile, (140 mg, 0.42 mmol) of 
K3[Fe(CN)6] was added and followed by (24 mg, 0.42 mmol) of 0.1 N KOH. The reaction mixture 
was stirred for 2 hours before (1M) of citric acid was added and extracted three times with DCM, 
the combined organic layer was washed with water and  brine, dried over Sodium sulfate, 
evaporated the solvent and the yellow crude product purified by flash column chromatography to 
obtain 190 in 52% yield as a colorless oil: 1H NMR (500 MHz,CDCl3) δ 6.31 (d, J = 9.7 Hz, 1H), 
6.12 (t, J = 7.8 Hz, 1H), 5.99 (s, 1H), 5.96 – 5.85 (m, 1H), 5.27 (ddd, J = 17.1, 3.7, 1.9 Hz, 1H), 
5.17 (dq, J = 10.5, 1.4 Hz, 2H), 4.62 – 4.50 (m, 2H), 4.50 – 4.31 (m, 2H), 3.41 (ddd, J = 12.3, 6.1, 
3.0 Hz, 2H), 3.36 (dt, J = 5.9, 2.7 Hz, 4H), 3.34 – 3.28 (m, 4H), 2.92 (t, J = 3.9 Hz, 1H), 2.89 (s, 
3H), 2.88 – 2.78 (m, 2H), 2.26 – 2.08 (m, 2H), 2.05 (s, 4H), 1.89 (dt, J = 13.1, 7.7 Hz, 3H), 1.68 
(p, J = 7.9, 7.4 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 199.8, 138.4, 133.1, 126.7, 123.7, 117.7, 







5-hydroxy-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one (Compound 3.129): 
 
a stirred solution of 2,6-dihydroxybenzoic acid (8.0 g, 51.94 mmol) in 1,2-dimethoxyethane 
(DME) (30 mL) at 0 oC acetone (4.9 mL, 67.53 mmol) and SOCl2 (4.85 mL, 67.53 mol) and DMAP 
(316 mg, 2.59 mmol) were added, and the mixture was stirred for 1hr at the same temperature then 
warmed to room temperature and stirred for another 23 hours. A saturated aqueous solution of 
NaHCO3 was added to the mixture until the pH=7, and the aqueous solution was extracted with 
ethyl acetate (50 mL x 3). The combined organic layers were washed with water and brine, dried 
over anhydrous Sodium sulfate, and the solvent was evaporated. The residue was purified by flash 
column chromatography to give the product 201 (9.67 g, Yield 96%) as a colorless oil; 1H NMR 
(400 MHz, CDCl3) δ 7.58 (t, J = 8.4 Hz, 1H), 7.03 (dd, J = 8.5, 0.9 Hz, 1H), 6.97 (d, J = 8.2 Hz, 
1H), 1.72 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 157.4, 157.1, 148.6, 136.3, 136.3, 117.9, 116.6, 
106.9, 25.5; HRMS (ESI) m/z calculated for C10H11O4 
+ [M+H]+: 195.0567, found 195.0492. 
2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-5-yl trifluoromethanesulfonate (3.124): 
 
A solution of alcohol (5.0 g, 25.77 mmol) in anhydrous dichloromethane was cooled to 0 °C, Et3N 
(7.5 mL, 53.8 mmol) was added and stirred at the same temperature for 10 minutes. 
Trifluoromethane sulfonic anhydride (5.20 mL, 30.9 mmol) was then added dropwise; then the 
reaction mixture was stirred at 0 °C for 3 h. Saturated aqueous of NaHCO3 was added, and the 
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organic materials were extracted with ethyl acetate (50 mL x 3). The combined organic layer was 
washed with water, brine, dried over anhydrous Sodium sulfate, and the solvent was evaporated 
under reduced pressure. The residue was purified by flash column chromatography to obtain white 
solid (6.76 g, 81%): 1H NMR (400 MHz, CDCl3) δ 7.58 (t, J = 8.4 Hz, 1H), 7.03 (dd, J = 8.4, 1.0 
Hz, 1H), 6.98 (dt, J = 8.2, 0.8 Hz, 1H), 1.74 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 157.4, 157.1, 
148.7, 136.2, 117.9, 116.6, 108.3, 106.9, 77.3, 77.0, 76.7, 25.5; HRMS (ESI) m/z calculated for 
C11H10F3O6S
+ [M+H]+ : 327.0150, found 327.0106. 
 5-allyl-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one (Compound 3.125): 
 
A mixture of triflate (5.0 g, 15.33 mol), [Pd(PPh3)4] (354 mg, 0.30 mol), and LiCl (4.0 g, 46.0 mol) 
in dry DMF 50 mL, allyltributyltin (4.9 mL, 15.71 mol) was added. The reaction mixture was 
heated to 100 ºC and for 14 h. Then the reaction mixture cooled to the room temperature diluted 
with ethyl acetate (100 mL). filtered through a pad of Celit. The organic solution was washed with 
water, brine and dried over Sodium sulfate, and the solvent removed in vacuo. The crude product 
was purified by flash column chromatography to give 203 (3.31g, 99%), as a light-yellow color 
oil: : 1H NMR (400 MHz, CDCl3) δ 7.29 (td, J = 8.0, 2.0 Hz, 1H), 6.82 (dd, J = 7.9, 1.9 Hz, 1H), 
6.74 – 6.65 (m, 1H), 5.89 (dddd, J = 16.1, 11.3, 7.6, 5.6 Hz, 1H), 4.96 – 4.85 (m, 2H), 3.75 (dd, J 
= 6.6, 1.9 Hz, 2H), 1.56 (d, J = 2.4 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 159.9, 157.0, 144.9, 
136.6, 135.3, 124.9, 115.9, 115.5, 111.9, 105.0, 38.1, 25.5; HRMS (ESI) m/z calculated for 
C13H15O3
+ [M+H]+ : 219.1021, found 219.0643. 
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 2-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-5-yl)acetaldehyde (Compound 3.136):  
 
A solution of alkene (3.2 gm, 14.7 mmo) in DCM 50 mL at -78 ºC, stream of ozone was bubbled 
through the solution at -78 °C for 20 minutes (the solution color convert to pale blue). Dimethyl 
sulfide was added, and the reaction warmed to room temperature. Triphenylphosphine was added 
and the reaction stirred for 12 hours. The volatiles were evaporated under reduced pressure and 
the resulting crude material was purified via flash chromatography to yield the title compound 
3.126 in 88 % yield as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 9.78 – 9.73 (m, 1H), 7.43 
(ddd, J = 7.9, 7.4, 1.1 Hz, 1H), 6.88 (dd, J = 8.3, 1.3 Hz, 1H), 6.84 (ddt, J = 7.5, 1.3, 0.5 Hz, 1H), 
4.14 (t, J = 0.9 Hz, 2H), 1.67 (d, J = 0.7 Hz, 6H). 13C NMR (125 MHz, CDCl3) δ 198.2, 160.9, 
157.1, 137.0, 135.7, 126.5, 117.0, 112.6, 105.8, 49.0, 25.6; HRMS (ESI) m/z calculated for 
C12H13O4
+ [M+H]+ : 221.0814, found 221.0712. 
2-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-5-yl)ethanol (Compound 3.137): 
 
To a solution of aldehyde (2.8 gm, 12.7 mmol) in methanol at -78 ºC, NaBH4 (970 mg, 25.4 mmol) 
was added. The reaction mixture was stirred for 1 hour at the same temperature; the saturated 
solution of ammonium chloride was added and extracted two times with ethyl acetate. The 
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combined organic layer was washed with water, brine and dried over anhydrous Sodium sulfate, 
the solvent was evaporated, and the crude product was purified by flash column chromatography 
to obtain alcohol in 85% as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.41 (dd, J = 8.2, 7.6 
Hz, 1H), 6.98 – 6.94 (m, 1H), 6.82 (dd, J = 8.2, 1.2 Hz, 1H), 3.86 (t, J = 6.2 Hz, 2H), 3.32 (t, J = 
6.4 Hz, 2H), 1.67 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 161.3, 157.1, 144.1, 135.4, 126.0, 115.9, 
112.7, 105.3, 77.3, 77.1, 76.8, 63.7, 37.3, 25.6; HRMS (ESI) m/z calculated for C12H15O4
+ 
[M+H]+: 223.0970, found 223.0910. 
5-(2-(methoxymethoxy)ethyl)-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one (Compound 3.141): 
                    
A solution of alcohol (2.1 gm, 9.46 mmol) in dry DCM at 0 ºC, DIPEA (5 mL, 28.4 mmol) was 
added and followed by dropwise of MOMCl (1.08 mL, 14.2 mmol), the reaction mixture was 
stirred for 3 hours at the same temperature, after the reaction completed, the organic solution 
washed with 10% HCl, 10% NaHCO3, and water, dried over Sodium sulfate, evaporated the 
solvent and purified the crude using flash column chromatography to obtain 74% as a colorless 
oil: 1H NMR (500 MHz, CDCl3) δ 7.36 (t, J = 7.9 Hz, 1H), 6.95 (dd, J = 7.7, 1.1 Hz, 1H), 6.78 
(dd, J = 8.2, 1.2 Hz, 1H), 4.53 (s, 2H), 3.73 (t, J = 6.6 Hz, 2H), 3.34 (t, J = 6.6 Hz, 2H), 3.20 (s, 
3H), 1.64 (s, 7H); HRMS (ESI) m/z calculated for C14H19O5





2-hydroxy-6-(2-(methoxymethoxy)ethyl)benzaldehyde (Compound 3.142): 
 
A solution of (1.7 gm, 6.4 mmol) of dioxone in DCM at -78 °C was treated with DIBAL-H (19.2 
mL, 19.2 mmol, 1 M solution in heptane). The reaction mixture was stirred at -78 °C for 2 hours 
and then quenched with 1 M HCl and MeOH. After warming to room temperature, H2O was added, 
and the aqueous layer was extracted three times with Et2O. The combined organic layers were 
washed with water and brine, dried over Magnesium sulfate, and evaporated the solvent, then 
purified the crude using flash column chromatography to obtain desired product in 71% yield as a 
pale yellow oil: 1H NMR (500 MHz, CDCl3) δ 11.95 (s, 1H), 10.29 (s, 1H), 7.38 (dd, J = 8.5, 7.4 
Hz, 1H), 6.81 (dt, J = 8.4, 0.8 Hz, 1H), 6.74 (dd, J = 7.4, 1.1 Hz, 1H), 4.52 (s, 2H), 3.71 (t, J = 6.6 
Hz, 2H), 3.18 (s, 3H), 3.15 (t, J = 6.6 Hz, 2H). 
Ethyl (E)-3-(2-hydroxy-6-(2-(methoxymethoxy)ethyl)phenyl)acrylate (Compound 3.143): 
 
To a solution of (1.0 gm, 4.76 mmol) of compound aldehyde 210 in dry THF, (2.0 gm, 5.71 mmol) 
of (Carbethoxymethylene)triphenylphosphorane 211 was added and the reaction mixture was 
stirred for 3 hours at room temperature under nitrogen atmosphere, when the reaction done the 
solvent was evaporated and purified through flash column chromatography to produce 212 in 87% 
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yield as a white solid: 1H NMR (500 MHz, CDCl3) δ 7.89 (d, J = 16.2 Hz, 1H), 7.13 (s, 1H), 7.09 
(t, J = 7.8 Hz, 1H), 6.84 – 6.77 (m, 2H), 6.75 – 6.71 (m, 1H), 4.58 (s, 2H), 4.27 (q, J = 7.1 Hz, 
2H), 3.70 (t, J = 7.2 Hz, 2H), 3.29 (s, 3H), 3.01 (t, J = 7.1 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H);  
Ethyl 3-(2-hydroxy-6-(2-(methoxymethoxy)ethyl)phenyl)propanoate (Compound 3.144): 
 
A solution of (1.1 gm, 3.93 mmol) of compound 212 in a mixture of ethyl acetate: ethanol (4:1) 
20 mL was charged with (5% w/w) of Pd/C under hydrogen atmosphere for 3 hours. the catalyst 
was filtered off through a pad of Celite and the filtrate concentrated to give the title compound that 
used for next step without any further purification: 1H NMR (500 MHz, CDCl3) δ 7.41 (s, 1H), 
7.03 (t, J = 7.8 Hz, 1H), 6.75 (ddd, J = 11.0, 7.9, 1.3 Hz, 2H), 4.59 (s, 2H), 4.13 (q, J = 7.1 Hz, 
2H), 3.72 (t, J = 7.2 Hz, 2H), 3.28 (s, 3H), 2.96 (t, J = 6.8 Hz, 2H), 2.87 (t, J = 7.2 Hz, 2H), 2.68 
(t, J = 6.7 Hz, 2H), 1.22 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 174.4, 153.7, 137.2, 




A mixture of (400 mg, 1.42 mmol) of compound 213, (320 mg, 2.12 mmol) of TBSCl, and (290 
mg, 4.25 mmol) of imidazole in dry DMF was stirred for 16 hours at room temperature. The 
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mixture was diluted with Ethyl acetate and washed with water. The organic layer was dried over 
anhydrous Magnesium sulfate and concentrated under reduced pressure to give a crude of TBS 
ether which purified using flash column chromatography obtain 86%. 1H NMR (500 MHz, CDCl3) 
δ 7.00 (t, J = 7.9 Hz, 1H), 6.79 (dd, J = 7.7, 1.3 Hz, 1H), 6.66 (dd, J = 8.1, 1.2 Hz, 1H), 4.59 (s, 
2H), 4.12 (q, J = 7.1 Hz, 2H), 3.70 (t, J = 7.3 Hz, 2H), 3.28 (s, 3H), 2.99 – 2.88 (m, 4H), 2.51 – 
2.45 (m, 2H), 1.23 (t, J = 7.1 Hz, 3H), 0.99 (s, 9H), 0.23 (s, 6H).13C NMR (100 MHz, CDCl3) δ 
173.2, 154.0, 138.4, 129.9, 126.7, 122.5, 116.3, 96.3, 77.4, 77.1, 76.7, 68.2, 60.3, 55.1, 34.2, 33.3, 
25.8, 22.3, 18.2, 14.3, -4.1; HRMS (ESI) m/z calculated for C21H37NaO5Si





To a stirred solution of ester 214 (200 mg, 0.5 mmol) in dry DCM (10 mL) at -78 ℃ was added a 
solution of DIBAL-H (3.0 M in heptane, 0.24 mL, 0.7 mmol) over 10 min. The mixture was kept 
at the same temperature for 2 hours. Then the saturated solution of NH4Cl (3 mL) was added at -
78 ºC. The mixture was warmed to room temperature, then the saturated solution of potassium 
sodium tartrate was added. The organic phase was separated, and the aqueous phase was extracted 
with DCM. The combined organic layer was washed with water and brine. The organic layers were 
dried over Sodium sulfate and concentrated. The residue was purified by flash chromatography to 
give the desired product in 70% yield as a colorless oil: : 1H NMR (400 MHz, CCDl3) δ 9.80 (t, J 
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= 1.5 Hz, 1H), 7.01 (t, J = 7.9 Hz, 1H), 6.80 (dd, J = 7.7, 1.2 Hz, 1H), 6.67 (dd, J = 8.1, 1.2 Hz, 
1H), 4.58 (s, 2H), 3.70 (t, J = 7.2 Hz, 2H), 3.27 (s, 3H), 2.95 (dd, J = 9.1, 6.8 Hz, 2H), 2.89 (t, J = 
7.2 Hz, 2H), 2.65 (ddd, J = 9.5, 6.7, 1.5 Hz, 2H), 0.98 (s, 9H), 0.23 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 202.0, 153.8, 138.3, 129.7, 126.8, 122.6, 116.4, 96.3, 68.2, 55.1, 44.0, 33.3, 25.8, 19.4, 
18.3, -4.1. 
Allyl (4-(2-((tert-butyldimethylsilyl)oxy)-6-(2-(methoxymethoxy)ethyl)benzyl)-5-hydroxy-3-
(nitromethyl)pentyl)(methyl)carbamate (Compound 3.147): 
 
a mixture of nitroalkene 159 (100 mg, 0.47 mmol), (S)-1a (30 mg, 0.093 mmol) and (165 mg, 
0.47mmol) of aldehyde 215 in dry toluene 1 mL at 0 ºC. the reaction mixture was stirred for 8 
hours. NaBH4 (36 mg, 0.93 mmol) was added at 0 ℃, and the reaction mixture was stirred for 30 
min at this temperature. The reaction was quenched by a saturated solution of NH4Cl, extracted 
two times with AcOEt. The combined organic layers were washed with brine, dried over Sodium 
sulfate, and concentrated in vacuo. Purification by flash column chromatography gave compound 
216 in 80% yield; HRMS (ESI) m/z [M+H]+ calc’d for C26H49N2O8Si




 PHAEUCAOLISIN D AND L 
Introduction: 
Terpenes are the largest diversity between natural products, about 60,000 compounds have been 
recognized, among these monoterpenes, sesquiterpenes, and diterpenes characterize nearly 400 
different structural families.96,97 These natural products have been identified from insects and 
plants of both on the earth and marine origins.98,99 Most terpenoids originate from plants essential 
compounds like vitamins, hormones and medicines.100 Among the vast terpene chemical family, 
sesquiterpenes are a subclass abundant in plant. Sesquiterpene (C15) generate significant amounts 
of different products with possible to be classified as multiproduct synthases101 (Figure 11). 
Figure 11:The structures of parent carbon skeletons of some sesquiterpenes 
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 Guaiane skeleton is a bicyclic sesquiterpene that have two fused rings with five and seven carbons 
respectively (Figure 2). 𝛼-Guaiene 4.1, 3,7-guaiadiene 4.2, guaia-6,9-diene 4.3, and 𝛾-gurjunene 
4.4 are representative sesquiterpenes were found in red wine.7102(Figure 12) 
 
 Figure 12: Guaiane skeleton 
The perhydroazulene skeleton, a key feature for some terpenes, Curcuminol 4.5 and  
Procurcumenol 4.6 are among the first sesquiterpenes that isolated from curcuma zedoaria in 1967 
and 1968 respectively, the structures were identified by IR, NMR, UV and some reactions.103 
zedoarondiol 4.7 isolated from the rhizoma of C. Heyneanain104(Figure 13) 
 




Fruchier’s group isolated Orobanone 4.8 from Orobanche repum-genistae.105 In 1986, Kuroyangi 
and his co-worker isolated isozedoarondiol 4.9, methylzedoarondiol 4.10 beside procurcumenol 
4.6 from Curcuma aromatica salis (Figure 14).106 
 
 
Figure 14: Natural products from Curcuma aromatica 
Qiu’s group isolated new guaiane-type sesquiterpenes (4.11−4.20), the name of those new natural 




Figure 15: Phaeocaulisins A−J 
Phaeocaulisins K-M (4.21-4.23) were isolated form rhizomes of Curcuma phaeocaulis by group 
of Qui in 2015 Compound 4.22 showed moderate activity (IC5054.27 ^ 4.23 mM), which was like 
that of hydrocortisone (Figure 16).108 
 
Figure 16: Phaeocaulisins K-M 
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Five new sesquiterpenoids (4.24-4.28), with Guaiane skeleton were isolated from the radix of 
Curcuma aromatica (Figure 17).109 
 
Figure 17: Natural products from Curcuma aromatica 
The general retrosynthetic pathway for the total synthesis of compound 4.14 would begin with 
iodation of commercially available methyl-4-methyl salicylate 4.29, then protected Henry product 
4.51 followed by Kende reaction and Grignard reaction (Scheme 82).  
 
                     
                                  






Results and discutions:  
 
First, we performed iodination of methyl 4-methylsalicylate 4.29 using N-iodo succinimide in the 
presence of p-toluene sulfonic acid at room temperature for 14 hours afforded 4.30.110 Heck 
reaction of compound 4.30 with allyl alcohol in the presence of sodium bicarbonate, tetra butyl 
ammonium bromide (TBAB) and palladium acetate produced compound 4.31.111 Compound 4.31 
could then react with methyl magnesium bromide (MeMgBr) via Grignard reaction to afford 4.32 
in good yield, followed by oxidation of the alcohol with DMP112 which gave the ketone 4.33 in 




Scheme 83: Synthesis of compound 4.34 
 
We converted the methyl ester 4.30 to α,α-dimethyl benzyl alcohol 4.35 via a Grignard reaction at 
40 ºC for two hours. protected the two hydroxy groups using dimethyl propene in the presence of 
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1% p-TsOH at 0 ºC for 16 hours in dry DMF gave compound 4.36.113 Heck reaction of compound 
4.36 with allyl alcohol generated aldehyde 4.37. Then, compound 4.37 was converted to 4.38 
though Henry reaction in the presence of catalytic amounts of (TMG). We examined PCC, DMP 
and Swern oxidation procedures to convert nitro alcohol 4.38 to nitro ketone 4.39; unfortunately, 
none of them worked. (Scheme 84). 
 
 
Scheme 84: Synthesis of compound 4.39 
 
To prepare the nitro ketone 4.39. Starting with Heck reaction of compound 4.36 with phenyl 
acrylate114 gave the unsaturated ester 4.40 that converted to 4.41 though hydrogenation in methanol 
and dichloromethane as a co-solvent in high yield. Using nitromethane in the presence of t-BuOK 
afforded 4.39 in 70% yield.115 The Grignard reaction of compound 4.39 at -10 ºC went smoothly 
in high yield to create compound 4.42. Through optimization of the deprotection of compound 
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4.42 with acids, we found that 40% of acetic acid gave the best result with 73% of compound 4.34 
with 10% yield of side product 4.43. Kende reaction was applied to convert compound 4.34 to 
desired product 4.14 but it decomposed (Scheme 85). 
       
Scheme 85: Attempt to synthesis of compound 4.14 
 
To solve this problem and discern why the tropone reaction did not work, we prepared compound 
4.47 in four steps using the same route that we used to prepare compound 4.43. The Heck reaction 
of 4.30 with phenyl acrylate produced compound 4.45 in 84% yield followed by hydrogenation in 
very good yield. Then a Henry reaction with compound 4.46 and nitromethane gave the nitro 
ketone 4.47 in 63% yield. Selective methylation of the nitro ketone with 1.5 equivalents of methyl 
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magnesium bromide at 0 ºC gave compound 4.48 in 83%. The reaction of 4.48 with potassium 
hydroxide and ferrocyanide did not gave the tropone but instead gave ketone 4.49 through a reverse 
Henry reaction (Scheme 86).  
 
Scheme 86: Attempt to synthesis tropone 
 
We concluded that the hydroxy groups influenced the cyclization reaction, so we changed our 
strategy. Starting with compound 4.38, protected the hydroxy group with TBS 116 using TBS-OTf 
at 0 ºC for two hours to produce 4.50. Then deprotection of acetonide with 40% acetic acid gave 




           
 
Scheme 87: Synthesis of compound 4.51 
 
Compound 4.51 was treated with potassium ferrocyanide in aqueous basic solution of 0.1 N 
potassium hydroxide afforded the tropone 4.53 in 71% yield (Scheme 88). Then removal of the 
TBS group using TBAF in 82 % gave the free alcohol 4.54 and converted to corresponding ketone 
4.55 using DMP in good yield. Finally, selective Grignard reaction using 2.0 equivalents of methyl 
magnesium bromide at -10 to 0 ºC for three hours produced the desired product 4.14 in 79% yield. 
 
                   
Scheme 88: Synthesis of compound 4.14 
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Having prepared compound 4.14 in good yield we worked towards preparing compound 4.22. We 
started from 4.34 and dehydrated117 using methane sulfonyl chloride in the presence of 
triethylamine at -20 to 0º C to afford nitro alkene 4.56 (Scheme 89). Then methylation on the nitro 
alkene through Gilman reagent118 (Me2CuLi) at -78 ºC to room temperature, produced compound 
4.57. Deprotection of acetonide using 40% acetic acid at 60 ºC for 5 hours furnished the phenol 
4.58 in 67% yield to set the stage for the Kende cyclization affording 4.59 and 4.59’ in 53% and 
29% respectively. The spectral data (H1NMR and C13 NMR) of 4.59 showed great agreement with 
those testified in the literature. 
     
Scheme 89: Synthesis of Compound 4.22 
Conclution: 
We successfully represented the first total synthesis of (±)-phaeoculisin D and (±)-phaeocaulisin 
L. The synthetic strategy depended on an oxidative dearomatization reaction using potassium 
ferrocyanide in a basic media. We found that the oxidative dearomatization reaction did not work 
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when there was a hydroxy group beta to the nitro carbon (compound 4.48) because it caused a 
reverse Henry reaction. After protection of the hydroxy group using TBS we were able to achieve 






Methyl 2-hydroxy-5-iodo-4-methylbenzoate (Compound 4.30): 
 
 
To a solution of (4 gm, 24.1 mmol, 1 eq.) of Methyl-2-hydroxy-4-methyl benzoate 4.29 and (2.75 
gm,14.4 mmol, 0.6 eq.) of p-toluene sulfonic acid in (120 mL) of acetonitrile was stirred for 10 
minutes then (6.5 gm , 28.9 mmol, 1.2 eq.) of NIS was added in one portion, the solution was 
stirred for 16 hours, evaporated the solvent and dissolved the crude product in ethyl acetate and 
washed with saturated solution of sodium thiosulfate, water and brine, dried, evaporated the 
solvent and purified using flash column chromatography to obtain 92% as a white solid; MP 65-
66 °C; FTIR (cm-1): 3143, 1670, 1605, 1325, 619 cm-1; 1H NMR (500 MHz, CDCl3) δ 10.55 (s, 
1H), 8.17 (s, 1H), 6.86 (s, 1H), 3.91 (s, 3H), 2.37 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 169.5, 
160.6, 146.4, 132.9, 119.6, 113.9, 111.8, 52.5, 23.6; HRMS (ESI) m/z [M+H]+  calc’d for 
C9H10IO3








Methyl 2-hydroxy-4-methyl-5-(3-oxopropyl) benzoate (Compound 4.31) 
 
 
A suspension of (5.0 gm, 17.1 mmol, 1 eq.) compound 4.30 with (192 mg, 0.85 mmol, 0.05 eq.) 
Pd(OAc)2, (3.6 gm, 42.8 mmol, 2.5 eq) NaHCO3 , (5.68 gm, 17.1 mmol, 1 eq.) TBAB, and (5gm) 
4Å MS in DMF (60 mL), and (3.5 mL, 51.3 mmol, 3.0 eq.) of degassed allyl alcohol were 
subsequently added and the mixture was stirred at 50 ºC for 16 hours. After cooling to room 
temperature, the brown suspension was filtered through a plug of Celite, diluting with ethyl 
acetate. Water was subsequently added, and the organic layer was separated then the aqueous layer 
was extracted two times with ethyl acetate. The combined organic layers were dried over 
Magnesium sulfate and concentrated under reduced pressure. Purification by flash 
chromatography, yield 83% as a light yellow oil: 1H NMR (400 MHz, CDCl3) δ 10.50 (s, 1H), 9.81 
(t, J = 1.2 Hz, 1H), 7.54 (s, 1H), 6.76 (s, 1H), 3.90 (s, 3H), 2.84 (dd, J = 8.2, 6.6 Hz, 2H), 2.73 – 
2.67 (m, 2H), 2.28 (d, J = 0.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 201.4, 177.6, 170.4, 170.4, 
160.0, 160.0, 145.2, 145.2, 129.6, 129.5, 129.2, 119.0, 118.9, 110.2, 52.1, 44.1, 24.4, 19.9; HRMS 
(ESI) m/z calculated for C12H15O4 










To a solution of (500 mg, 2.25 mmol, 1.0 eq.) of compound 4.31 in (10 ml) dry tetrahydrofuran at 
0 °C, ( 3 mL, 3 M, 4 eq.) of methyl magnesium bromide was added dropwise at 0 C, then the 
reaction was warmed to room temperature for 2 hours, the reaction mixture was cooled again to 0 
°C and (2 ml) of saturated solution of ammonium chloride was added then extracted two times 
with ethyl acetate, the combine organic layers washed with water and brine, dried over Sodium 
sulfate, and evaporated the solvent then purified using flash column chromatography to obtain 
86% of compound 3 as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 8.79 (s, 1H), 6.79 (s, 1H), 
6.62 (s, 1H), 3.81 (h, J = 6.1 Hz, 1H), 2.98 (s, 1H), 2.60 (ddd, J = 13.8, 9.3, 6.7 Hz, 1H), 2.49 (ddd, 
J = 13.9, 9.1, 7.2 Hz, 1H), 2.19 (s, 3H), 1.66 – 1.62 (m, 2H), 1.61 (s, 7H), 1.21 (d, J = 6.2 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 153.4, 136.6, 131.1, 128.7, 125.7, 119.0, 77.4, 77.1, 76.7, 75.7, 












A solution (400 mg, 1.68 mmol) of compound 4.33 in (5 mL) in dry dichloromethane, (717 mg, 
1.68 mmol) of DMP was added at room temperature under nitrogen atmosphere with stirring for 
20 minutes, the solvent evaporated, and the crude compound purified by flash column 
chromatography to yield compound 4 in 81%, as a colorless oil; 1H NMR (400 MHz, CDCl3) δ 
8.92 (s, 1H), 6.91 (s, 1H), 6.76 – 6.73 (m, 1H), 3.94 (h, J = 6.1 Hz, 1H), 2.73 (ddd, J = 13.8, 9.3, 
6.7 Hz, 1H), 2.62 (ddd, J = 13.9, 9.1, 7.2 Hz, 1H), 2.32 (s, 3H), 1.76 (t, J = 1.5 Hz, 2H), 1.73 (s, 
7H), 1.33 (d, J = 6.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 153.5, 136.7, 131.3, 128.8, 125.9, 











3-iodo-4-Methyl-6-hydroxy-α,α-dimethyl benzyl alcohol (compound 4.35): 
 
 
To a solution (5 gm, 17.1 mmol, 1.0 eq.) of compound 4.30  in (50 mL) of dry diethyl ether  ( 17.1 
mL, 3M) of methyl magnesium bromide solution was added dropwise at 0 °C then the reaction 
mixture was warmed to 60 °C for 2 hours, (10 mL) of saturated solution of ammonium chloride 
was added at 0°C and extracted three times with ethyl acetate, dried over Sodium sulfate, 
evaporated the solvent under reduce pressure and purified using flash coumn chromatography to 
obtained 94% as a colorless oil; 1H NMR (400 MHz, CDCl3) δ 8.93 (s, 1H), 7.40 (s, 1H), 6.73 (s, 
1H), 2.69 (s, 1H), 2.30 (s, 3H), 1.60 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 155.9, 142.2, 135.4, 
131.1, 119.2, 88.7, 75.5, 30.5, 27.7; HRMS (ESI) m/z [M+H]+ calc’d for C10H14IO2 
+: 293.0038, 
found 293.0029. 
6-Iodo-2,2,4,4,7-pentamethyl-4H-1,3-benzodioxin (compound 4.36): 
 
A solution (4 gm, 13,7 mmol, 1 eq.) of compound 4.35 and (2.95 gm, 41 mmol, 3.0 eq.) methoxy 
propene in (50 mL) dry DMF at 0 °C (130  mg, 0.68 mmol, 0.05 eq.) of  p-toluene sulfonic acid 
mono hydride was stirred for 16 hours at the same temperature, then the reaction was quenched 
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with (10 mL) of saturated solution of NaHCO3, diluted with ethyl acetate and washed with water, 
brine, dried over anhydrous Sodium sulfate, evaporated the solvent and purified using flash 
column chromatography to obtain 95% of compound 7 as a colorless oil: 1H NMR (400 MHz, 
CDCl3) δ 7.43 (s, 1H), 6.71 (s, 1H), 2.32 (s, 3H), 1.49 (s, 7H), 1.47 (s, 7H); 
13C NMR (100 MHz, 
CDCl3) δ 150.4, 140.9, 135.2, 129.8, 119.1, 99.5, 90.7, 72.7, 32.0, 27.9, 27.3.;HRMS (ESI) m/z 
[M+H]+ calc’d for C13H18IO2+: 333.0351, found.333.0446. 
3-(2,2,4,4,7-pentamethyl-4H-benzo[d][1,3]dioxin-6-yl)propanal (compound 4.37): 
 
             
 
A mixture of compound 4.36 (3 gm, 9.03 mmol, 1 eq.), Pd(OAc)2 (101 mg, 0.45 mmol, 0.05 eq.), 
NaHCO3 (1.9 gm, 22.6 mmol, 2.5 eq), NBu4Br (3.0 gm, 9.03 mmol, 1 eq.), and (3 gm) 4Å MS 
in  dry DMF (40 mL), degassed allyl alcohol (1.62 mL, 27.09 mmol, 3.0 eq.) was subsequently 
added and the mixture was stirred at 50 ºC for 16 hours. After cooling to room temperature, the 
brown suspension was filtered through a pad of Celite. Water was subsequently added and 
extracted several times with Ethyl acetate. The combined organic layers washed with water and 
brine, dried over Magnesium sulfate, and concentrated under reduced pressure. Purification by 
flash column chromatography to obtain 82% as ayellow oil; ; 1H NMR (500 MHz, CDCl3) δ 9.79 
(t, J = 1.5 Hz, 1H), 6.79 (s, 1H), 6.59 (s, 1H), 2.85 (dd, J = 8.4, 7.0 Hz, 2H), 2.68 (td, J = 7.6, 7.2, 
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1.5 Hz, 2H), 2.21 (s, 3H), 1.49 (s, 6H), 1.46 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 201.7, 148.3, 
135.6, 131.3, 127.4, 125.2, 119.0, 99.0, 73.0, 44.5, 32.0, 27.3, 25.1, 19.1; HRMS (ESI) m/z  
[M+Na]+ calc’d for C16H22O3Na 
+: 285.1467, found 285.1449. 
1-nitro-4-(2,2,4,4,7-pentamethyl-4H-benzo[d][1,3]dioxin-6-yl)butan-2-ol (Compound 4.38) 
                 
 
To a solution (2 g, 6.18 mmol, 1.0 eq.) of compound 4.37 in dry THF (30 mL), (3.4 mL, 61.8 
mmol, 10 eq.) of nitromethane and (75 µL, 0.61 mmol, 10 mol%.) of TMG were added at room 
temperature and stirred for 12 hours. Saturated solution of ammonium chloride was added and 
extracted two times with ethyl acetate. The combined organic layers washed with water, and brine, 
dried over anhydrous ammonium sulfate. The solvent was evaporated under reduced pressure and 
the crude product was purified by flash column chromatography to obtain 82% of nitro alcohol as 
a colorless oil; 1H NMR (500 MHz, CDCl3) δ 6.80 (s, 1H), 6.60 (s, 1H), 4.43 – 4.36 (m, 2H), 4.33 
(s, 1H), 2.86 (s, 1H), 2.77 (ddd, J = 13.9, 9.8, 5.5 Hz, 1H), 2.62 (ddd, J = 14.0, 9.7, 6.7 Hz, 1H), 
2.22 (s, 3H), 1.80 – 1.66 (m, 2H), 1.50 (s, 6H), 1.48 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 148.2, 
135.6, 131.9, 127.4, 125.4, 119.0, 99.1, 80.8, 73.1, 68.4, 34.6, 32.0, 32.0, 28.5, 27.3, 27.3, 19.1; 
HRMS (ESI) m/z [M+H]+ calc’d for C15H21O2 





Phenyl (E)-3-(2,2,4,4,7-pentamethyl-4H-benzo[d][1,3]dioxin-6-yl)acrylate (Compound 4.40): 
 
 A mixture (4.0 gm, 12.05, 1.0 eq.) of compound 4.36, (2.67 gm, 18.07 mmol, 1.5 eq.) of phenyl 
acrylate, (135 mg, 0.6 mmol, 0.05 eq.) of palladium acetate, (732 mg, 2.4 mmol, 0.2 eq.) of tri-o-
tolylphosphine, and (10.1 mL, 72, mmol, 6 eq.) triethylamine in dry dimethyl formamide was 
heated to 80 °C for 16 hours. It was filtered on a short pad of silica gel and diluted with ethyl 
acetate, then washed three times with water and brine before dried over anhydrous sodium sulfate, 
evaporated the solvent and purified by flash column chromatography to obtain 83% as pale-yellow 
oil; 1H NMR (500 MHz, CDCl3) δ 7.95 (d, J = 15.8 Hz, 1H), 7.27 (dd, J = 8.5, 7.4 Hz, 2H), 7.13 
– 7.09 (m, 1H), 7.04 (dd, J = 8.6, 1.1 Hz, 2H), 6.56 (d, J = 0.9 Hz, 1H), 6.32 (d, J = 15.9 Hz, 1H), 
2.28 (s, 3H), 1.45 (s, 5H), 1.40 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 165.9, 152.3, 151.1, 144.1, 
138.5, 129.6, 128.1, 126.6, 125.9, 124.0, 121.9, 119.6, 116.1, 99.8, 73.2, 32.2, 27.5, 19.8.; HRMS 
(ESI) m/z [M+H]+ calc’d for C22H25O4







Phenyl 3-(2,2,4,4,7-pentamethyl-4H-benzo[d][1,3]dioxin-6-yl)propanoate (Compound 4.41): 
 
Compound 4.40 (3.12 gm, 10.0 mmol) was dissolved in a mixture of (50 mL of tetrahydrofuran: 
water (10:1) and (150 mg, 5%w/w) of Pd/C was added and the reaction was running under 
hydrogen atmosphere for 2 hours. Then filtered through celite, evaporated the solvent and purified 
it using flash column chromatography to obtain 92% as a colorless oil; 1H NMR (500 MHz, CDCl3) 
δ 7.22 (dd, J = 8.6, 7.4 Hz, 1H), 6.90 (tt, J = 7.4, 1.1 Hz, 1H), 6.84 – 6.79 (m, 2H), 6.60 (d, J = 0.8 
Hz, 1H), 3.66 (s, 3H), 2.90 – 2.82 (m, 2H), 2.58 – 2.51 (m, 2H), 2.23 (d, J = 0.7 Hz, 3H), 1.50 (s, 
6H), 1.48 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 173.8, 155.9, 148.3, 135.8, 131.6, 129.8, 127.4, 
125.3, 120.8, 119.0, 115.5, 99.2, 73.2, 51.9, 35.1, 32.1, 28.2, 27.4, 19.2; HRMS (ESI) m/z 
[M+Na]+ calc’d for C22H26NaO4








1-nitro-4-(2,2,4,4,7-pentamethyl-4H-benzo[d][1,3]dioxin-6-yl)butan-2-one (Compound 4.39) 
 
A mixture (0.63 mL, 11.3 mmol) of nitromethane and (1.26 gm, 11.3 mmol) potassium t-butoxide 
in dry DMSO (30 mL) was stirred for 30 minutes before a solution of (2.0 gm, 5.65 mmol) of 
compound 4.41 in dry DMSO was added dropwise at 10 °C. The reaction mixture was stirred at 
room temperature for 16 hours. Hydrochloric acid (10%) was added then extracted three times 
with ethyl acetate, the combine organic layers washed with water, brine, dried over anhydrous 
sodium sulfate, evaporated the solvent and purified using flash column chromatography to obtain 
the nitro ketone in 63% as a pale yellow oil yield 71% as a pale-yellow oil; ;  1H NMR (500 MHz, 
CDCl3) δ 6.77 (s, 1H), 6.61 (s, 1H), 5.18 (s, 2H), 2.89 (dd, J = 8.1, 6.8 Hz, 2H), 2.76 (t, J = 7.7 Hz, 
2H), 2.21 (d, J = 0.7 Hz, 3H), 1.50 (s, 6H), 1.47 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 195.8, 










To a solution of (0.5 gm, 1.55 mmol, 1.0 eq.) of compound 4.39 in dry THF (10 mL) under argon 
at -20 °C, (623 µL, 18.7 mmol, 1.2 eq.) of 3 M methyl magnesium bromide was added dropwise 
then the reaction mixture was warmed to 0 °C for 3 hours before it quenched by (2 mL) of saturated 
solution of ammonium chloride, diluted with ethyl acetate and washed with water and brine, dried 
over anhydrous sodium sulfate, evaporated the solvent, and purified by flash column 
chromatography to obtain 92% of compound 4.42; 1H NMR (500 MHz, CDCl3) δ 6.77 (s, 1H), 
6.60 (s, 1H), 4.52 – 4.43 (m, 2H), 2.68 – 2.62 (m, 2H), 2.22 (s, 3H), 1.78 – 1.73 (m, 2H), 1.50 (s, 
6H), 1.48 (s, 6H), 1.39 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 148.1, 135.4, 131.9, 127.4, 125.1, 
118.9, 98.9, 84.1, 77.3, 77.0, 76.8, 72.9, 71.6, 40.6, 31.9, 27.2, 26.7, 24.4, 18.9; HRMS (ESI) m/z 









To a solution of compound 4.42 (100 mg, 0.3 mmol)  in acetonitrile (2 mL) and of 40% acetic acid 
(1 mL) was added and stirred at 60 °C for six hours, poured the solution in 10 gm of ice and 
saturated solution of sodium carbonate was added until the pH 7, extracted two times with ethyl 
acetate the combine organic layers washed with water and brine, dried the solvent over anhydrous 
Sodium sulfate, evaporated the solvent and purified using flash column chromatography to obtain 
77% of compound 4.43 as a colorless oil; 1H NMR (400 MHz, CDCl3) δ 8.70 (s, 1H), 6.77 (s, 1H), 
6.65 (s, 1H), 4.46 (q, J = 11.8 Hz, 2H), 2.95 (s, 1H), 2.64 – 2.56 (m, 2H), 2.20 (s, 3H), 1.75 – 1.69 
(m, 2H), 1.63 (s, 6H), 1.37 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 153.9, 136.7, 130.3, 129.0, 
125.9, 119.4, 84.3, 76.0, 71.8, 40.9, 30.6, 26.9, 24.6, 18.9; HRMS (ESI) m/z [M+H]+ calc’d for 
C15H24NO5













 A mixture (4.0 gm, 12.05, 1.0 eq.) of compound 4.30, (2.67 gm, 18.07 mmol, 1.5 eq.) of phenyl 
acrylate, (135 mg, 0.6 mmol, 0.05 eq.) of palladium acetate , (732 mg, 2.4 mmol, 0.2 eq.) of tri-o-
tolylphosphine, and (10.1 mL, 72, mmol, 6 eq.) triethylamine in dry DMF (40 mL) was heated to 
80 °C for 20 h. It was filtered on a short pad of celite and diluted with ethyl acetate, then washed 
with water three times and with brine before dried with anhydrous sodium sulfate, evaporated the 
solvent and purified by flash column chromatography to obtain 74%: 1H NMR (500 MHz, CDCl3) 
δ 10.86 (s, 1H), 8.15 (s, 1H), 8.01 (d, J = 15.8 Hz, 1H), 7.39 (dd, J = 8.5, 7.5 Hz, 2H), 7.26 – 7.21 
(m, 1H), 7.18 – 7.13 (m, 2H), 6.84 (d, J = 0.9 Hz, 1H), 6.50 (d, J = 15.8 Hz, 1H), 3.96 (s, 3H), 
2.45 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 170.1, 165.4, 162.7, 150.8, 146.6, 142.9, 129.4, 128.7, 













Compound 4.45 (2 gm, 6.32 mmol) was dissolved in a mixture of (50 mL of tetrahydrofuran:water 
, 10:1) and (100 mg, 5%w/w) Pd/C was added and the reaction was running under hydrogen for 2 
hours. Then filtered through celite, evaporated the solvent and purified it using flash column 
chromatography to obtain 86% as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 10.58 (s, 1H), 
7.36 (dd, J = 8.5, 7.5 Hz, 2H), 7.23 – 7.18 (m, 1H), 7.06 – 7.03 (m, 2H), 6.81 (d, J = 0.9 Hz, 1H), 
3.90 (s, 3H), 3.02 – 2.96 (m, 2H), 2.82 (t, J = 7.5 Hz, 2H), 2.33 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 171.4, 170.4, 160.1, 150.6, 145.4, 129.5, 129.4, 129.4, 125.9, 121.5, 119.0, 115.3, 110.2, 
52.1, 34.8, 27.3, 19.9.     
Methyl 2-hydroxy-4-methyl-5-(4-nitro-3-oxobutyl)benzoate (Compound 4.47): 
 
 
A mixture of nitromethane (1.33 mL, 24.8 mmol, 3.0 eq.) and potassium t-butoxide (2.28 gm, 24.8 
mmol, 3.0 eq.)  in dry DMSO (30 mL) was stirred for 30 minutes before a solution of compound 
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4.47 (2.6 gm, 8.28 mmol, 1.0 eq.) in dry DMSO (10 mL) was added dropwise at 10 °C the reaction 
mixture was stirred at room temperature for 16 hours.10% of hydrochloric acid was added and 
extracted three times with Ethyl acetate, the combine organic layers was washed with water, brine, 
dried over anhydrous sodium sulfate, evaporated the solvent and purified using flash column 
chromatography to obtain the nitro ketone in 63% as a pale yellow oil: 1H NMR (500 MHz, CDCl3) 
δ 10.52 (s, 1H), 7.53 (s, 1H), 6.78 (s, 1H), 5.21 (s, 2H), 3.91 (s, 3H), 2.89 (dd, J = 7.9, 6.3 Hz, 2H), 
2.79 (ddd, J = 8.0, 6.8, 0.9 Hz, 2H), 2.28 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 195.1, 170.2, 
160.2, 145.0, 129.4, 128.7, 119.2, 110.3, 83.2, 52.2, 40.8, 25.5, 19.9. 
 
Methyl 2-hydroxy-5-(3-hydroxy-3-methyl-4-nitrobutyl)-4-methylbenzoate (Compound 4.48)  
 
 
To a solution of of compound 4.47 (100 mg, 0.33 mmol, 1.0 eq.) in dry THF (4 mL) under argon 
at -20 C, (135 µL, 0.4 mmol, 1.2 eq) of 3 M methyl magnesium bromide was added dropwise then 
the reaction mixture was warmed to 0 C for 3 hours before it quenched with (2 mL) of saturated 
solution of ammonium chloride, diluted with ethyl acetate and washed with water and brine, dried 
over anhydrous sodium sulfate, evaporated the solvent, and purified by flash column 
chromatography to obtain colorless oil: 1H NMR (500 MHz, CDCl3) δ 6.77 (s, 1H), 6.64 (s, 1H), 










To a solution of of compound 4.38 (1.65 gm, 5.1 mmol, 1.0 eq.) in dry dichloromethane (20 mL) 
at 0 °C under argon, triethyl amine(1.72 mL, 12.24 mmol, 2.4 eq.) was added and stirred at 0 °C 
for 5 minutes before TBSOTF was added, the reaction mixture was stirred for two hours, water 
was added and the two layers were separated, the aqueous layer was extracted two times with 
dichloromethane, the combined organic layers washed with water and brine, dried over anhydrous 
sodium sulfate, evaporated the solvent and purified using flash column chromatography to yield 
84 % as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 6.78 (s, 1H), 6.61 (s, 1H), 4.49 – 4.43 (m, 
1H), 4.43 – 4.34 (m, 2H), 2.63 – 2.55 (m, 2H), 2.22 (s, 3H), 1.79 (dt, J = 11.1, 5.6 Hz, 2H), 1.52 
(d, J = 3.7 Hz, 6H), 1.48 (s, 6H), 0.87 (s, 9H), 0.03 (d, J = 26.1 Hz, 6H); 13C NMR (125 MHz, 
CDCl3) δ 148.2, 135.3, 131.9, 127.4, 125.2, 119.0, 98.9, 80.9, 77.3, 77.3, 77.1, 76.8, 72.9, 69.9, 








           
            
To a solution of compound 4.42 (1.0 g, 2.12 mmol) in acetonitrile (10 mL), 40% acetic acid (8 
mL) was added and stirred at 60 °C for six hours. The solution was cooled and poured in 50 gm of 
ice, saturated solution of sodium carbonate was added until the pH=7, extracted two times with 
ethyl acetate the combine organic layers washed with water and brine, dried the solvent over 
anhydrous Sodium sulfate, evaporated the solvent and purified using flash column 
chromatography to obtain 77% of compound 4.43 as a colorless oil yield 77% as a colorless oil: 
1H NMR (500 MHz, CDCl3) δ 6.78 (s, 1H), 6.61 (s, 1H), 4.49 – 4.43 (m, 1H), 4.43 – 4.34 (m, 2H), 
2.63 – 2.55 (m, 2H), 2.22 (s, 3H), 1.79 (dt, J = 11.1, 5.6 Hz, 2H), 1.52 (d, J = 3.7 Hz, 6H), 1.48 (s, 
6H), 0.87 (s, 9H), 0.03 (d, J = 26.1 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 148.3, 135.5, 132.0, 
127.5, 125.3, 119.1, 99.1, 81.1, 73.0, 70.0, 36.1, 32.1, 32.0, 28.2, 27.4, 27.3, 25.8, 19.1, 18.1, -4.5, 
-5.0; HRMS (ESI) m/z [M+H]+  calc’d for C23H39NaO5Si 










To a solution of compound 4.51 (500 mg, 1.76 mmol, 1.0 eq.) in acetonitrile (5 mL), potassium 
ferrocyanide (2.32 mg, 7.06 mmol) was added followed by (70.6 mL, 7.06 mmol) of 0.1 N 
potassium hydroxide at room temperature. The reaction mixture was stirred for two hours at room 
temperature then acidified with (1M citric acid) to pH=3, chloroform (10 mL) was added and 
stirred for 30 minutes, the two layers separated and the aqueous layer was extracted two times with 
chloroform, the organic layers washed with water and brine, dried over anhydrous sodium sulfate, 
evaporated the solvent and purified using flash column chromatography to obtain 71%: 1H NMR 
(400 MHz, CDCl3) δ 6.56 (s, 1H), 6.23 (d, J = 1.4 Hz, 1H), 4.86 – 4.79 (m, 1H), 2.62 (td, J = 12.6, 
7.4 Hz, 1H), 2.33 – 2.19 (m, 1H), 2.13 – 2.02 (m, 1H), 2.00 (d, J = 1.2 Hz, 4H), 1.83 (s, 3H), 1.75 
(ddt, J = 12.7, 5.9, 1.6 Hz, 1H), 1.39 (d, J = 9.0 Hz, 6H), 0.88 (s, 9H), 0.13 (d, J = 12.9 Hz, 6H); 
13C NMR (100 MHz, CDCl3) δ 187.5, 167.1, 159.4, 140.4, 128.6, 73.7, 71.6, 54.2, 35.9, 33.7, 29.1, 
28.6, 25.7, 20.3, 18.4, 18.1, -4.5, -5.0; HRMS (ESI) m/z calculated for C20H33O3Si 
+ [M+H]+ : 









To a solution of compound 4.53 (200 mg, 0.57 mmol), TBAF (0.57 mL of 1M solution in THF, 
0.57 mmol)  was added and the reaction mixture was stirred for 30 minutes before it quenched 
with water and extracted two times with ethyl acetate, the combined organic layers were washed 
with water and brine. The solvent was evaporated under reduce pressure and purified the crude 
product using flash column chromatography to obtain 81% of free alcohol as a pale yellow solid: 
1H NMR (400 MHz, CDCl3) δ 7.52 (s, 1H), 6.96 (s, 1H), 6.34 (s, 1H), 5.03 (t, J = 6.9 Hz, 1H), 
2.94 (dddd, J = 17.7, 9.1, 4.3, 1.6 Hz, 1H), 2.77 – 2.62 (m, 2H), 2.44 (ddq, J = 20.4, 8.2, 4.1 Hz, 
2H), 2.24 (d, J = 1.1 Hz, 3H), 1.82 (ddt, J = 13.5, 9.0, 6.8 Hz, 1H), 1.52 (d, J = 7.3 Hz, 6H), 1.48 
– 1.32 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 187.8, 154.5, 148.3, 146.5, 145.9, 140.7, 130.8, 
80.0, 77.4, 77.0, 76.7, 74.8, 32.9, 32.8, 29.2, 29.0, 24.5; HRMS (ESI) m/z calculated for C14H19O3 













To a solution of compound 4.54 (100 mg, 0.43 mmol, 1.0 eq.) in dry dichloromethane (3 mL), 
(218 mg, 0.51 mmol) of DMP was added at room temperature, the reaction mixture was stirred for 
30 minutes. The solvent was evaporated, and the residue was purified via flash column 
chromatography to obtain 81% of tropone ketone as a colorless oil; IR: 2984, 1702, 1687, 1217, 
1109, 906, 1H NMR (500 MHz, CDCl3) δ 7.72 (s, 1H), 7.13 (d, J = 1.2 Hz, 1H), 3.00 – 2.95 (m, 
2H), 2.67 – 2.63 (m, 2H), 2.35 (d, J = 1.2 Hz, 3H), 1.57 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 
206.4, 188.4, 164.6, 155.4, 143.9, 143.8, 137.6, 125.8, 74.4, 33.7, 29.7, 29.2, 28.3, 22.6; HRMS 
(ESI) m/z calculated for C14H17O3 
+ [M+H]+ : 233.1178, found 233.1109. 




A solution of compound 4.54 (80 mg, 0.34 mmol, 1.0 eq.) in dry tetrahydrofuran (4 mL) at -20 °C, 
(230 µL, 0.68 mmol) of methyl magnesium bromide was added dropwise, then the reaction mixture 
warmed to 0 °C for two hours before it quenched with saturated solution of ammonium chloride 
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and diluted with ethyl acetate and washed with water and brine, dried over anhydrous sodium 
sulfate, evaporated the solvent and purified the crude product by flash column chromatography to 
yield 79% of phaeocaulisin D as a yellow oil; IR, 2983, 1704, 1603, 1554, 1297, 1146, 1020, 1H 
NMR (400 MHz, MeOD) δ 7.80 (s, 1H), 6.89 (s, 1H), 2.83 (ddd, J = 17.6, 9.0, 2.9 Hz, 1H), 2.70 
(dt, J = 17.7, 8.1 Hz, 1H), 2.21 (d, J = 1.0 Hz, 3H), 2.10 (ddd, J = 13.0, 7.9, 2.9 Hz, 1H), 1.96 (dt, 
J = 13.0, 8.6 Hz, 1H), 1.48 (d, J = 2.8 Hz, 6H), 1.33 (s, 3H); 13C NMR (100 MHz, MeOD) δ 187.1, 
155.9, 150.3, 146.9, 146.9, 139.3, 130.1, 83.3, 74.0, 38.6, 31.1, 27.8, 27.6, 26.1, 23.1; HRMS (ESI) 
m/z calculated for C15H21O3 
+ [M+H]+ : 249.1486, found 249.1463. 
 




To a solution of compound 4.34 (400 mg, 1.24 mmol) in dichloromethane (10 mL) at -20 °C , 
methane sulfonyl chloride (115 µL, 1.48 mmol) was added and the reaction mixture was stirred 
for 10 minutes before of triethylamine (0.420 mL, 2.96 mmol) was added. The reaction mixture 
was stirred for 45 min at -20 °C. The reaction mixture was diluted with CH2Cl2, and washed with 
water, 5% aqueous bicarbonate solution, water, and brine. The organic layer was dried over 
anhydrous Sodium sulfate and concentrated under reduced pressure. The residual oil was purified 
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by flash column chromatography to produce yellow oil in 77% yield as yellow oil, 1H NMR (400 
MHz, CDCl3) δ 7.23 – 7.18 (m, 1H), 6.88 (dt, J = 13.4, 1.5 Hz, 1H), 6.69 (s, 1H), 6.57 (s, 1H), 
2.69 (dd, J = 8.5, 6.7 Hz, 2H), 2.44 (qd, J = 7.5, 1.4 Hz, 2H), 2.17 (s, 3H), 1.44 (s, 7H), 1.43 (s, 
6H); 13C NMR (100 MHz, CDCl3) δ 147.4, 140.5, 138.9, 134.3, 129.4, 126.3, 124.4, 118.1, 98.0, 
71.8, 30.8, 29.9, 28.2, 26.1, 17.9; HRMS (ESI) m/z calculated for C17H24NO4 
+ [M+H]+ : 306.1700, 
found 306.1744 
 




First preparing the Me2CuLi, to a mixture of CuI (336 mg, 1.77 mmol, 2 eq.) in diethyl ether (5 
mL) was slowly added (2.2 mL, 3.54 mmol, 4.0 eq.) of methyl lithium solution (1.6 M)  at 0 °C  
dropwise over 10 min, and the mixture was stirring at 0 °C for 30 min. In another flask, (270 mg, 
0.88 mmol, 1.0 eq.) of compound 4.56 was dissolved in dry diethyl ether (10 mL) and cooled to -
78°C then a solution of Me2CuLi was added dropwise over 5 minutes and stirred for 2 hours at -
78°C then warmed to room temperature overnight. The solution cooled to 0 °C then saturated 
solution of ammonium chloride was added and extracted two times with ethyl acetate The 
combined organic layers was dried, evaporated the solvent under reduce pressure and the crude 
product was purified using flash column chromatography to obtain colorless oil in 60%,  1H NMR 
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(500 MHz, CDCl3) δ 6.76 (s, 1H), 6.60 (s, 1H), 4.35 (dd, J = 11.7, 6.4 Hz, 1H), 4.23 (dd, J = 11.7, 
7.7 Hz, 1H), 2.61 (ddd, J = 13.8, 10.8, 5.5 Hz, 1H), 2.52 (ddd, J = 13.9, 10.7, 5.8 Hz, 1H), 2.43 – 
2.33 (m, 1H), 2.21 (s, 3H), 1.62 (ddt, J = 13.7, 11.0, 5.6 Hz, 1H), 1.51 (s, 6H), 1.48 (s, 7H), 1.09 
(d, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 148.0, 135.3, 132.2, 127.2, 125.0, 118.9, 98.9, 
81.4, 77.3, 77.1, 76.8, 72.9, 34.6, 32.8, 31.9, 29.8, 27.2, 27.2, 19.0, 17.2; HRMS (ESI) m/z 
calculated for C18H28NO4 
+ [M+Na]+ : 344.1833, found 344.1428. 
 




To a solution (100 mg, 0.311 mmol, 1 eq. ) of compound 4.57 in acetonitrile (2 mL) and 40% 
acetic acid (1 mL) was added and stirred at 60 °C for six hours the solution was cooled and poured 
in 10 gm of ice and saturated solution of sodium carbonate was added until the pH=7, extracted 
two times with ethyl acetate the combine organic layers washed with water and brine, dried the 
solvent over anhydrous Sodium sulfate, evaporated the solvent and purified using flash column 
chromatography to obtain 67% as a colorless oil, 1H NMR (500 MHz, CDCl3) δ 6.76 (s, 1H), 6.65 
– 6.61 (m, 1H), 4.33 (dd, J = 11.7, 6.4 Hz, 1H), 4.21 (dd, J = 11.7, 7.8 Hz, 1H), 2.62 (s, 1H), 2.58 
(ddd, J = 13.8, 10.7, 5.5 Hz, 1H), 2.49 (ddd, J = 13.8, 10.6, 5.8 Hz, 1H), 2.36 (dddd, J = 14.6, 7.8, 
6.7, 5.5 Hz, 1H), 2.22 – 2.17 (m, 3H), 1.62 (s, 6H), 1.61 – 1.52 (m, 1H), 1.53 – 1.39 (m, 1H), 1.08 
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(d, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 153.6, 136.5, 130.4, 128.7, 125.7, 119.2, 81.5, 




To a solution (50 mg, 0.178 mmol, 1.0 eq.) of compound 4.58 in acetonitrile (2 mL), potassium 
ferrocyanide (243 mg, 0.711 mmol, 4.0 eq.) was added followed by (7.1 mL, 0.711 mmol, 4.0 eq.) 
of 0.1 N potassium hydroxide at room temperature. The reaction mixture was stirred for two hours 
then acidified with (1M citric acid) to pH=3, (10 mL) of chloroform was added and stirred for 30 
minutes, the two layers separated and the aqueous layer was extracted two times with chloroform 
the organic layers washed with water and brine, dried over anhydrous Sodium sulfate, evaporated 
the solvent under reduce pressure and purified using flash column chromatography to obtain 52% 
of Phaeocaulisine L as a colorless oil and 29% of another isomer. 1H NMR (500 MHz, CDCl3) δ 
7.33 (s, 1H), 6.99 (s, 1H), 3.19 (h, J = 7.1 Hz, 1H), 2.90 (dddd, J = 17.5, 8.8, 6.0, 1.6 Hz, 1H), 2.79 
(dddd, J = 17.1, 8.9, 6.1, 1.3 Hz, 1H), 2.23 (d, J = 1.1 Hz, 4H), 2.24 – 2.15 (m, 4H), 1.65 – 1.55 
(m, 4H), 1.55 (s, 6H), 1.54 (s, 6H), 1.23 (d, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 187.6, 
154.3, 150.5, 147.9, 146.0, 139.8, 130.6, 77.3, 77.0, 76.8, 74.5, 45.1, 34.7, 30.6, 29.3, 29.2, 25.0, 
20.5; HRMS (ESI) m/z calc’d for C15H21O2 
+ [M+H]+ : 232.1536, found 232.1463. 
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APPENDIX A THE 1HNMR AND 13C NMR FOR CHAPTER ONE 
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